BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, Falk V, González-juanatey JR, Harjola V, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GMC, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P; Authors/Task Force Members, Document Reviewers. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the spec. Eur J Heart Fail 2016;18:891-975. [DOI: 10.1002/ejhf.592] [Cited by in Crossref: 3626] [Cited by in F6Publishing: 3057] [Article Influence: 604.3] [Reference Citation Analysis]
Number Citing Articles
1 Chen X, Jiang W, Lin X, Lundborg CS, Wen Z, Lu W, Marrone G. Effect of an exercise-based cardiac rehabilitation program "Baduanjin Eight-Silken-Movements with self-efficacy building" for heart failure (BESMILE-HF study): study protocol for a randomized controlled trial. Trials 2018;19:150. [PMID: 29490680 DOI: 10.1186/s13063-018-2531-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
2 Teng TK, Cooper L, Tay WT, Luo N, Sharma A, Whellan D, Anand I, Pina IL, Tromp J, Richards AM, Kraus WE, Connor CMO, Mentz RJ, Lam CS. Association between body surface area and prescribed doses of guideline‐directed medications among international patients with heart failure and reduced ejection fraction. Eur J Heart Fail 2020;22:754-8. [DOI: 10.1002/ejhf.1648] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
3 Bertero E, Maack C. Metabolic remodelling in heart failure. Nat Rev Cardiol 2018;15:457-70. [PMID: 29915254 DOI: 10.1038/s41569-018-0044-6] [Cited by in Crossref: 138] [Cited by in F6Publishing: 127] [Article Influence: 46.0] [Reference Citation Analysis]
4 Bozkurt B, Coats AJS, Tsutsui H, Abdelhamid CM, Adamopoulos S, Albert N, Anker SD, Atherton J, Böhm M, Butler J, Drazner MH, Michael Felker G, Filippatos G, Fiuzat M, Fonarow GC, Gomez-Mesa JE, Heidenreich P, Imamura T, Jankowska EA, Januzzi J, Khazanie P, Kinugawa K, Lam CSP, Matsue Y, Metra M, Ohtani T, Francesco Piepoli M, Ponikowski P, Rosano GMC, Sakata Y, Seferović P, Starling RC, Teerlink JR, Vardeny O, Yamamoto K, Yancy C, Zhang J, Zieroth S. Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure: Endorsed by the Canadian Heart Failure Society, Heart Failure Association of India, Cardiac Society of Australia and New Zealand, and Chinese Heart Failure Association. Eur J Heart Fail 2021;23:352-80. [PMID: 33605000 DOI: 10.1002/ejhf.2115] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 23.0] [Reference Citation Analysis]
5 Zhou W, Cheng Y, Zhu P, Nasser MI, Zhang X, Zhao M. Implication of Gut Microbiota in Cardiovascular Diseases. Oxid Med Cell Longev 2020;2020:5394096. [PMID: 33062141 DOI: 10.1155/2020/5394096] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
6 Zhang Y, Coats AJ, Zheng Z, Adamo M, Ambrosio G, Anker SD, Butler J, Xu D, Mao J, Khan MS, Bai L, Mebazaa A, Ponikowski P, Tang Q, Ruschitzka F, Seferovic P, Tschöpe C, Zhang S, Gao C, Zhou S, Senni M, Zhang J, Metra M. Management of heart failure patients with COVID ‐19: a joint position paper of the Chinese Heart Failure Association & National Heart Failure Committee and the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 2020;22:941-56. [DOI: 10.1002/ejhf.1915] [Cited by in Crossref: 38] [Cited by in F6Publishing: 31] [Article Influence: 19.0] [Reference Citation Analysis]
7 Rickenbacher P, Kaufmann BA, Maeder MT, Bernheim A, Goetschalckx K, Pfister O, Pfisterer M, Brunner-La Rocca HP; TIME-CHF Investigators. Heart failure with mid-range ejection fraction: a distinct clinical entity? Insights from the Trial of Intensified versus standard Medical therapy in Elderly patients with Congestive Heart Failure (TIME-CHF). Eur J Heart Fail 2017;19:1586-96. [PMID: 28295985 DOI: 10.1002/ejhf.798] [Cited by in Crossref: 75] [Cited by in F6Publishing: 59] [Article Influence: 15.0] [Reference Citation Analysis]
8 D'Amario D, Canonico F, Rodolico D, Borovac JA, Vergallo R, Montone RA, Galli M, Migliaro S, Restivo A, Massetti M, Crea F. Telemedicine, Artificial Intelligence and Humanisation of Clinical Pathways in Heart Failure Management: Back to the Future and Beyond. Card Fail Rev 2020;6:e16. [PMID: 32612852 DOI: 10.15420/cfr.2019.17] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
9 Lüsebrink E, Orban M, Kupka D, Scherer C, Hagl C, Zimmer S, Luedike P, Thiele H, Westermann D, Massberg S, Schäfer A, Orban M. Prevention and treatment of pulmonary congestion in patients undergoing venoarterial extracorporeal membrane oxygenation for cardiogenic shock. Eur Heart J 2020;41:3753-61. [PMID: 33099278 DOI: 10.1093/eurheartj/ehaa547] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 15.0] [Reference Citation Analysis]
10 Hägglund E, Strömberg A, Hagerman I, Lyngå P. Theory Testing of Patient Perspectives Using a Mobile Health Technology System in Heart Failure Self-care. J Cardiovasc Nurs 2019;34:448-53. [DOI: 10.1097/jcn.0000000000000595] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
11 Uysal H, Öz Alkan H, Enç N, Yiğit Z. Assessment of Dietary Habits in Patients With Chronic Heart Failure. J Nurs Res 2020;28:e65. [PMID: 31107776 DOI: 10.1097/jnr.0000000000000329] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Scheiber D, Zweck E, Albermann S, Jelenik T, Spieker M, Bönner F, Horn P, Schultheiss HP, Aleshcheva G, Escher F, Boeken U, Akhyari P, Roden M, Kelm M, Szendroedi J, Westenfeld R. Human myocardial mitochondrial oxidative capacity is impaired in mild acute heart transplant rejection. ESC Heart Fail 2021. [PMID: 34490749 DOI: 10.1002/ehf2.13607] [Reference Citation Analysis]
13 Dinatolo E, Sciatti E, Anker MS, Lombardi C, Dasseni N, Metra M. Updates in heart failure: what last year brought to us. ESC Heart Fail 2018;5:989-1007. [PMID: 30570225 DOI: 10.1002/ehf2.12385] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
14 Ziaeian B, Heidenreich PA, Xu H, DeVore AD, Matsouaka RA, Hernandez AF, Bhatt DL, Yancy CW, Fonarow GC. Medicare Expenditures by Race/Ethnicity After Hospitalization for Heart Failure With Preserved Ejection Fraction. JACC Heart Fail 2018;6:388-97. [PMID: 29655830 DOI: 10.1016/j.jchf.2017.12.007] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
15 Al-Balushi S, Alam MF, Abid AR, Sharfi A. The Effect of Ivabradine on Hospitalization of Heart Failure Patients: A Retrospective Cohort Study. Heart Views 2021;22:165-73. [PMID: 34760047 DOI: 10.4103/HEARTVIEWS.HEARTVIEWS_23_20] [Reference Citation Analysis]
16 Matsumoto Y, Fukushima S, Shimahara Y, Kawamoto N, Tadokoro N, Kuroda K, Nakajima S, Watanabe T, Seguchi O, Yanase M, Fukushima N, Shimizu H, Kobayashi J, Fujita T. Early postoperative heparinization reduce hemolysis in patients with HeartMate II devices. J Artif Organs 2020;23:19-26. [PMID: 31482437 DOI: 10.1007/s10047-019-01129-z] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
17 Kindermann I, Wedegärtner SM, Bernhard B, Ukena J, Lenski D, Karbach J, Schwantke I, Ukena C, Böhm M. Changes in quality of life, depression, general anxiety, and heart-focused anxiety after defibrillator implantation. ESC Heart Fail 2021;8:2502-12. [PMID: 34047078 DOI: 10.1002/ehf2.13416] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
18 Czarzasta K, Wojno O, Zera T, Puchalska L, Dobruch J, Cudnoch-Jedrzejewska A. The influence of post-infarct heart failure and high fat diet on the expression of apelin APJ and vasopressin V1a and V1b receptors. Neuropeptides 2019;78:101975. [PMID: 31645268 DOI: 10.1016/j.npep.2019.101975] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
19 Berger C, Prieur C, Bochaton T, Berthiller J, Luyt CE, Bonnefoy-Cudraz E. Patients with acute heart failure treated with the CARRESS-HF diuretic protocol in association with canrenoate potassium: Tolerance of high doses of canrenoate potassium. Arch Cardiovasc Dis 2020;113:679-89. [PMID: 32948466 DOI: 10.1016/j.acvd.2020.05.017] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
20 Díez-López C, Salazar-Mendiguchía J. Clinical presentations of hypertrophic cardiomyopathy and implications for therapy. Glob Cardiol Sci Pract 2018;2018:19. [PMID: 30393631 DOI: 10.21542/gcsp.2018.19] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
21 Arora L, Krishnan S, Subramani S, Sharma A, Hanada S, Villablanca PA, Núñez-Gil IJ, Ramakrishna H. Functional Tricuspid Regurgitation: Analysis of Percutaneous Transcatheter Techniques and Current Outcomes. J Cardiothorac Vasc Anesth 2021;35:921-31. [PMID: 32247538 DOI: 10.1053/j.jvca.2020.02.036] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
22 Roux-Marson C, Baranski JB, Fafin C, Exterman G, Vigneau C, Couchoud C, Moranne O, Investigators PSPA. Medication burden and inappropriate prescription risk among elderly with advanced chronic kidney disease. BMC Geriatr 2020;20:87. [PMID: 32131742 DOI: 10.1186/s12877-020-1485-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
23 Berliner D, Bauersachs J. Current Drug Therapy in Chronic Heart Failure: the New Guidelines of the European Society of Cardiology (ESC). Korean Circ J 2017;47:543-54. [PMID: 28955380 DOI: 10.4070/kcj.2017.0030] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
24 Cheshire C, Bhagra CJ, Bhagra SK. A review of the management of patients with advanced heart failure in the intensive care unit. Ann Transl Med 2020;8:828. [PMID: 32793673 DOI: 10.21037/atm-20-1048] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
25 Paradela-Dobarro B, Fernández-Trasancos Á, Bou-Teen D, Eiras S, González-Ferreiro R, Agra RM, Varela-Román A, Castro-Pais AI, Carreira MC, Casanueva FF, Álvarez E, González-Juanatey JR. Evolution and bad prognostic value of advanced glycation end products after acute heart failure: relation with body composition. Cardiovasc Diabetol 2017;16:115. [PMID: 28915840 DOI: 10.1186/s12933-017-0598-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
26 Raffaello WM, Henrina J, Huang I, Lim MA, Suciadi LP, Siswanto BB, Pranata R. Clinical Characteristics of De Novo Heart Failure and Acute Decompensated Chronic Heart Failure: Are They Distinctive Phenotypes That Contribute to Different Outcomes? Card Fail Rev 2020;7:e02. [PMID: 33708417 DOI: 10.15420/cfr.2020.20] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
27 Ammenwerth E, Modre-Osprian R, Fetz B, Gstrein S, Krestan S, Dörler J, Kastner P, Welte S, Rissbacher C, Pölzl G. HerzMobil, an Integrated and Collaborative Telemonitoring-Based Disease Management Program for Patients With Heart Failure: A Feasibility Study Paving the Way to Routine Care. JMIR Cardio 2018;2:e11. [PMID: 31758765 DOI: 10.2196/cardio.9936] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
28 van der Bijl P, Khidir M, Leung M, Mertens B, Ajmone Marsan N, Delgado V, Bax JJ. Impact of QRS complex duration and morphology on left ventricular reverse remodelling and left ventricular function improvement after cardiac resynchronization therapy. Eur J Heart Fail 2017;19:1145-51. [DOI: 10.1002/ejhf.769] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 3.2] [Reference Citation Analysis]
29 Notarius CF, Floras JS. Sympathetic neural responses in heart failure during exercise and after exercise training. Clinical Science 2021;135:651-69. [DOI: 10.1042/cs20201306] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Vijh R, Wong ST, Grandy M, Peterson S, Ezzat AM, Gibb AG, Hawkins NM. Identifying heart failure in patients with chronic obstructive lung disease through the Canadian Primary Care Sentinel Surveillance Network in British Columbia: a case derivation study. CMAJ Open 2021;9:E376-83. [PMID: 33863795 DOI: 10.9778/cmajo.20200183] [Reference Citation Analysis]
31 Jaiswal A, Gadela NV, Baran D, Balakumaran K, Scatola A, Radojevic J, Gluck J, Arora S, Hammond J, Ali A, Jennings DL, Baker WL. Clinical outcomes of older adults listed for heart transplantation in the United States. J Am Geriatr Soc 2021. [PMID: 34105139 DOI: 10.1111/jgs.17271] [Reference Citation Analysis]
32 Liu J, Zheng X, Zhang C, Zhang C, Bu P. Lcz696 Alleviates Myocardial Fibrosis After Myocardial Infarction Through the sFRP-1/Wnt/β-Catenin Signaling Pathway. Front Pharmacol 2021;12:724147. [PMID: 34539406 DOI: 10.3389/fphar.2021.724147] [Reference Citation Analysis]
33 Beladan CC, Botezatu SB. Anemia and Management of Heart Failure Patients. Heart Fail Clin 2021;17:195-206. [PMID: 33673945 DOI: 10.1016/j.hfc.2020.12.002] [Reference Citation Analysis]
34 Lund LH. Complex relationships between co-morbidity, outcomes, and treatment effect in heart failure. Eur J Heart Fail 2018;20:511-3. [PMID: 29316135 DOI: 10.1002/ejhf.1107] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
35 Kalayci A, Peacock WF, Nagurney JT, Hollander JE, Levy PD, Singer AJ, Shapiro NI, Cheng RK, Cannon CM, Blomkalns AL, Walters EL, Christenson RH, Chen-Tournoux A, Nowak RM, Lurie MD, Pang PS, Kastner P, Masson S, Gibson CM, Gaggin HK, Januzzi JL Jr. Echocardiographic assessment of insulin-like growth factor binding protein-7 and early identification of acute heart failure. ESC Heart Fail. 2020;7:1664-1675. [PMID: 32406612 DOI: 10.1002/ehf2.12722] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
36 Cao G, Fan C, Liu Y, Huang H, Li J, Liang J, Tao B, Yuan J. A telehealth program benefits discharged patients with heart failure. Acta Cardiologica. [DOI: 10.1080/00015385.2021.1999571] [Reference Citation Analysis]
37 Vinereanu D, Mǎrgulescu AD. The fallacy of resting echocardiographic parameters of cardiac function in heart failure with preserved ejection fraction: add global longitudinal strain to the list: Editorial comment. Eur J Heart Fail 2017;19:901-3. [DOI: 10.1002/ejhf.828] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
38 Groenewegen A, Rutten FH. Near-home heart failure care. Eur J Heart Fail 2019;21:110-1. [PMID: 30520538 DOI: 10.1002/ejhf.1345] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
39 Reddy YN, Obokata M, Egbe A, Yang JH, Pislaru S, Lin G, Carter R, Borlaug BA. Left atrial strain and compliance in the diagnostic evaluation of heart failure with preserved ejection fraction. Eur J Heart Fail 2019;21:891-900. [DOI: 10.1002/ejhf.1464] [Cited by in Crossref: 59] [Cited by in F6Publishing: 50] [Article Influence: 19.7] [Reference Citation Analysis]
40 Cittadini A, Salzano A, Iacoviello M, Triggiani V, Rengo G, Cacciatore F, Maiello C, Limongelli G, Masarone D, Perticone F, Cimellaro A, Perrone Filardi P, Paolillo S, Mancini A, Volterrani M, Vriz O, Castello R, Passantino A, Campo M, Modesti PA, De Giorgi A, Monte IP, Puzzo A, Ballotta A, D'Assante R, Arcopinto M, Gargiulo P, Sciacqua A, Bruzzese D, Colao A, Napoli R, Suzuki T, Eagle KA, Ventura HO, Marra AM, Bossone E. Multiple hormonal and metabolic deficiency syndrome predicts outcome in heart failure: the T.O.S.CA. Registry. Eur J Prev Cardiol 2021:zwab020. [PMID: 33693736 DOI: 10.1093/eurjpc/zwab020] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
41 Lionte C, Sorodoc V, Bologa C, Tuchilus C, Jaba E. Usefulness of Transthoracic Echocardiography Parameters and Brain Natriuretic Peptide as Mortality Predictors in Hospitalized Acutely Poisoned Patients: A Prospective Observational Study. Basic Clin Pharmacol Toxicol 2017;120:498-504. [DOI: 10.1111/bcpt.12711] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
42 Engstrom N, Dobson G, Ng K, Letson H. Fragmented QRS is associated with ventricular arrhythmias in heart failure patients: A systematic review and meta-analysis. Ann Noninvasive Electrocardiol 2021;:e12910. [PMID: 34766402 DOI: 10.1111/anec.12910] [Reference Citation Analysis]
43 Chambela MDC, Mediano MFF, Carneiro FM, Ferreira RR, Waghabi MC, Mendes VG, Oliveira LS, de Holanda MT, de Sousa AS, da Costa AR, Xavier SS, da Silva GMS, Saraiva RM. Impact of pharmaceutical care on the quality of life of patients with heart failure due to chronic Chagas disease: Randomized clinical trial. Br J Clin Pharmacol 2020;86:143-54. [PMID: 31659776 DOI: 10.1111/bcp.14152] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
44 Peña-Peña ML, Monserrat L. Risk Stratification in Patients With Nonisquemic Dilated Cardiomyopathy. The Role of Genetic Testing. Rev Esp Cardiol (Engl Ed) 2019;72:333-40. [PMID: 30792015 DOI: 10.1016/j.rec.2018.10.017] [Reference Citation Analysis]
45 Suita K, Fujita T, Cai W, Hidaka Y, Jin H, Prajapati R, Umemura M, Yokoyama U, Sato M, Knollmann BC, Okumura S, Ishikawa Y. Vidarabine, an anti-herpesvirus agent, prevents catecholamine-induced arrhythmias without adverse effect on heart function in mice. Pflugers Arch 2018;470:923-35. [PMID: 29453615 DOI: 10.1007/s00424-018-2121-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
46 Matsue Y, Suzuki M, Torii S, Yamaguchi S, Fukamizu S, Ono Y, Fujii H, Kitai T, Nishioka T, Sugi K, Onishi Y, Noda M, Kagiyama N, Satoh Y, Yoshida K, Goldsmith SR. Prognostic impact of early treatment with tolvaptan in patients with acute heart failure and renal dysfunction. Int J Cardiol 2016;221:188-93. [PMID: 27404673 DOI: 10.1016/j.ijcard.2016.07.063] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
47 Peng Z, Zhan Q, Xie X, Li H, Tu Y, Bai Y, Huang X, Lai W, Zhao B, Zeng Q, Xu D. Association between admission plasma 2-oxoglutarate levels and short-term outcomes in patients with acute heart failure: a prospective cohort study. Mol Med 2019;25:8. [PMID: 30922225 DOI: 10.1186/s10020-019-0078-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
48 Maack C, Eschenhagen T, Hamdani N, Heinzel FR, Lyon AR, Manstein DJ, Metzger J, Papp Z, Tocchetti CG, Yilmaz MB, Anker SD, Balligand JL, Bauersachs J, Brutsaert D, Carrier L, Chlopicki S, Cleland JG, de Boer RA, Dietl A, Fischmeister R, Harjola VP, Heymans S, Hilfiker-Kleiner D, Holzmeister J, de Keulenaer G, Limongelli G, Linke WA, Lund LH, Masip J, Metra M, Mueller C, Pieske B, Ponikowski P, Ristić A, Ruschitzka F, Seferović PM, Skouri H, Zimmermann WH, Mebazaa A. Treatments targeting inotropy. Eur Heart J 2019;40:3626-44. [PMID: 30295807 DOI: 10.1093/eurheartj/ehy600] [Cited by in Crossref: 42] [Cited by in F6Publishing: 42] [Article Influence: 21.0] [Reference Citation Analysis]
49 Ponikowski P, Kirwan BA, Anker SD, Dorobantu M, Drozdz J, Fabien V, Filippatos G, Haboubi T, Keren A, Khintibidze I, Kragten H, Martinez FA, McDonagh T, Metra M, Milicic D, Nicolau JC, Ohlsson M, Parhomenko A, Pascual-Figal DA, Ruschitzka F, Sim D, Skouri H, van der Meer P, Jankowska EA. Rationale and design of the AFFIRM-AHF trial: a randomised, double-blind, placebo-controlled trial comparing the effect of intravenous ferric carboxymaltose on hospitalisations and mortality in iron-deficient patients admitted for acute heart failure. Eur J Heart Fail. 2019;21:1651-1658. [PMID: 31883356 DOI: 10.1002/ejhf.1710] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 6.7] [Reference Citation Analysis]
50 Chen YL, Hang CL, Su CH, Wu PJ, Chen HC, Fang HY, Fang YN, Cheng CI, Fu M, Chen SM. Feature and impact of guideline-directed medication prescriptions for heart failure with reduced ejection fraction accompanied by chronic kidney disease. Int J Med Sci 2021;18:2570-80. [PMID: 34104088 DOI: 10.7150/ijms.55119] [Reference Citation Analysis]
51 Xu Y, Lee S, Martin E, D'souza AG, Doktorchik CTA, Jiang J, Lee S, Eastwood CA, Fine N, Hemmelgarn B, Todd K, Quan H. Enhancing ICD-Code-Based Case Definition for Heart Failure Using Electronic Medical Record Data. J Card Fail 2020;26:610-7. [PMID: 32304875 DOI: 10.1016/j.cardfail.2020.04.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
52 Nuzzi V, Pellicori P, Nikolaidou T, Kallvikbacka-bennett A, Torromeo C, Barilla’ F, Salekin D, Kaur K, Monzo L, Cleland JG, Clark AL. Clinical and prognostic association of total atrial conduction time in patients with heart failure: a report from Studies Investigating Co-morbidities Aggravating Heart Failure. Journal of Cardiovascular Medicine 2019;20:442-9. [DOI: 10.2459/jcm.0000000000000802] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
53 Zhang J, Sun Y, Zhou K, Zhang X, Chen Y, Hu J, Zhong C, Liu Y, Shang H. Rationale and design of the AUGUST-AHF Study. ESC Heart Fail 2020;7:3124-33. [PMID: 32567238 DOI: 10.1002/ehf2.12787] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
54 Mavrogeni SI, Dimitroulas T, Kitas GD. Cardiovascular magnetic resonance in the diagnosis and management of cardiac and vascular involvement in the systemic vasculitides. Curr Opin Rheumatol 2019;31:16-24. [PMID: 30407225 DOI: 10.1097/BOR.0000000000000560] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
55 Čerlinskaitė K, Hollinger A, Mebazaa A, Cinotti R. Finding the balance between costs and quality in heart failure: a global challenge. Eur J Heart Fail 2018;20:1175-8. [PMID: 29673007 DOI: 10.1002/ejhf.1195] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
56 López B, Ravassa S, Moreno MU, José GS, Beaumont J, González A, Díez J. Diffuse myocardial fibrosis: mechanisms, diagnosis and therapeutic approaches. Nat Rev Cardiol 2021;18:479-98. [PMID: 33568808 DOI: 10.1038/s41569-020-00504-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
57 Yang R, Lv J, Yu C, Guo Y, Pei P, Huang N, Yang L, Millwood IY, Walters RG, Chen Y, Du H, Tao R, Chen J, Chen Z, Clarke R, Huang T, Li L; China Kadoorie Biobank Collaborative Group. Modification effect of ideal cardiovascular health metrics on genetic association with incident heart failure in the China Kadoorie Biobank and the UK Biobank. BMC Med 2021;19:259. [PMID: 34674714 DOI: 10.1186/s12916-021-02122-1] [Reference Citation Analysis]
58 Numan S, Kaluza K. Systematic review of guidelines for the diagnosis and treatment of iron deficiency anemia using intravenous iron across multiple indications. Curr Med Res Opin 2020;36:1769-82. [PMID: 32936683 DOI: 10.1080/03007995.2020.1824898] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
59 Pieske B, Maggioni AP, Lam CSP, Pieske-Kraigher E, Filippatos G, Butler J, Ponikowski P, Shah SJ, Solomon SD, Scalise AV, Mueller K, Roessig L, Gheorghiade M. Vericiguat in patients with worsening chronic heart failure and preserved ejection fraction: results of the SOluble guanylate Cyclase stimulatoR in heArT failurE patientS with PRESERVED EF (SOCRATES-PRESERVED) study. Eur Heart J. 2017;38:1119-1127. [PMID: 28369340 DOI: 10.1093/eurheartj/ehw593] [Cited by in Crossref: 170] [Cited by in F6Publishing: 150] [Article Influence: 34.0] [Reference Citation Analysis]
60 Verdú-Rotellar JM, Frigola-Capell E, Alvarez-Pérez R, da Silva D, Enjuanes C, Domingo M, Mena A, Muñoz MA. Validation of heart failure diagnosis registered in primary care records in two primary care centres in Barcelona (Spain) and factors related. A cross-sectional study. Eur J Gen Pract 2017;23:107-13. [PMID: 28376668 DOI: 10.1080/13814788.2017.1305104] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
61 Schrage B, Uijl A, Benson L, Westermann D, Ståhlberg M, Stolfo D, Dahlström U, Linde C, Braunschweig F, Savarese G. Association Between Use of Primary-Prevention Implantable Cardioverter-Defibrillators and Mortality in Patients With Heart Failure: A Prospective Propensity Score–Matched Analysis From the Swedish Heart Failure Registry. Circulation 2019;140:1530-9. [DOI: 10.1161/circulationaha.119.043012] [Cited by in Crossref: 41] [Cited by in F6Publishing: 10] [Article Influence: 13.7] [Reference Citation Analysis]
62 Bazoukis G, Thomopoulos C, Tse G, Tsioufis K, Nihoyannopoulos P. Global longitudinal strain predicts responders after cardiac resynchronization therapy-a systematic review and meta-analysis. Heart Fail Rev 2021. [PMID: 33782788 DOI: 10.1007/s10741-021-10094-w] [Reference Citation Analysis]
63 Tint D, Florea R, Micu S. New Generation Cardiac Contractility Modulation Device-Filling the Gap in Heart Failure Treatment. J Clin Med 2019;8:E588. [PMID: 31035648 DOI: 10.3390/jcm8050588] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
64 Vincenzi A, Cesana F, Cirò A, Garatti L, Achilli F. Sacubitril/Valsartan in “Field Practice” Patients with Advanced Heart Failure: A Monocentric Italian Experience. Cardiology 2017;138:13-6. [DOI: 10.1159/000484877] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
65 Svahn S, Lövheim H, Isaksson U, Sandman PO, Gustafsson M. Cardiovascular drug use among people with cognitive impairment living in nursing homes in northern Sweden. Eur J Clin Pharmacol 2020;76:525-37. [PMID: 31915846 DOI: 10.1007/s00228-019-02778-y] [Reference Citation Analysis]
66 Metra M. February 2017 at a glance: fibrosis, acute heart failure and neurologic abnormalities. Eur J Heart Fail 2017;19:165-6. [PMID: 28157268 DOI: 10.1002/ejhf.760] [Reference Citation Analysis]
67 Kansakar S, Guragain A, Verma D, Sharma P, Dhungana B, Bhattarai B, Yadav S, Gautam N. Soluble Guanylate Cyclase Stimulators in Heart Failure. Cureus 2021;13:e17781. [PMID: 34659992 DOI: 10.7759/cureus.17781] [Reference Citation Analysis]
68 Giannoni A, Gentile F, Sciarrone P, Borrelli C, Pasero G, Mirizzi G, Vergaro G, Poletti R, Piepoli MF, Emdin M, Passino C. Upright Cheyne-Stokes Respiration in Patients With Heart Failure. Journal of the American College of Cardiology 2020;75:2934-46. [DOI: 10.1016/j.jacc.2020.04.033] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 5.5] [Reference Citation Analysis]
69 Kuan WS, Ibrahim I, Chan SP, Li Z, Liew OW, Frampton C, Troughton R, Pemberton CJ, Chong JPC, Tan LL, Lin W, Ooi SBS, Richards AM. Mid-regional pro-adrenomedullin outperforms N-terminal pro-B-type natriuretic peptide for the diagnosis of acute heart failure in the presence of atrial fibrillation. Eur J Heart Fail 2020;22:692-700. [PMID: 31808279 DOI: 10.1002/ejhf.1660] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
70 Loncar G, Bozic B, Neskovic AN, Cvetinovic N, Lainscak M, Prodanovic N, Dungen H, von Haehling S, Radojicic Z, Trippel T, Putnikovic B, Markovic-nikolic N, Popovic V. Androgen status in non-diabetic elderly men with heart failure. The Aging Male 2017;20:215-24. [DOI: 10.1080/13685538.2017.1350155] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
71 Andersson C, Lyass A, Xanthakis V, Larson MG, Mitchell GF, Cheng S, Vasan RS. Risk factor-based subphenotyping of heart failure in the community. PLoS One 2019;14:e0222886. [PMID: 31613888 DOI: 10.1371/journal.pone.0222886] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
72 Timonet-Andreu E, Canca-Sanchez JC, Sepulveda-Sanchez J, Ortiz-Tomé C, Rivas-Ruiz F, Toribio-Toribio JC, Mora-Banderas A, Morales-Asencio JM. Overestimation of hours dedicated to family caregiving of persons with heart failure. J Adv Nurs 2018;74:2312-21. [PMID: 29808478 DOI: 10.1111/jan.13727] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
73 Bucci T, Ames PRJ, Triggiani M, Parente R, Ciampa A, Pignatelli P, Pastori D; Multicenter ATHERO-APS Study group. Cardiac and vascular features of arterial and venous primary antiphospholipid syndrome. The multicenter ATHERO-APS study. Thromb Res 2022;209:69-74. [PMID: 34891057 DOI: 10.1016/j.thromres.2021.12.001] [Reference Citation Analysis]
74 Fluschnik N, Ojeda F, Zeller T, Jørgensen T, Kuulasmaa K, Becher PM, Sinning C, Blankenberg S, Westermann D. Predictive value of long-term changes of growth differentiation factor-15 over a 27-year-period for heart failure and death due to coronary heart disease. PLoS One 2018;13:e0197497. [PMID: 29771963 DOI: 10.1371/journal.pone.0197497] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
75 Möckel M. [Biomarkers in the diagnosis of cardiovascular emergencies : Acute coronary syndrome and differential diagnoses]. Internist (Berl) 2019;60:564-70. [PMID: 31062038 DOI: 10.1007/s00108-019-0620-9] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
76 Pagnesi M, Adamo M, Sama IE, Anker SD, Cleland JG, Dickstein K, Filippatos GS, Lang CC, Ng LL, Ponikowski P, Ravera A, Samani NJ, Zannad F, van Veldhuisen DJ, Voors AA, Metra M. Impact of mitral regurgitation in patients with worsening heart failure: insights from BIOSTAT-CHF. Eur J Heart Fail 2021. [PMID: 34164895 DOI: 10.1002/ejhf.2276] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
77 Vogiatzi G, Pantazis A, Tousoulis D. Antithrombotic Treatment in Cardiomyopathies. CPD 2020;26:2762-8. [DOI: 10.2174/1381612826666200429230726] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
78 Huang C, Qiu S, Fan X, Jiao G, Zhou X, Sun M, Weng N, Gao S, Tao X, Zhang F, Chen W. Evaluation of the effect of Shengxian Decoction on doxorubicin-induced chronic heart failure model rats and a multicomponent comparative pharmacokinetic study after oral administration in normal and model rats. Biomed Pharmacother 2021;144:112354. [PMID: 34794233 DOI: 10.1016/j.biopha.2021.112354] [Reference Citation Analysis]
79 Xu Y, Fu EL, Trevisan M, Jernberg T, Sjölander A, Clase CM, Carrero JJ. Stopping renin-angiotensin system inhibitors after hyperkalemia and risk of adverse outcomes. Am Heart J 2022;243:177-86. [PMID: 34610282 DOI: 10.1016/j.ahj.2021.09.014] [Reference Citation Analysis]
80 Farré N, Lupon J, Roig E, Gonzalez-Costello J, Vila J, Perez S, de Antonio M, Solé-González E, Sánchez-Enrique C, Moliner P, Ruiz S, Enjuanes C, Mirabet S, Bayés-Genís A, Comin-Colet J; GICCAT Investigators. Clinical characteristics, one-year change in ejection fraction and long-term outcomes in patients with heart failure with mid-range ejection fraction: a multicentre prospective observational study in Catalonia (Spain). BMJ Open 2017;7:e018719. [PMID: 29273666 DOI: 10.1136/bmjopen-2017-018719] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
81 Potapov EV, Antonides C, Crespo-Leiro MG, Combes A, Färber G, Hannan MM, Kukucka M, de Jonge N, Loforte A, Lund LH, Mohacsi P, Morshuis M, Netuka I, Özbaran M, Pappalardo F, Scandroglio AM, Schweiger M, Tsui S, Zimpfer D, Gustafsson F. 2019 EACTS Expert Consensus on long-term mechanical circulatory support. Eur J Cardiothorac Surg 2019;56:230-70. [PMID: 31100109 DOI: 10.1093/ejcts/ezz098] [Cited by in Crossref: 88] [Cited by in F6Publishing: 78] [Article Influence: 44.0] [Reference Citation Analysis]
82 Nikoo MH, Jamali Z, Razeghian-Jahromi I, Sayadi M, Verdecchia P, Abtahi F. Fragmented QRS as an early predictor of left ventricular systolic dysfunction in healthy individuals: a nested case-control study in the era of speckle tracking echocardiography. Cardiovasc Ultrasound 2020;18:33. [PMID: 32791984 DOI: 10.1186/s12947-020-00216-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
83 Ludwig S, Theis C, Brown B, Witthohn A, Lux W, Goette A. Incidence and costs of cardiac device infections: retrospective analysis using German health claims data. J Comp Eff Res 2018;7:483-92. [PMID: 29132224 DOI: 10.2217/cer-2017-0080] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 4.2] [Reference Citation Analysis]
84 Lehrke M, Marx N. Diabetes Mellitus and Heart Failure. The American Journal of Medicine 2017;130:S40-50. [DOI: 10.1016/j.amjmed.2017.04.010] [Cited by in Crossref: 60] [Cited by in F6Publishing: 49] [Article Influence: 12.0] [Reference Citation Analysis]
85 Volpe M, Rubattu S, Battistoni A. ARNi: A Novel Approach to Counteract Cardiovascular Diseases. Int J Mol Sci. 2019;20. [PMID: 31035359 DOI: 10.3390/ijms20092092] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 4.7] [Reference Citation Analysis]
86 Kapil V, Khambata RS, Jones DA, Rathod K, Primus C, Massimo G, Fukuto JM, Ahluwalia A, Garland CJ. The Noncanonical Pathway for In Vivo Nitric Oxide Generation: The Nitrate-Nitrite-Nitric Oxide Pathway. Pharmacol Rev 2020;72:692-766. [DOI: 10.1124/pr.120.019240] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 12.5] [Reference Citation Analysis]
87 Aengevaeren VL, Hopman MT, Thijssen DH, van Kimmenade RR, de Boer M, Eijsvogels TM. Endurance exercise-induced changes in BNP concentrations in cardiovascular patients versus healthy controls. International Journal of Cardiology 2017;227:430-5. [DOI: 10.1016/j.ijcard.2016.11.016] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
88 Kobayashi M, Gargani L, Palazzuoli A, Ambrosio G, Bayés-Genis A, Lupon J, Pellicori P, Pugliese NR, Reddy YNV, Ruocco G, Duarte K, Huttin O, Rossignol P, Coiro S, Girerd N. Association between right-sided cardiac function and ultrasound-based pulmonary congestion on acutely decompensated heart failure: findings from a pooled analysis of four cohort studies. Clin Res Cardiol 2021;110:1181-92. [PMID: 32770373 DOI: 10.1007/s00392-020-01724-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
89 Bytyçi I, Dini FL, Bajraktari A, Pugliese NR, D'Agostino A, Bajraktari G, Lindqvist P, Henein MY. Speckle Tracking-Derived Left Atrial Stiffness Predicts Clinical Outcome in Heart Failure Patients with Reduced to Mid-Range Ejection Fraction. J Clin Med 2020;9:E1244. [PMID: 32344825 DOI: 10.3390/jcm9051244] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
90 Held M, Weiner S, Walthelm J, Joa F, Hoffmann J, Güder G, Pfeuffer-Jovic E. [Functional characterization of patients with isolated post-capillary or combined post-capillary and pre-capillary pulmonary hypertension]. Dtsch Med Wochenschr 2021;146:e88-94. [PMID: 34670324 DOI: 10.1055/a-1555-0345] [Reference Citation Analysis]
91 Geng X, Zhang J, Zhang Y, Hu H, Yang J, Cui W. Revisiting the clinical evidence of heart rate target in patients with heart failure treated with beta-blockers. Anatol J Cardiol 2021;25:762-73. [PMID: 34734809 DOI: 10.5152/AnatolJCardiol.2021.90] [Reference Citation Analysis]
92 Kim HB, Hong YJ, Park HJ, Ahn Y, Jeong MH. Effects of Fimasartan/Amlodipine Fixed-Dose Combination on Left Ventricular Systolic Function and Infarct Size in Rat Myocardial Infarction Model. Chonnam Med J 2019;55:144-9. [PMID: 31598471 DOI: 10.4068/cmj.2019.55.3.144] [Reference Citation Analysis]
93 Huntley D, Mollar A, Buesa J, Rodríguez S, Giménez E, Sanchis J, Núñez J, Navarro D. Are pathogenic intestinal bacteria present in stool specimens from patients with chronic heart failure? Diagn Microbiol Infect Dis 2018;91:141-3. [PMID: 29433998 DOI: 10.1016/j.diagmicrobio.2018.01.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
94 Aalen JM, Remme EW, Larsen CK, Andersen OS, Krogh M, Duchenne J, Hopp E, Ross S, Beela AS, Kongsgaard E, Bergsland J, Odland HH, Skulstad H, Opdahl A, Voigt J, Smiseth OA. Mechanism of Abnormal Septal Motion in Left Bundle Branch Block. JACC: Cardiovascular Imaging 2019;12:2402-13. [DOI: 10.1016/j.jcmg.2018.11.030] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 8.3] [Reference Citation Analysis]
95 Squire I. Measurement of circulating natriuretic peptides to identify community‐based patients at risk of incident heart failure — should we? Eur J Heart Fail 2019;21:460-1. [DOI: 10.1002/ejhf.1391] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
96 Zhao J, Zeng Y, Shen X. Efficacy and safety of early initiation of Sacubitril/Valsartan in patients after acute myocardial infarction: A meta-analysis. Clin Cardiol 2021;44:1354-9. [PMID: 34464468 DOI: 10.1002/clc.23717] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
97 Linde C, Abraham WT, Gold MR, Daubert JC, Tang ASL, Young JB, Sherfesee L, Hudnall JH, Fagan DH, Cleland JG. Predictors of short-term clinical response to cardiac resynchronization therapy. Eur J Heart Fail 2017;19:1056-63. [PMID: 28295869 DOI: 10.1002/ejhf.795] [Cited by in Crossref: 23] [Cited by in F6Publishing: 15] [Article Influence: 4.6] [Reference Citation Analysis]
98 Kim J, Park JK, Shin MS, Choi J, Kim SH, Park YM, On YK, Choi N, Heo S. Cognitive Function of Recipients of Primary or Secondary Defibrillator Therapy: A Comparative Study Involving Nondefibrillator Patients With Systolic Heart Failure. J Cardiovasc Nurs 2022;37:8-16. [PMID: 34870947 DOI: 10.1097/JCN.0000000000000706] [Reference Citation Analysis]
99 Liu M, Ai J, Feng J, Zheng J, Tang K, Shuai Z, Yang J. Effect of paeoniflorin on cardiac remodeling in chronic heart failure rats through the transforming growth factor β1/Smad signaling pathway. Cardiovasc Diagn Ther 2019;9:272-80. [PMID: 31275817 DOI: 10.21037/cdt.2019.06.01] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
100 Landolfo M, Piani F, Esposti DD, Cosentino E, Bacchelli S, Dormi A, Borghi C. Effects of sacubitril valsartan on clinical and echocardiographic parameters of outpatients with heart failure and reduced ejection fraction. Int J Cardiol Heart Vasc 2020;31:100656. [PMID: 33134479 DOI: 10.1016/j.ijcha.2020.100656] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
101 Cicenia M, Silvetti MS, Drago F. When Should Premature Ventricular Contractions Be Considered as a Red Flag in Children with Cardiomyopathy? J Cardiovasc Dev Dis 2021;8:176. [PMID: 34940531 DOI: 10.3390/jcdd8120176] [Reference Citation Analysis]
102 Badano LP, Nagueh SF, Muraru D. Left atrial function: an overlooked metrics in clinical routine echocardiography. Eur J Heart Fail 2019;21:901-3. [DOI: 10.1002/ejhf.1475] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
103 Kadoglou NP, Mandila C, Karavidas A, Farmakis D, Matzaraki V, Varounis C, Arapi S, Perpinia A, Parissis J. Effect of functional electrical stimulation on cardiovascular outcomes in patients with chronic heart failure. Eur J Prev Cardiol 2017;24:833-9. [PMID: 28079427 DOI: 10.1177/2047487316687428] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
104 Moraes LN, Fernandez GJ, Vechetti-Júnior IJ, Freire PP, Souza RWA, Villacis RAR, Rogatto SR, Reis PP, Dal-Pai-Silva M, Carvalho RF. Integration of miRNA and mRNA expression profiles reveals microRNA-regulated networks during muscle wasting in cardiac cachexia. Sci Rep 2017;7:6998. [PMID: 28765595 DOI: 10.1038/s41598-017-07236-2] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 4.8] [Reference Citation Analysis]
105 Janovska P, Melenovsky V, Svobodova M, Havlenova T, Kratochvilova H, Haluzik M, Hoskova E, Pelikanova T, Kautzner J, Monzo L, Jurcova I, Adamcova K, Lenkova L, Buresova J, Rossmeisl M, Kuda O, Cajka T, Kopecky J. Dysregulation of epicardial adipose tissue in cachexia due to heart failure: the role of natriuretic peptides and cardiolipin. J Cachexia Sarcopenia Muscle 2020;11:1614-27. [PMID: 33084249 DOI: 10.1002/jcsm.12631] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
106 Wolsk E, Claggett B, Køber L, Pocock S, Yusuf S, Swedberg K, McMurray JJV, Granger CB, Pfeffer MA, Solomon SD. Contribution of cardiac and extra-cardiac disease burden to risk of cardiovascular outcomes varies by ejection fraction in heart failure. Eur J Heart Fail 2018;20:504-10. [PMID: 29193462 DOI: 10.1002/ejhf.1073] [Cited by in Crossref: 38] [Cited by in F6Publishing: 30] [Article Influence: 7.6] [Reference Citation Analysis]
107 Derosa G, Maffioli P, Scelsi L, Bestetti A, Vanasia M, Cicero AF, Spinardi L, Bentivenga C, Esposti DD, Caprio M, Borghi C, Pitt B, Cosentino E. Canrenone on cardiovascular mortality in congestive heart failure. Pharmacological Research 2019;141:46-52. [DOI: 10.1016/j.phrs.2018.11.037] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
108 Yang SW, Zhou YJ, Zhao YX, Liu YY, Tian XF, Wang ZJ, Jia DA, Han HY, Hu B, Shen H, Gao F, Wang LY, Lin J, Pan GZ, Zhang J, Guo ZF, Du J, Hu DY. The serum anion gap is associated with disease severity and all-cause mortality in coronary artery disease. J Geriatr Cardiol 2017;14:392-400. [PMID: 29056946 DOI: 10.11909/j.issn.1671-5411.2017.06.008] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
109 van der Pol A, Hoes MF, de Boer RA, van der Meer P. Cardiac foetal reprogramming: a tool to exploit novel treatment targets for the failing heart. J Intern Med 2020;288:491-506. [PMID: 32557939 DOI: 10.1111/joim.13094] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
110 Gasior M, Gierlotka M, Pyka Ł, Zdrojewski T, Wojtyniak B, Chlebus K, Rozentryt P, Niedziela J, Jankowski P, Nessler J, Opolski G, Hoffman P, Jankowska E, Polonski L, Ponikowski P. Temporal trends in secondary prevention in myocardial infarction patients discharged with left ventricular systolic dysfunction in Poland. Eur J Prev Cardiolog 2018;25:960-9. [DOI: 10.1177/2047487318770830] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
111 Fedson S. Rethinking the Meaning of Palliation in Heart Failure. Curr Heart Fail Rep 2020;17:309-13. [PMID: 32876934 DOI: 10.1007/s11897-020-00483-x] [Reference Citation Analysis]
112 Kjeldsen KP, Schmidt TA. Potassium homoeostasis and pathophysiology of hyperkalaemia. Eur Heart J Suppl 2019;21:A2-5. [PMID: 30837798 DOI: 10.1093/eurheartj/suy033] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
113 Ventura HO, Mehra MR. Blood pressure and goal titration of neurohormonal antagonists: the tortoise wins again? Eur J Heart Fail 2018;20:501-3. [PMID: 29333669 DOI: 10.1002/ejhf.1094] [Reference Citation Analysis]
114 Boczar K, Sławuta A, Ząbek A, Dębski M, Vijayaraman P, Gajek J, Lelakowski J, Małecka B. Cardiac resynchronization therapy with His bundle pacing. Pacing Clin Electrophysiol 2019;42:374-80. [DOI: 10.1111/pace.13611] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
115 Pan W, Yang D, Yu P, Yu H. Comparison of predictive value of NT-proBNP, sST2 and MMPs in heart failure patients with different ejection fractions. BMC Cardiovasc Disord 2020;20:208. [PMID: 32354356 DOI: 10.1186/s12872-020-01493-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
116 Gustafsson F, Rogers JG. Left ventricular assist device therapy in advanced heart failure: patient selection and outcomes: LVAD therapy in HF. Eur J Heart Fail 2017;19:595-602. [DOI: 10.1002/ejhf.779] [Cited by in Crossref: 137] [Cited by in F6Publishing: 108] [Article Influence: 27.4] [Reference Citation Analysis]
117 Wang AY. Optimally managing hyperkalemia in patients with cardiorenal syndrome. Nephrol Dial Transplant 2019;34:iii36-44. [PMID: 31800079 DOI: 10.1093/ndt/gfz225] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
118 Alexandrou ME, Papagianni A, Tsapas A, Loutradis C, Boutou A, Piperidou A, Papadopoulou D, Ruilope L, Bakris G, Sarafidis P. Effects of mineralocorticoid receptor antagonists in proteinuric kidney disease: a systematic review and meta-analysis of randomized controlled trials. J Hypertens 2019;37:2307-24. [PMID: 31688290 DOI: 10.1097/HJH.0000000000002187] [Cited by in Crossref: 17] [Cited by in F6Publishing: 8] [Article Influence: 8.5] [Reference Citation Analysis]
119 Fan M, Chen Z, Huang Y, Xia Y, Chen A, Lu D, Wu Y, Zhang N, Zhang P, Li S, Chen J, Zhang Y, Sun A, Zou Y, Hu K, Qian J, Ge J. Overexpression of the histidine triad nucleotide-binding protein 2 protects cardiac function in the adult mice after acute myocardial infarction. Acta Physiol (Oxf) 2020;228:e13439. [PMID: 31900976 DOI: 10.1111/apha.13439] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
120 Kucukseymen S, Arafati A, Al-Otaibi T, El-Rewaidy H, Fahmy AS, Ngo LH, Nezafat R. Noncontrast Cardiac Magnetic Resonance Imaging Predictors of Heart Failure Hospitalization in Heart Failure With Preserved Ejection Fraction. J Magn Reson Imaging 2021. [PMID: 34559435 DOI: 10.1002/jmri.27932] [Reference Citation Analysis]
121 Tomasoni D, Adamo M, Lombardi CM, Metra M. Highlights in heart failure. ESC Heart Fail 2019;6:1105-27. [PMID: 31997538 DOI: 10.1002/ehf2.12555] [Cited by in Crossref: 28] [Cited by in F6Publishing: 20] [Article Influence: 14.0] [Reference Citation Analysis]
122 Pharithi RB, Ferre-Vallverdu M, Maisel AS, O'Connell E, Walshe M, Sweeney C, Barton J, McDonald K, O'Hare D, Watson C, Gallagher J, Ledwidge M, McDonald K. Sacubitril-Valsartan in a routine community population: attention to volume status critical to achieving target dose. ESC Heart Fail 2020;7:158-66. [PMID: 31903729 DOI: 10.1002/ehf2.12547] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
123 Khan MS, Vaduganathan M. What Makes Sodium-Glucose Co-Transporter-2 Inhibitors Stand out in Heart Failure? Curr Diab Rep 2020;20:63. [PMID: 33040170 DOI: 10.1007/s11892-020-01347-3] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
124 Sedlar N, Lainscak M, Mårtensson J, Strömberg A, Jaarsma T, Farkas J. Factors related to self-care behaviours in heart failure: A systematic review of European Heart Failure Self-Care Behaviour Scale studies. Eur J Cardiovasc Nurs 2017;16:272-82. [PMID: 28168895 DOI: 10.1177/1474515117691644] [Cited by in Crossref: 61] [Cited by in F6Publishing: 56] [Article Influence: 12.2] [Reference Citation Analysis]
125 Devaux Y, Nossent AY; on behalf of EU‐CardioRNA COST Action CA17129. A role for m6A RNA methylation in heart failure development? Eur J Heart Fail 2020;22:67-9. [DOI: 10.1002/ejhf.1714] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
126 Curigliano G, Lenihan D, Fradley M, Ganatra S, Barac A, Blaes A, Herrmann J, Porter C, Lyon AR, Lancellotti P, Patel A, DeCara J, Mitchell J, Harrison E, Moslehi J, Witteles R, Calabro MG, Orecchia R, de Azambuja E, Zamorano JL, Krone R, Iakobishvili Z, Carver J, Armenian S, Ky B, Cardinale D, Cipolla CM, Dent S, Jordan K; ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org. Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations. Ann Oncol 2020;31:171-90. [PMID: 31959335 DOI: 10.1016/j.annonc.2019.10.023] [Cited by in Crossref: 164] [Cited by in F6Publishing: 123] [Article Influence: 164.0] [Reference Citation Analysis]
127 Jankowska EA, Tkaczyszyn M, Drozd M, Ponikowski P. Monitoring of iron status in patients with heart failure. Eur Heart J Suppl 2019;21:M32-5. [PMID: 31908613 DOI: 10.1093/eurheartj/suz231] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
128 Doehner W. Dementia and the heart failure patient. Eur Heart J Suppl 2019;21:L28-31. [PMID: 31885510 DOI: 10.1093/eurheartj/suz242] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
129 Kremer D, ter Maaten JM, Voors AA. Bio-adrenomedullin as a potential quick, reliable, and objective marker of congestion in heart failure: Bio-adrenomedullin as a potential quick, reliable, and objective marker of congestion in heart failure. Eur J Heart Fail 2018;20:1363-5. [DOI: 10.1002/ejhf.1245] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 4.5] [Reference Citation Analysis]
130 Lavall D, Hagendorff A, Schirmer SH, Böhm M, Borger MA, Laufs U. Mitral valve interventions in heart failure. ESC Heart Fail 2018;5:552-61. [PMID: 29676043 DOI: 10.1002/ehf2.12287] [Cited by in Crossref: 29] [Cited by in F6Publishing: 19] [Article Influence: 7.3] [Reference Citation Analysis]
131 Cotter G, Metra M, Davison BA, Jondeau G, Cleland JGF, Bourge RC, Milo O, O'Connor CM, Parker JD, Torre-Amione G, van Veldhuisen DJ, Kobrin I, Rainisio M, Senger S, Edwards C, McMurray JJV, Teerlink JR; VERITAS Investigators. Systolic blood pressure reduction during the first 24 h in acute heart failure admission: friend or foe? Eur J Heart Fail 2018;20:317-22. [PMID: 28871621 DOI: 10.1002/ejhf.889] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 2.6] [Reference Citation Analysis]
132 Popovic D, Arena R, Guazzi M. A flattening oxygen consumption trajectory phenotypes disease severity and poor prognosis in patients with heart failure with reduced, mid-range, and preserved ejection fraction. Eur J Heart Fail 2018;20:1115-24. [PMID: 29405511 DOI: 10.1002/ejhf.1140] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
133 Gusdal AK, Josefsson K, Thors Adolfsson E, Martin L. Nurses’ attitudes toward family importance in heart failure care. European Journal of Cardiovascular Nursing 2016;16:256-66. [DOI: 10.1177/1474515116687178] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 3.2] [Reference Citation Analysis]
134 Bauersachs J. Heart failure drug treatment: the fantastic four. Eur Heart J 2021;42:681-3. [PMID: 33447845 DOI: 10.1093/eurheartj/ehaa1012] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 16.0] [Reference Citation Analysis]
135 Esfandiari S, Wolsk E, Granton D, Azevedo L, Valle FH, Gustafsson F, Mak S. Pulmonary Arterial Wedge Pressure at Rest and During Exercise in Healthy Adults: A Systematic Review and Meta-analysis. Journal of Cardiac Failure 2019;25:114-22. [DOI: 10.1016/j.cardfail.2018.10.009] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
136 Täubel J, Hauke W, Rump S, Viereck J, Batkai S, Poetzsch J, Rode L, Weigt H, Genschel C, Lorch U, Theek C, Levin AA, Bauersachs J, Solomon SD, Thum T. Novel antisense therapy targeting microRNA-132 in patients with heart failure: results of a first-in-human Phase 1b randomized, double-blind, placebo-controlled study. Eur Heart J 2021;42:178-88. [PMID: 33245749 DOI: 10.1093/eurheartj/ehaa898] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 22.0] [Reference Citation Analysis]
137 Siliste R, Antohi E, Pepoyan S, Nakou E, Vardas P. Anticoagulation in heart failure without atrial fibrillation: gaps and dilemmas in current clinical practice. Eur J Heart Fail 2018;20:978-88. [DOI: 10.1002/ejhf.1153] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
138 Khan MS, Butler J, Greene SJ. The real world of de novo heart failure: the next frontier for heart failure clinical trials? Eur J Heart Fail 2020;22:1786-9. [DOI: 10.1002/ejhf.1844] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
139 Girerd N, Seronde MF, Coiro S, Chouihed T, Bilbault P, Braun F, Kenizou D, Maillier B, Nazeyrollas P, Roul G, Fillieux L, Abraham WT, Januzzi J Jr, Sebbag L, Zannad F, Mebazaa A, Rossignol P; INI-CRCT, Great Network, and the EF-HF Group. Integrative Assessment of Congestion in Heart Failure Throughout the Patient Journey. JACC Heart Fail 2018;6:273-85. [PMID: 29226815 DOI: 10.1016/j.jchf.2017.09.023] [Cited by in Crossref: 64] [Cited by in F6Publishing: 50] [Article Influence: 12.8] [Reference Citation Analysis]
140 Cernea S. Heart Failure and Chronic Kidney Disease in Type 2 Diabetes. Journal of Interdisciplinary Medicine 2016;1:252-8. [DOI: 10.1515/jim-2016-0066] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
141 Ferreira JP, Rossignol P, Machu JL, Sharma A, Girerd N, Anker SD, Cleland JG, Dickstein K, Filippatos G, Hillege HL, Lang CC, Ter Maaten JM, Metra M, Ng L, Ponikowski P, Samani NJ, van Veldhuisen DJ, Zwinderman AH, Voors A, Zannad F. Mineralocorticoid receptor antagonist pattern of use in heart failure with reduced ejection fraction: findings from BIOSTAT-CHF. Eur J Heart Fail 2017;19:1284-93. [PMID: 28580625 DOI: 10.1002/ejhf.900] [Cited by in Crossref: 50] [Cited by in F6Publishing: 42] [Article Influence: 10.0] [Reference Citation Analysis]
142 Chen Z, Lin Q, Li J, Wang X, Ju J, Xu H, Shi D. Estimated Glomerular Filtration Rate Is Associated With an Increased Risk of Death in Heart Failure Patients With Preserved Ejection Fraction. Front Cardiovasc Med 2021;8:643358. [PMID: 33981733 DOI: 10.3389/fcvm.2021.643358] [Reference Citation Analysis]
143 Leng S, Tan RS, Zhao X, Allen JC, Koh AS, Zhong L. Validation of a rapid semi-automated method to assess left atrial longitudinal phasic strains on cine cardiovascular magnetic resonance imaging. J Cardiovasc Magn Reson 2018;20:71. [PMID: 30396356 DOI: 10.1186/s12968-018-0496-1] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 6.3] [Reference Citation Analysis]
144 Meng Y, Zhu S, Xie Y, Zhang Y, Qian M, Gao L, Li M, Lin Y, Wu W, Wang J, Yang Y, Lv Q, Zhang L, Li Y, Xie M. Prognostic Value of Right Ventricular 3D Speckle-Tracking Strain and Ejection Fraction in Patients With HFpEF. Front Cardiovasc Med 2021;8:694365. [PMID: 34277743 DOI: 10.3389/fcvm.2021.694365] [Reference Citation Analysis]
145 Khder Y, Shi V, McMurray JJV, Lefkowitz MP. Sacubitril/Valsartan (LCZ696) in Heart Failure. Handb Exp Pharmacol 2017;243:133-65. [PMID: 28004291 DOI: 10.1007/164_2016_77] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
146 Kozhuharov N, Sabti Z, Wussler D, Nowak A, Badertscher P, Twerenbold R, Wildi K, Stallone F, Vogt F, Hilti J, Puelacher C, du Fay de Lavallaz J, Shrestha S, Flores D, Nestelberger T, Koechlin L, Boeddinghaus J, Zimmermann T, Walter J, Schumacher C, Rentsch K, von Eckardstein A, Keller DI, Goudev A, Pfister O, Breidthardt T, Mueller C; BASEL V Investigators. Prospective validation of N-terminal pro B-type natriuretic peptide cut-off concentrations for the diagnosis of acute heart failure. Eur J Heart Fail 2019;21:813-5. [PMID: 31020757 DOI: 10.1002/ejhf.1471] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
147 Chivulescu M, Aabel E, Dejgaard L, Steen T, Dunlop O, Haugaa KH. Cardiac Arrest in a Patient With Arrhythmic Mitral Valve Prolapse Syndrome: Multiple Possible Etiologies. JACC Case Rep 2021;3:1769-73. [PMID: 34825207 DOI: 10.1016/j.jaccas.2021.08.019] [Reference Citation Analysis]
148 Mordi IR, Ouwerkerk W, Anker SD, Cleland JG, Dickstein K, Metra M, Ng LL, Samani NJ, van Veldhuisen DJ, Zannad F, Voors AA, Lang CC. Heart failure treatment up-titration and outcome and age: an analysis of BIOSTAT-CHF. Eur J Heart Fail 2021;23:436-44. [PMID: 32216000 DOI: 10.1002/ejhf.1799] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
149 Chung ML, Liljeroos M, Moser DK, Lennie TA. Perceived Control Prevents Perception of Negative Changes in Life as a Result of Caring for a Patient With Heart Failure. J Cardiovasc Nurs 2021;36:206-11. [PMID: 32541246 DOI: 10.1097/JCN.0000000000000717] [Reference Citation Analysis]
150 Grabka M, Kocierz-Woźnowska M, Wybraniec M, Turski M, Wita M, Wita K, Mizia-Stec K. Left ventricular reverse remodeling in patients with anterior wall ST-segment elevation acute myocardial infarction treated with primary percutaneous coronary intervention. Postepy Kardiol Interwencyjnej 2018;14:373-82. [PMID: 30603027 DOI: 10.5114/aic.2018.79867] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
151 Mascia G, Paoletti Perini A, Cartei S, Binazzi B, Gigliotti F, Solimene F, Mascioli G, Giaccardi M. Sleep-disordered breathing and effectiveness of cardiac resynchronization therapy in heart failure patients: gender differences? Sleep Med 2019;64:106-11. [PMID: 31678699 DOI: 10.1016/j.sleep.2019.06.019] [Reference Citation Analysis]
152 Jirak P, Fejzic D, Paar V, Wernly B, Pistulli R, Rohm I, Jung C, Hoppe UC, Schulze PC, Lichtenauer M, Yilmaz A, Kretzschmar D. Influences of Ivabradine treatment on serum levels of cardiac biomarkers sST2, GDF-15, suPAR and H-FABP in patients with chronic heart failure. Acta Pharmacol Sin 2018;39:1189-96. [PMID: 29239349 DOI: 10.1038/aps.2017.167] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
153 Taieb DJ, Amara DW. [Home monitoring follow-up of implantable cardiac defibrillators and stimulators : Current situation in France and possible future after ETAPESprogram]. Ann Cardiol Angeiol (Paris) 2021;70:322-5. [PMID: 34635327 DOI: 10.1016/j.ancard.2021.08.004] [Reference Citation Analysis]
154 Jacob J, Llauger L, Herrero-Puente P, Martín-Sánchez FJ, Llorens P, Roset A, Gil V, Fuentes M, Lucas-Imbernón FJ, Miró Ò; ICASEMES-Research Group. Acute heart failure and adverse events associated with the presence of renal dysfunction and hyperkalaemia. EAHFE- renal dysfunction and hyperkalaemia. Eur J Intern Med 2019;67:89-96. [PMID: 31331793 DOI: 10.1016/j.ejim.2019.07.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
155 Jiang SY, Shen YH, Zhao XG. Adrenaline use is associated with excess organ injury and mortality in cardiogenic shock: facts and fiction. Crit Care 2016;20:292. [PMID: 27677447 DOI: 10.1186/s13054-016-1460-9] [Reference Citation Analysis]
156 Sharma A, Zhao X, Hammill BG, Hernandez AF, Fonarow GC, Felker GM, Yancy CW, Heidenreich PA, Ezekowitz JA, DeVore AD. Trends in Noncardiovascular Comorbidities Among Patients Hospitalized for Heart Failure: Insights From the Get With The Guidelines-Heart Failure Registry. Circ Heart Fail 2018;11:e004646. [PMID: 29793934 DOI: 10.1161/CIRCHEARTFAILURE.117.004646] [Cited by in Crossref: 58] [Cited by in F6Publishing: 38] [Article Influence: 19.3] [Reference Citation Analysis]
157 Tang L, Liu W, Yang Y, Han W, Li K. Relationship between sleep and cognitive function in patients with heart failure: A systematic review. J Psychosom Res 2020;130:109913. [PMID: 31918359 DOI: 10.1016/j.jpsychores.2019.109913] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
158 Satriano UM, Nenna A, Spadaccio C, Pollari F, Fischlein T, Chello M, Nappi F. Guidelines on prosthetic heart valve management in infective endocarditis: a narrative review comparing American Heart Association/American College of Cardiology and European Society of Cardiology guidelines. Ann Transl Med 2020;8:1625. [PMID: 33437824 DOI: 10.21037/atm-20-5134] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
159 Bekfani T, Nisser J, Derlien S, Hamadanchi A, Fröb E, Dannberg G, Lichtenauer M, Smolenski UC, Lehmann G, Möbius-Winkler S, Schulze PC. Psychosocial factors, mental health, and coordination capacity in patients with heart failure with preserved ejection fraction compared with heart failure with reduced ejection fraction. ESC Heart Fail 2021;8:3268-78. [PMID: 34121363 DOI: 10.1002/ehf2.13468] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
160 Ahmed SW, Sultan FAT, Awan S, Ahmed I. Prognostic Significance of CMR Findings in Patients with Known Coronary Artery Disease - Experience from a South Asian Country. J Clin Imaging Sci 2020;10:75. [PMID: 33274119 DOI: 10.25259/JCIS_153_2020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
161 Sotiriou E, Heiner S, Jansen T, Brandt M, Schmidt KH, Kreitner KF, Emrich T, Schultheiss HP, Schulz E, Münzel T, Wenzel P. Therapeutic implications of a combined diagnostic workup including endomyocardial biopsy in an all-comer population of patients with heart failure: a retrospective analysis. ESC Heart Fail 2018;5:630-41. [PMID: 29745463 DOI: 10.1002/ehf2.12296] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
162 Uijl A, Lund LH, Vaartjes I, Brugts JJ, Linssen GC, Asselbergs FW, Hoes AW, Dahlström U, Koudstaal S, Savarese G. A registry-based algorithm to predict ejection fraction in patients with heart failure. ESC Heart Fail 2020;7:2388-97. [PMID: 32548911 DOI: 10.1002/ehf2.12779] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
163 Cui X, Zhou J, Pivodic A, Dahlström U, Ge J, Fu M. Temporal trends in cause-specific readmissions and their risk factors in heart failure patients in Sweden. Int J Cardiol 2020;306:116-22. [PMID: 32145935 DOI: 10.1016/j.ijcard.2020.02.048] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
164 Tocchetti CG, Cadeddu C, Di Lisi D, Femminò S, Madonna R, Mele D, Monte I, Novo G, Penna C, Pepe A, Spallarossa P, Varricchi G, Zito C, Pagliaro P, Mercuro G. From Molecular Mechanisms to Clinical Management of Antineoplastic Drug-Induced Cardiovascular Toxicity: A Translational Overview. Antioxid Redox Signal 2019;30:2110-53. [PMID: 28398124 DOI: 10.1089/ars.2016.6930] [Cited by in Crossref: 52] [Cited by in F6Publishing: 48] [Article Influence: 10.4] [Reference Citation Analysis]
165 Ziaeian B, Heidenreich PA, Xu H, DeVore AD, Matsouaka RA, Hernandez AF, Bhatt DL, Yancy CW, Fonarow GC. Race/Ethnic Differences in Outcomes Among Hospitalized Medicare Patients With Heart Failure and Preserved Ejection Fraction. JACC Heart Fail 2017;5:483-93. [PMID: 28501527 DOI: 10.1016/j.jchf.2017.02.012] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.8] [Reference Citation Analysis]
166 Trauzeddel RF, Nordine M, Groesdonk HV, Michels G, Pfister R, Reuter DA, Scheeren TWL, Berger C, Treskatsch S. [Perioperative optimization using hemodynamically focused echocardiography in high-risk patients-A practice guide]. Anaesthesist 2021. [PMID: 33660043 DOI: 10.1007/s00101-021-00934-7] [Reference Citation Analysis]
167 Hashemi D, Motzkus L, Blum M, Kraft R, Tanacli R, Tahirovic E, Doeblin P, Zieschang V, Zamani SM, Kelm M, Kuehne T, Pieske B, Alogna A, Edelmann F, Duengen HD, Kelle S. Myocardial deformation assessed among heart failure entities by cardiovascular magnetic resonance imaging. ESC Heart Fail 2021;8:890-7. [PMID: 33539681 DOI: 10.1002/ehf2.13193] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
168 Gallagher J, James S, Keane C, Fitzgerald A, Travers B, Quigley E, Hecht C, Zhou S, Watson C, Ledwidge M, McDonald K. Heart Failure Virtual Consultation: bridging the gap of heart failure care in the community - A mixed-methods evaluation. ESC Heart Fail 2017;4:252-8. [PMID: 28772044 DOI: 10.1002/ehf2.12163] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
169 Mcdonald K, Gallagher J. The practice gap in heart failure-the elephant in the room: Viewpoint. Eur J Heart Fail 2017;19:301-3. [DOI: 10.1002/ejhf.734] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
170 Arfaras-Melainis A, Polyzogopoulou E, Triposkiadis F, Xanthopoulos A, Ikonomidis I, Mebazaa A, Parissis J. Heart failure and sepsis: practical recommendations for the optimal management. Heart Fail Rev 2020;25:183-94. [PMID: 31227942 DOI: 10.1007/s10741-019-09816-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
171 Zhang H, Zhabyeyev P, Wang S, Oudit GY. Role of iron metabolism in heart failure: From iron deficiency to iron overload. Biochim Biophys Acta Mol Basis Dis 2019;1865:1925-37. [PMID: 31109456 DOI: 10.1016/j.bbadis.2018.08.030] [Cited by in Crossref: 30] [Cited by in F6Publishing: 17] [Article Influence: 7.5] [Reference Citation Analysis]
172 Parente EB, Harjutsalo V, Forsblom C, Groop PH; FinnDiane Study Group. The impact of central obesity on the risk of hospitalization or death due to heart failure in type 1 diabetes: a 16-year cohort study. Cardiovasc Diabetol 2021;20:153. [PMID: 34315479 DOI: 10.1186/s12933-021-01340-4] [Reference Citation Analysis]
173 Silljé HHW, de Boer RA. Heart failure: Macrophages take centre stage in the heart-brain-kidney axis. Nat Rev Nephrol 2017;13:388-90. [PMID: 28555651 DOI: 10.1038/nrneph.2017.73] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
174 Belyavskiy E, Pieske-Kraigher E, Tadic M. Blood pressure control in heart failure: Is everything black and white? J Clin Hypertens (Greenwich) 2019;21:1132-4. [PMID: 31282593 DOI: 10.1111/jch.13633] [Reference Citation Analysis]
175 Aceña A, Franco-Peláez JA, Gutierrez-Landaluce C, Pello AM, Cristóbal C, Tarín N, Huelmos A, Carda R, Martín-Mariscal ML, Alonso J, González-Parra E, González-Casaus ML, Lorenzo Ó, López Bescos L, Egido J, Tuñón J. Sun exposure influences the prognostic power of components of mineral metabolism in patients with coronary artery disease. Nutr Metab Cardiovasc Dis 2017;27:762-7. [PMID: 28803689 DOI: 10.1016/j.numecd.2017.06.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
176 Lewis GA, Schelbert EB, Williams SG, Cunnington C, Ahmed F, McDonagh TA, Miller CA. Biological Phenotypes of Heart Failure With Preserved Ejection Fraction. J Am Coll Cardiol. 2017;70:2186-2200. [PMID: 29050567 DOI: 10.1016/j.jacc.2017.09.006] [Cited by in Crossref: 99] [Cited by in F6Publishing: 88] [Article Influence: 19.8] [Reference Citation Analysis]
177 Glezer M, Vasyuk Y, Karpov Y. Efficacy of Ivabradine in Combination with Beta-Blockers Versus Uptitration of Beta-Blockers in Patients with Stable Angina (CONTROL-2 Study). Adv Ther 2018;35:341-52. [PMID: 29508153 DOI: 10.1007/s12325-018-0681-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
178 Leem J, Lee SMK, Park JH, Lee S, Chung H, Lee JM, Kim W, Lee S, Woo JS. Efficacy and safety of electroacupuncture in acute decompensated heart failure: a study protocol for a randomized, patient- and assessor-blinded, sham controlled trial. BMC Complement Altern Med 2017;17:361. [PMID: 28697773 DOI: 10.1186/s12906-017-1864-3] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
179 Ikeda Y, Ishii S, Fujita T, Iida Y, Kaida T, Nabeta T, Maekawa E, Yanagisawa T, Koitabashi T, Takeuchi I, Inomata T, Ako J. Prognostic impact of intestinal wall thickening in hospitalized patients with heart failure. International Journal of Cardiology 2017;230:120-6. [DOI: 10.1016/j.ijcard.2016.12.063] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
180 Volkov D, Lopin D, Rybchynskyi S, Skoryi D. His-optimized cardiac resynchronization therapy in a patient with heart failure and right bundle branch block: a case report. Eur Heart J Case Rep 2021;5:ytab277. [PMID: 34661056 DOI: 10.1093/ehjcr/ytab277] [Reference Citation Analysis]
181 Bencivenga L, Komici K, Femminella GD, Paolillo S, Gargiulo P, Formisano R, Assante R, Nappi C, Puzone B, Sepe I, Cittadini A, Vitale DF, Ferrara N, Cuocolo A, Filardi PP, Rengo G. Impact of the number of comorbidities on cardiac sympathetic derangement in patients with reduced ejection fraction heart failure. Eur J Intern Med 2021;86:86-90. [PMID: 33485737 DOI: 10.1016/j.ejim.2021.01.010] [Reference Citation Analysis]
182 Mullens W, Auricchio A, Martens P, Witte K, Cowie MR, Delgado V, Dickstein K, Linde C, Vernooy K, Leyva F, Bauersachs J, Israel CW, Lund LH, Donal E, Boriani G, Jaarsma T, Berruezo A, Traykov V, Yousef Z, Kalarus Z, Nielsen JC, Steffel J, Vardas P, Coats A, Seferovic P, Edvardsen T, Heidbuchel H, Ruschitzka F, Leclercq C. Optimized implementation of cardiac resynchronization therapy: a call for action for referral and optimization of care. Europace 2021:euaa411. [PMID: 34037728 DOI: 10.1093/europace/euaa411] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
183 Khan MS, Samman Tahhan A, Vaduganathan M, Greene SJ, Alrohaibani A, Anker SD, Vardeny O, Fonarow GC, Butler J. Trends in prevalence of comorbidities in heart failure clinical trials. Eur J Heart Fail 2020;22:1032-42. [PMID: 32293090 DOI: 10.1002/ejhf.1818] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 8.5] [Reference Citation Analysis]
184 Harjola VP, Giannakoulas G, von Lewinski D, Matskeplishvili S, Mebazaa A, Papp Z, Schwinger RHG, Pollesello P, Parissis JT. Use of levosimendan in acute heart failure. Eur Heart J Suppl 2018;20:I2-I10. [PMID: 30555279 DOI: 10.1093/eurheartj/suy039] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
185 Liao CT, Yang CT, Toh HS, Chang WT, Chang HY, Kuo FH, Lee MC, Hua YM, Tang HJ, Strong C, Ou HT. Cost-effectiveness evaluation of add-on dapagliflozin for heart failure with reduced ejection fraction from perspective of healthcare systems in Asia-Pacific region. Cardiovasc Diabetol 2021;20:204. [PMID: 34627231 DOI: 10.1186/s12933-021-01387-3] [Reference Citation Analysis]
186 Myhre PL, Januzzi JL Jr, Butler J, Vaduganathan M. De novo heart failure: where the journey begins. Eur J Heart Fail 2019;21:1245-7. [PMID: 31496006 DOI: 10.1002/ejhf.1586] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
187 Park C, Won MH, Son YJ. Mediating effects of social support between Type D personality and self-care behaviours among heart failure patients. J Adv Nurs 2021;77:1315-24. [PMID: 33249650 DOI: 10.1111/jan.14682] [Reference Citation Analysis]
188 Yandrapalli S, Khan MH, Rochlani Y, Aronow WS. Sacubitril/valsartan in cardiovascular disease: evidence to date and place in therapy. Ther Adv Cardiovasc Dis 2018;12:217-31. [PMID: 29921166 DOI: 10.1177/1753944718784536] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
189 Hao Y, Zhang L, Zhang Z, Chen L, He N, Zhu S. Tai Chi exercise and functional electrical stimulation of lower limb muscles for rehabilitation in older adults with chronic systolic heart failure: a non-randomized clinical trial. Braz J Med Biol Res 2019;52:e8786. [PMID: 31778439 DOI: 10.1590/1414-431X20198786] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
190 Mullens W, Damman K, Harjola VP, Mebazaa A, Brunner-La Rocca HP, Martens P, Testani JM, Tang WHW, Orso F, Rossignol P, Metra M, Filippatos G, Seferovic PM, Ruschitzka F, Coats AJ. The use of diuretics in heart failure with congestion - a position statement from the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2019;21:137-155. [PMID: 30600580 DOI: 10.1002/ejhf.1369] [Cited by in Crossref: 218] [Cited by in F6Publishing: 157] [Article Influence: 72.7] [Reference Citation Analysis]
191 Vitale C, Spoletini I, Rosano GM. Frailty in Heart Failure: Implications for Management. Card Fail Rev 2018;4:104-6. [PMID: 30206485 DOI: 10.15420/cfr.2018.22.2] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 7.0] [Reference Citation Analysis]
192 Kolentinis M, Le M, Nagel E, Puntmann VO. Contemporary Cardiac MRI in Chronic Coronary Artery Disease. Eur Cardiol 2020;15:e50. [PMID: 32612708 DOI: 10.15420/ecr.2019.17] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
193 Nabati M, Namazi SS, Yazdani J, Sharif Nia H. Relation Between Aortic Stiffness Index and Distensibility with Age in Hypertensive Patients. Int J Gen Med 2020;13:297-303. [PMID: 32606894 DOI: 10.2147/IJGM.S253357] [Reference Citation Analysis]
194 Kresoja K, Lauten A, Orban M, Rommel K, Alushi B, Besler C, Braun D, Unterhuber M, Stangl K, Landmesser U, Massberg S, Thiele H, Hausleiter J, Lurz P. Transcatheter tricuspid valve repair in the setting of heart failure with preserved or reduced left ventricular ejection fraction. Eur J Heart Fail 2020;22:1817-25. [DOI: 10.1002/ejhf.1975] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
195 Arshi B, van den Berge JC, van Dijk B, Deckers JW, Ikram MA, Kavousi M. Implications of the ACC/AHA risk score for prediction of heart failure: the Rotterdam Study. BMC Med 2021;19:43. [PMID: 33588853 DOI: 10.1186/s12916-021-01916-7] [Reference Citation Analysis]
196 Kobayashi M, Rossignol P, Ferreira JP, Aragão I, Paku Y, Iwasaki Y, Watanabe M, Fudim M, Duarte K, Zannad F, Girerd N. Prognostic value of estimated plasma volume in acute heart failure in three cohort studies. Clin Res Cardiol 2019;108:549-61. [DOI: 10.1007/s00392-018-1385-1] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
197 Bo B, Zhou Y, Zheng Q, Wang G, Zhou K, Wei J. The Molecular Mechanisms Associated with Aerobic Exercise-Induced Cardiac Regeneration. Biomolecules 2020;11:E19. [PMID: 33375497 DOI: 10.3390/biom11010019] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
198 Adamson C, Jhund PS, Docherty KF, Bělohlávek J, Chiang CE, Diez M, Drożdż J, Dukát A, Howlett J, Ljungman CEA, Petrie MC, Schou M, Inzucchi SE, Køber L, Kosiborod MN, Martinez FA, Ponikowski P, Sabatine MS, Solomon SD, Bengtsson O, Langkilde AM, Lindholm D, Sjöstrand M, McMurray JJV. Efficacy of dapagliflozin in heart failure with reduced ejection fraction according to body mass index. Eur J Heart Fail 2021. [PMID: 34272791 DOI: 10.1002/ejhf.2308] [Reference Citation Analysis]
199 Borovac JA, Glavas D, Bozic J, Novak K. Predicting the 1-Year All-Cause Mortality After Hospitalisation for an Acute Heart Failure Event: A Real-World Derivation Cohort for the Development of the S2PLiT-UG Score. Heart Lung Circ 2020;29:687-95. [PMID: 31122839 DOI: 10.1016/j.hlc.2019.03.021] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
200 Scali MC, Cortigiani L, Simionuc A, Gregori D, Marzilli M, Picano E. Exercise-induced B-lines identify worse functional and prognostic stage in heart failure patients with depressed left ventricular ejection fraction. Eur J Heart Fail 2017;19:1468-78. [PMID: 28198075 DOI: 10.1002/ejhf.776] [Cited by in Crossref: 52] [Cited by in F6Publishing: 41] [Article Influence: 10.4] [Reference Citation Analysis]
201 Filomena D, Cimino S, Monosilio S, Galea N, Mancuso G, Francone M, Tonti G, Pedrizzetti G, Maestrini V, Fedele F, Agati L. Impact of intraventricular haemodynamic forces misalignment on left ventricular remodelling after myocardial infarction. ESC Heart Fail 2021. [PMID: 34939359 DOI: 10.1002/ehf2.13719] [Reference Citation Analysis]
202 Moura B, Aimo A, Al-Mohammad A, Flammer A, Barberis V, Bayes-Genis A, Brunner-La Rocca HP, Fontes-Carvalho R, Grapsa J, Hülsmann M, Ibrahim N, Knackstedt C, Januzzi JL, Lapinskas T, Sarrias A, Matskeplishvili S, Meijers WC, Messroghli D, Mueller C, Pavo N, Simonavičius J, Teske AJ, van Kimmenade R, Seferovic P, Coats AJS, Emdin M, Richards AM. Integration of imaging and circulating biomarkers in heart failure: a consensus document by the Biomarkers and Imaging Study Groups of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 2021;23:1577-96. [PMID: 34482622 DOI: 10.1002/ejhf.2339] [Reference Citation Analysis]
203 Cuthbert JJ, Kearsley JW, Kazmi S, Kallvikbakka-Bennett A, Weston J, Davis J, Rimmer S, Clark AL. The impact of heart failure and chronic obstructive pulmonary disease on mortality in patients presenting with breathlessness. Clin Res Cardiol 2019;108:185-93. [PMID: 30091083 DOI: 10.1007/s00392-018-1342-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
204 Rossini R, Iorio A. The gap in heart failure: Understanding pulse pressure across heart failure phenotypes in the real world. Int J Cardiol 2018;254:254-5. [PMID: 29407103 DOI: 10.1016/j.ijcard.2017.12.024] [Reference Citation Analysis]
205 Lin SN, Phang KK, Toh SH, Chee KH, Zaman Huri H. Heart Failure With Type 2 Diabetes Mellitus: Association Between Antihyperglycemic Agents, Glycemic Control, and Ejection Fraction. Front Endocrinol (Lausanne) 2020;11:448. [PMID: 32754118 DOI: 10.3389/fendo.2020.00448] [Reference Citation Analysis]
206 Felker GM, Borentain M, Cleland JG, DeSouza MM, Kessler PD, O'Connor CM, Seiffert D, Teerlink JR, Voors AA, McMurray JJV. Rationale and design for the development of a novel nitroxyl donor in patients with acute heart failure. Eur J Heart Fail 2019;21:1022-31. [PMID: 31168885 DOI: 10.1002/ejhf.1504] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
207 Paolillo S, Mapelli M, Bonomi A, Corrà U, Piepoli M, Veglia F, Salvioni E, Gentile P, Lagioia R, Metra M, Limongelli G, Sinagra G, Cattadori G, Scardovi AB, Carubelli V, Scrutino D, Badagliacca R, Raimondo R, Emdin M, Magrì D, Correale M, Parati G, Caravita S, Spadafora E, Re F, Cicoira M, Frigerio M, Bussotti M, Minà C, Oliva F, Battaia E, Belardinelli R, Mezzani A, Pastormerlo L, Di Lenarda A, Passino C, Sciomer S, Iorio A, Zambon E, Guazzi M, Pacileo G, Ricci R, Contini M, Apostolo A, Palermo P, Clemenza F, Marchese G, Binno S, Lombardi C, Passantino A, Perrone Filardi P, Agostoni P. Prognostic role of β-blocker selectivity and dosage regimens in heart failure patients. Insights from the MECKI score database. Eur J Heart Fail 2017;19:904-14. [PMID: 28233458 DOI: 10.1002/ejhf.775] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
208 Jiang H, Holm J, Friberg Ö, Vanky F, Vidlund M, Tajik B, Yang Y, Svedjeholm R. Utility of NT-proBNP as an objective marker of postoperative heart failure after coronary artery bypass surgery: a prospective observational study. Perioper Med (Lond) 2021;10:21. [PMID: 34253255 DOI: 10.1186/s13741-021-00194-4] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
209 Pitt B, Bushinsky DA, Kitzman DW, Ruschitzka F, Metra M, Filippatos G, Rossignol P, Du Mond C, Garza D, Berman L, Lainscak M; Patiromer-204 Investigators. Evaluation of an individualized dose titration regimen of patiromer to prevent hyperkalaemia in patients with heart failure and chronic kidney disease. ESC Heart Fail 2018;5:257-66. [PMID: 29369537 DOI: 10.1002/ehf2.12265] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 8.0] [Reference Citation Analysis]
210 Fayssoil A, Abasse S, Silverston K. Cardiac Involvement Classification and Therapeutic Management in Patients with Duchenne Muscular Dystrophy. J Neuromuscul Dis. 2017;4:17-23. [PMID: 28269790 DOI: 10.3233/jnd-160194] [Cited by in Crossref: 23] [Cited by in F6Publishing: 14] [Article Influence: 5.8] [Reference Citation Analysis]
211 Roset A, Jacob J, Herrero-Puente P, Alquézar A, Martín-Sanchez FJ, Llorens P, Llauger L, Gil V, Miró Ò; ICA-SEMES research group. Characteristics and prognosis of patients with acute heart failure without troponin determination: The EAHFE-TROPICA3 study. Arch Cardiovasc Dis 2019;112:390-9. [PMID: 31014989 DOI: 10.1016/j.acvd.2019.02.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
212 Titz M, Schwameis M, Kienbacher C, Buchtele N, Roth D, Duma A, Nagele P, Schörgenhofer C, Herkner H. Generalisability of randomised trials evaluating perioperative β-blocker therapy in noncardiac surgery. Br J Anaesth 2020;125:926-34. [PMID: 32888632 DOI: 10.1016/j.bja.2020.08.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
213 Jorsal A, Pryds K, Mcmurray JJV, Wiggers H, Sommer A, Nielsen JC, Nielsen RR. Optimizing heart failure treatment following cardiac resynchronization therapy. Clin Res Cardiol 2020;109:638-45. [DOI: 10.1007/s00392-019-01553-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
214 Adamo M, Fiorelli F, Melica B, D'Ortona R, Lupi L, Giannini C, Silva G, Fiorina C, Branca L, Chiari E, Chizzola G, Spontoni P, Espada Guerreiro C, Curello S, Petronio AS, Metra M. COAPT-Like Profile Predicts Long-Term Outcomes in Patients With Secondary Mitral Regurgitation Undergoing MitraClip Implantation. JACC Cardiovasc Interv 2021;14:15-25. [PMID: 33309313 DOI: 10.1016/j.jcin.2020.09.050] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
215 Kessing D, Denollet J, Widdershoven J, Kupper N. Self-Care and Pathophysiological Function in Patients with Chronic Heart Failure. Int J Behav Med 2019;26:629-44. [PMID: 31755034 DOI: 10.1007/s12529-019-09822-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
216 Seo M, Yamada T, Tamaki S, Watanabe T, Morita T, Furukawa Y, Kawasaki M, Kikuchi A, Kawai T, Abe M, Nakamura J, Yamamoto K, Kayama K, Kawahira M, Tanabe K, Kimura T, Ueda K, Sakamoto D, Sakata Y, Fukunami M. Prognostic significance of cardiac I-123-metaiodobenzylguanidine imaging in patients with reduced, mid-range, and preserved left ventricular ejection fraction admitted for acute decompensated heart failure: a prospective study in Osaka Prefectural Acute Heart Failure Registry (OPAR). Eur Heart J Cardiovasc Imaging. 2020;. [PMID: 32091079 DOI: 10.1093/ehjci/jeaa025] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
217 Mihos CG, Yucel E, Capoulade R, Orencole MP, Upadhyay GA, Santana O, Singh JP, Picard MH. Impact of cardiac resynchronization therapy on mitral valve apparatus geometry and clinical outcomes in patients with secondary mitral regurgitation. Echocardiography 2017;34:1561-7. [DOI: 10.1111/echo.13690] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
218 Zamirian M, Afsharizadeh F, Moaref A, Abtahi F, Amirmoezi F, Attar A. Reduced myocardial reserve in cirrhotic patients: an evaluation by dobutamine stress speckle tracking and tissue Doppler imaging (TDI) echocardiography. J Cardiovasc Thorac Res 2019;11:127-31. [PMID: 31384407 DOI: 10.15171/jcvtr.2019.22] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
219 Stavropoulos K, Imprialos KP, Doumas M. Sacubitril/valsartan instead of renin-angiotensin system inhibition alone: A step forward in resistant hypertension. J Clin Hypertens 2018;20:65-8. [DOI: 10.1111/jch.13146] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
220 Rossignol P, Williams B, Mayo MR, Warren S, Arthur S, Ackourey G, White WB, Agarwal R. Patiromer versus placebo to enable spironolactone use in patients with resistant hypertension and chronic kidney disease (AMBER): results in the pre-specified subgroup with heart failure. Eur J Heart Fail 2020;22:1462-71. [PMID: 32452085 DOI: 10.1002/ejhf.1860] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
221 Nagueh SF. Non-invasive assessment of left ventricular filling pressure: Non-invasive estimation of LV filling pressure. Eur J Heart Fail 2018;20:38-48. [DOI: 10.1002/ejhf.971] [Cited by in Crossref: 48] [Cited by in F6Publishing: 36] [Article Influence: 9.6] [Reference Citation Analysis]
222 Sousa MM, Almeida TDCF, Gouveia BLA, Freire MEM, Oliveira SHDS. Validation of persuasive audiovisual communication to reduce salt consumption by people with heart failure. Rev Esc Enferm USP 2021;55:e03751. [PMID: 34190894 DOI: 10.1590/S1980-220X2020006503751] [Reference Citation Analysis]
223 Madelaire C, Gustafsson F, Køber L, Torp-Pedersen C, Andersson C, Kristensen SL, Gislason G, Schou M. Identification of Patients with New-Onset Heart Failure and Reduced Ejection Fraction in Danish Administrative Registers. Clin Epidemiol 2020;12:589-94. [PMID: 32606984 DOI: 10.2147/CLEP.S251710] [Cited by in Crossref: 5] [Article Influence: 2.5] [Reference Citation Analysis]
224 Chapman B, DeVore AD, Mentz RJ, Metra M. Clinical profiles in acute heart failure: an urgent need for a new approach. ESC Heart Fail 2019;6:464-74. [PMID: 31021532 DOI: 10.1002/ehf2.12439] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
225 Brusich S, Zeljković I, Pavlovic N, Anić A, Jurišić Z, Židan D, Klasan M, Čubranić Z, Dickstein K, Linde C, Normand C, Manola S. Croatian National Data and Comparison with European Practice: Data from the Cardiac Resynchronization Therapy Survey II Multicenter Registry. Cardiol Res Pract 2018;2018:3479846. [PMID: 30498599 DOI: 10.1155/2018/3479846] [Reference Citation Analysis]
226 Bakker ALM, Mathijssen H, Azzahhafi J, Swaans MJ, Veltkamp M, Keijsers RGM, Akdim F, Post MC, Grutters JC. Effectiveness and safety of infliximab in cardiac Sarcoidosis. Int J Cardiol 2021;330:179-85. [PMID: 33582196 DOI: 10.1016/j.ijcard.2021.02.022] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
227 He C, Zhang S, He H, You Z, Lin X, Zhang L, Chen J, Lin K. Predictive value of plasma volume status for contrast-induced nephropathy in patients with heart failure undergoing PCI. ESC Heart Fail 2021;8:4873-81. [PMID: 34704403 DOI: 10.1002/ehf2.13681] [Reference Citation Analysis]
228 Wang MJ, Zheng YM, Jin HX. Ultrafiltration for patients with acute decompensated heart failure: A systematic review and meta-analysis. Medicine (Baltimore) 2021;100:e28029. [PMID: 34918656 DOI: 10.1097/MD.0000000000028029] [Reference Citation Analysis]
229 Nakamura T, Kamiya K, Hamazaki N, Matsuzawa R, Nozaki K, Ichikawa T, Yamashita M, Maekawa E, Reed JL, Noda C, Meguro K, Yamaoka-Tojo M, Matsunaga A, Ako J. Quadriceps Strength and Mortality in Older Patients With Heart Failure. Can J Cardiol 2021;37:476-83. [PMID: 32622879 DOI: 10.1016/j.cjca.2020.06.019] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
230 Shchekochikhin D, Nikiforova T, Shilova A, Nesterov A, Baturina O, Gognieva D, Kozlovskaya N, Syrkin A, Kopylov P. Evaluation of discriminative capacity of two formulas of CKD-EPI to predict complications after the first episode of heart failure with preserved ejection fraction. Int J Nephrol Renovasc Dis 2019;12:113-8. [PMID: 31190950 DOI: 10.2147/IJNRD.S196976] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
231 Feng S, Janwanishstaporn S, Teerlink JR, Metra M, Cotter G, Davison B, Felker GM, Filippatos G, Pang P, Ponikowski P, Sama IE, Voors AA, Greenberg B. Association of left ventricular ejection fraction with worsening renal function in patients with acute heart failure: insights from the RELAX-AHF-2 study. Eur J Heart Fail 2021;23:58-67. [PMID: 32964537 DOI: 10.1002/ejhf.2012] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
232 Ashraf H, Rosenthal JL. Right Heart Failure. Cardiology Clinics 2020;38:175-83. [DOI: 10.1016/j.ccl.2020.01.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
233 Bertoldi LF, Montisci A, Delmas C, Pappalardo F. Weaning from Impella and mobilization of Impella patients. Eur Heart J Suppl 2021;23:A41-5. [PMID: 33815014 DOI: 10.1093/eurheartj/suab008] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
234 Harjola VP, Mullens W, Banaszewski M, Bauersachs J, Brunner-La Rocca HP, Chioncel O, Collins SP, Doehner W, Filippatos GS, Flammer AJ, Fuhrmann V, Lainscak M, Lassus J, Legrand M, Masip J, Mueller C, Papp Z, Parissis J, Platz E, Rudiger A, Ruschitzka F, Schäfer A, Seferovic PM, Skouri H, Yilmaz MB, Mebazaa A. Organ dysfunction, injury and failure in acute heart failure: from pathophysiology to diagnosis and management. A review on behalf of the Acute Heart Failure Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). Eur J Heart Fail 2017;19:821-36. [PMID: 28560717 DOI: 10.1002/ejhf.872] [Cited by in Crossref: 127] [Cited by in F6Publishing: 101] [Article Influence: 25.4] [Reference Citation Analysis]
235 Rao P, Katz D, Hieda M, Sabe M. How to Manage Temporary Mechanical Circulatory Support Devices in the Critical Care Setting: Translating Physiology to the Bedside. Heart Fail Clin 2020;16:283-93. [PMID: 32503752 DOI: 10.1016/j.hfc.2020.03.001] [Reference Citation Analysis]
236 Li S, Li X. Prognostic Significance of Low Systolic Blood Pressure at Discharge in Patients with Heart Failure and Preserved Ejection Fraction. High Blood Press Cardiovasc Prev 2017;24:405-12. [PMID: 28725953 DOI: 10.1007/s40292-017-0223-2] [Reference Citation Analysis]
237 Jankowska EA, Drozd M, Ponikowski P. Iron Deficiency Treatment in Patients with Heart Failure. Handb Exp Pharmacol 2017;243:561-76. [PMID: 28405775 DOI: 10.1007/164_2017_30] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
238 Brandt MM, Nguyen ITN, Krebber MM, van de Wouw J, Mokry M, Cramer MJ, Duncker DJ, Verhaar MC, Joles JA, Cheng C. Limited synergy of obesity and hypertension, prevalent risk factors in onset and progression of heart failure with preserved ejection fraction. J Cell Mol Med 2019;23:6666-78. [PMID: 31368189 DOI: 10.1111/jcmm.14542] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
239 Hirsch VG, Tongers J, Bode J, Berliner D, Widder JD, Escher F, Mutsenko V, Chung B, Rostami F, Guba‐quint A, Giannitsis E, Schultheiss H, Vogt C, Bauersachs J, Wollert KC, Kempf T. Cardiac iron concentration in relation to systemic iron status and disease severity in non‐ischaemic heart failure with reduced ejection fraction. Eur J Heart Fail 2020;22:2038-46. [DOI: 10.1002/ejhf.1781] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 5.5] [Reference Citation Analysis]
240 Bratsos S. Efficacy of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor-Neprilysin Inhibitors in the Treatment of Chronic Heart Failure: A Review of Landmark Trials. Cureus. 2019;11:e3913. [PMID: 30931184 DOI: 10.7759/cureus.3913] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
241 Yang H, Tian J, Meng B, Wang K, Zheng C, Liu Y, Yan J, Han Q, Zhang Y. Application of Extreme Learning Machine in the Survival Analysis of Chronic Heart Failure Patients With High Percentage of Censored Survival Time. Front Cardiovasc Med 2021;8:726516. [PMID: 34778396 DOI: 10.3389/fcvm.2021.726516] [Reference Citation Analysis]
242 Peretto G, Barison A, Forleo C, Di Resta C, Esposito A, Aquaro GD, Scardapane A, Palmisano A, Emdin M, Resta N, Santoni A, Guaricci AI, Santobuono VE, Pepe M, Favale S, Ferrari M, Benedetti S, Della Bella P, Sala S. Late gadolinium enhancement role in arrhythmic risk stratification of patients with LMNA cardiomyopathy: results from a long-term follow-up multicentre study. EP Europace 2020;22:1864-72. [DOI: 10.1093/europace/euaa171] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
243 Mele D, Pestelli G, Molin DD, Trevisan F, Smarrazzo V, Luisi GA, Fucili A, Ferrari R. Echocardiographic Evaluation of Left Ventricular Output in Patients with Heart Failure: A Per-Beat or Per-Minute Approach? Journal of the American Society of Echocardiography 2020;33:135-147.e3. [DOI: 10.1016/j.echo.2019.09.009] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
244 Haberl T, Wiedemann D, Laufer G, Zimpfer D. Surgical Technique for Redo-Sternotomy Sparing Heartware HVAD Exchanges. Operative Techniques in Thoracic and Cardiovascular Surgery 2018;23:76-89. [DOI: 10.1053/j.optechstcvs.2018.11.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
245 Luan L, Hu H, Li SC. A Review of Studies of Quality of Life for Chinese-Speaking Patients with Ischemic Heart Disease. Value Health Reg Issues 2018;15:82-90. [PMID: 29474184 DOI: 10.1016/j.vhri.2017.08.013] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
246 Nicolas JD, Khan A, Markus A, Mohamed BA, Toischer K, Alves F, Salditt T. X-ray diffraction and second harmonic imaging reveal new insights into structural alterations caused by pressure-overload in murine hearts. Sci Rep 2020;10:19317. [PMID: 33168890 DOI: 10.1038/s41598-020-76163-6] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
247 Soloveva A, Fedorova D, Villevalde S, Zvartau N, Mareev Y, Sitnikova M, Shlyakhto E, Fudim M. Addressing Orthostatic Hypotension in Heart Failure: Pathophysiology, Clinical Implications and Perspectives. J Cardiovasc Transl Res 2020;13:549-69. [PMID: 32748206 DOI: 10.1007/s12265-020-10044-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
248 Barandiarán Aizpurua A, Franssen FME, van Empel V, Brunner-La Rocca HP. An old debate still in the β-phase? Eur J Heart Fail 2018;20:557-9. [PMID: 29327802 DOI: 10.1002/ejhf.1086] [Reference Citation Analysis]
249 Bitar S, Thilly N, Agrinier N. Sustained adherence to ESC guideline‐recommended medications is associated with lower long‐term mortality in heart failure and reduced ejection fraction: Insights from the EPICAL2 cohort. J Clin Pharm Ther 2020;45:793-803. [DOI: 10.1111/jcpt.13176] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
250 Raat W, Smeets M, Janssens S, Vaes B. Impact of primary care involvement and setting on multidisciplinary heart failure management: a systematic review and meta-analysis. ESC Heart Fail 2021;8:802-18. [PMID: 33405392 DOI: 10.1002/ehf2.13152] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
251 Khan MS, Samman Tahhan A, Vaduganathan M, Greene SJ, Alrohaibani A, Anker SD, Vardeny O, Fonarow GC, Butler J. Trends in prevalence of comorbidities in heart failure clinical trials. Eur J Heart Fail 2020;22:1032-42. [PMID: 32293090 DOI: 10.1002/ejhf.1818] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
252 Bahrmann P, Hardt R. [Chronic heart failure in older patients : Updated national healthcare guidelines on chronic heart failure from a geriatric perspective]. Z Gerontol Geriatr 2018;51:165-8. [PMID: 29374297 DOI: 10.1007/s00391-018-1371-2] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
253 van Boven N, Kardys I, van Vark LC, Akkerhuis KM, de Ronde MWJ, Khan MAF, Merkus D, Liu Z, Voors AA, Asselbergs FW, van den Bos EJ, Boersma E, Hillege H, Duncker DJ, Pinto YM, Postmus D. Serially measured circulating microRNAs and adverse clinical outcomes in patients with acute heart failure. Eur J Heart Fail 2018;20:89-96. [PMID: 28948688 DOI: 10.1002/ejhf.950] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 6.4] [Reference Citation Analysis]
254 Vergaro G, Sciarrone P, Prontera C, Masotti S, Musetti V, Valleggi A, Giannoni A, Senni M, Emdin M, Passino C. Renin profiling predicts neurohormonal response to sacubitril/valsartan. ESC Heart Fail 2021;8:719-24. [PMID: 33216460 DOI: 10.1002/ehf2.13085] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
255 Tennøe AH, Murbræch K, Andreassen JC, Fretheim H, Garen T, Gude E, Andreassen A, Aakhus S, Molberg Ø, Hoffmann-Vold AM. Left Ventricular Diastolic Dysfunction Predicts Mortality in Patients With Systemic Sclerosis. J Am Coll Cardiol 2018;72:1804-13. [PMID: 30286924 DOI: 10.1016/j.jacc.2018.07.068] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 9.3] [Reference Citation Analysis]
256 Muscari A, Bianchi G, Forti P, Magalotti D, Pandolfi P, Zoli M; Pianoro Study Group. The association of proBNPage with manifestations of age-related cardiovascular, physical, and psychological impairment in community-dwelling older adults. Geroscience 2021. [PMID: 33987773 DOI: 10.1007/s11357-021-00381-7] [Reference Citation Analysis]
257 Ekman I, Wolf A, Vaughan Dickson V, Bosworth HB, Granger BB. Unmet expectations of medications and care providers among patients with heart failure assessed to be poorly adherent: results from the Chronic Heart Failure Intervention to Improve MEdication Adherence (CHIME) study. European Journal of Cardiovascular Nursing 2017;16:646-54. [DOI: 10.1177/1474515117707669] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
258 Van Aelst LNL, Abraham M, Sadoune M, Lefebvre T, Manivet P, Logeart D, Launay JM, Karim Z, Puy H, Cohen-Solal A. Iron status and inflammatory biomarkers in patients with acutely decompensated heart failure: early in-hospital phase and 30-day follow-up. Eur J Heart Fail 2017;19:1075-6. [PMID: 28516737 DOI: 10.1002/ejhf.837] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
259 Pearson MJ, Mungovan SF, Smart NA. Effect of exercise on diastolic function in heart failure patients: a systematic review and meta-analysis. Heart Fail Rev 2017;22:229-42. [PMID: 28229273 DOI: 10.1007/s10741-017-9600-0] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
260 Persson HL, Lyth J, Lind L. The Health Diary Telemonitoring and Hospital-Based Home Care Improve Quality of Life Among Elderly Multimorbid COPD and Chronic Heart Failure Subjects. Int J Chron Obstruct Pulmon Dis 2020;15:527-41. [PMID: 32210547 DOI: 10.2147/COPD.S236192] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
261 Coats AJS. Drug dosing for heart failure: does sex or size matter? Nat Rev Cardiol 2019;16:705-6. [PMID: 31628437 DOI: 10.1038/s41569-019-0298-7] [Reference Citation Analysis]
262 Xiao P, Li H, Li X, Song D. Analytical barriers in clinical B-type natriuretic peptide measurement and the promising analytical methods based on mass spectrometry technology. Clinical Chemistry and Laboratory Medicine (CCLM) 2019;57:954-66. [DOI: 10.1515/cclm-2018-0956] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
263 Tesoro L, Ramirez-Carracedo R, Hernandez I, Diez-Mata J, Pascual M, Saura M, Sanmartin M, Zamorano JL, Zaragoza C. Ivabradine induces cardiac protection by preventing cardiogenic shock-induced extracellular matrix degradation. Rev Esp Cardiol (Engl Ed) 2020:S1885-5857(20)30415-1. [PMID: 33132099 DOI: 10.1016/j.rec.2020.09.012] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
264 Gierula J, Kearney MT, Witte KK. Devices in heart failure; diagnosis, detection and disease modification. Br Med Bull 2018;125:91-102. [PMID: 29342243 DOI: 10.1093/bmb/ldx051] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
265 Agasthi P, Lee JZ, Amin M, Al-Saffar F, Goel V, Tseng A, Almader-Douglas D, Killu AM, Deshmukh AJ, Del-Carpio Munoz F, Mulpuru SK. Catheter ablation for treatment of atrial fibrillation in patients with heart failure with reduced ejection fraction: A systematic review and meta-analysis. J Arrhythm 2019;35:171-81. [PMID: 31007780 DOI: 10.1002/joa3.12146] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
266 Di Bella G, Pizzino F, Aquaro GD, Piaggi P, Venuti G, Carerj S, Pingitore A. High-risk patients with mild-moderate left ventricular dysfunction after a previous myocardial infarction. A long-term prognostic data by cardiac magnetic resonance. Int J Cardiol 2017;245:13-9. [PMID: 28757089 DOI: 10.1016/j.ijcard.2017.07.064] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
267 Mullens W, Auricchio A, Martens P, Witte K, Cowie MR, Delgado V, Dickstein K, Linde C, Vernooy K, Leyva F, Bauersachs J, Israel CW, Lund LH, Donal E, Boriani G, Jaarsma T, Berruezo A, Traykov V, Yousef Z, Kalarus Z, Cosedis Nielsen J, Steffel J, Vardas P, Coats A, Seferovic P, Edvardsen T, Heidbuchel H, Ruschitzka F, Leclercq C. Optimized implementation of cardiac resynchronization therapy: a call for action for referral and optimization of care: A joint position statement from the Heart Failure Association (HFA), European Heart Rhythm Association (EHRA), and European Association of Cardiovascular Imaging (EACVI) of the European Society of Cardiology. Eur J Heart Fail 2020;22:2349-69. [PMID: 33136300 DOI: 10.1002/ejhf.2046] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 15.0] [Reference Citation Analysis]
268 Turcato G, Sanchis-Gomar F, Cervellin G, Zorzi E, Sivero V, Salvagno GL, Tenci A, Lippi G. Evaluation of Neutrophil-lymphocyte and Platelet-lymphocyte Ratios as Predictors of 30-day Mortality in Patients Hospitalized for an Episode of Acute Decompensated Heart Failure. J Med Biochem 2019;38:452-60. [PMID: 31496909 DOI: 10.2478/jomb-2018-0044] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
269 Wintrich J, Kindermann I, Böhm M. [Update on heart failure]. Herz 2020;45:158-69. [PMID: 29869700 DOI: 10.1007/s00059-018-4715-1] [Reference Citation Analysis]
270 Hamano T. Mineral and bone disorders in conventional hemodialysis: Challenges and solutions. Semin Dial 2018;31:592-8. [PMID: 29900589 DOI: 10.1111/sdi.12729] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
271 Klein P, Anker SD, Wechsler A, Skalsky I, Neuzil P, Annest LS, Bifi M, Mcdonagh T, Frerker C, Schmidt T, Sievert H, Demaria AN, Kelle S. Less invasive ventricular reconstruction for ischaemic heart failure. Eur J Heart Fail 2019;21:1638-50. [DOI: 10.1002/ejhf.1669] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 5.3] [Reference Citation Analysis]
272 Cherney DZI, Zinman B, Inzucchi SE, Koitka-Weber A, Mattheus M, von Eynatten M, Wanner C. Effects of empagliflozin on the urinary albumin-to-creatinine ratio in patients with type 2 diabetes and established cardiovascular disease: an exploratory analysis from the EMPA-REG OUTCOME randomised, placebo-controlled trial. Lancet Diabetes Endocrinol. 2017;5:610-621. [PMID: 28666775 DOI: 10.1016/s2213-8587(17)30182-1] [Cited by in Crossref: 189] [Cited by in F6Publishing: 81] [Article Influence: 37.8] [Reference Citation Analysis]
273 Sugiura A, Weber M, Tabata N, Goto T, Öztürk C, Lin M, Zimmer S, Nickenig G, Sinning JM. QRS duration is a risk indicator of adverse outcomes after MitraClip. Catheter Cardiovasc Interv 2021;98:E594-601. [PMID: 33527610 DOI: 10.1002/ccd.29505] [Reference Citation Analysis]
274 Lund LH. Improving long-term outcomes with left ventricular assist devices-referral, selection, experience, and technology: Editorial comment. Eur J Heart Fail 2019;21:101-2. [DOI: 10.1002/ejhf.1309] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
275 Löfman I, Szummer K, Dahlström U, Jernberg T, Lund LH. Associations with and prognostic impact of chronic kidney disease in heart failure with preserved, mid-range, and reduced ejection fraction: Associations with and prognostic impact of CKD in HF. Eur J Heart Fail 2017;19:1606-14. [DOI: 10.1002/ejhf.821] [Cited by in Crossref: 71] [Cited by in F6Publishing: 62] [Article Influence: 14.2] [Reference Citation Analysis]
276 Noto T, Zhou G, Schuele S, Templer J, Zelano C. Automated analysis of breathing waveforms using BreathMetrics: a respiratory signal processing toolbox. Chem Senses 2018;43:583-97. [PMID: 29985980 DOI: 10.1093/chemse/bjy045] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
277 Trevisan M, de Deco P, Xu H, Evans M, Lindholm B, Bellocco R, Barany P, Jernberg T, Lund LH, Carrero JJ. Incidence, predictors and clinical management of hyperkalaemia in new users of mineralocorticoid receptor antagonists. Eur J Heart Fail 2018;20:1217-26. [PMID: 29667759 DOI: 10.1002/ejhf.1199] [Cited by in Crossref: 55] [Cited by in F6Publishing: 48] [Article Influence: 13.8] [Reference Citation Analysis]
278 Ovsenik A, Podbregar M, Fabjan A. Cerebral blood flow impairment and cognitive decline in heart failure. Brain Behav 2021;11:e02176. [PMID: 33991075 DOI: 10.1002/brb3.2176] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
279 Tsai JP, Sung KT, Su CH, Lai YH, Kuo JY, Yun CH, Yen CH, Hou CJ, Wu TH, Peng MC, Hung TC, Yeh HI, Hung CL. Diagnostic accuracy of left atrial remodelling and natriuretic peptide levels for preclinical heart failure. ESC Heart Fail 2019;6:723-32. [PMID: 30993903 DOI: 10.1002/ehf2.12430] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
280 Ferreira JP, Mogensen UM, Jhund PS, Desai AS, Rouleau JL, Zile MR, Rossignol P, Zannad F, Packer M, Solomon SD, McMurray JJV. Serum potassium in the PARADIGM-HF trial. Eur J Heart Fail 2020;22:2056-64. [PMID: 32809261 DOI: 10.1002/ejhf.1987] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
281 De Pooter J, Kamoen V, El Haddad M, Stroobandt R, De Buyzere M, Jordaens L, Timmermans F. Gender differences in electro-mechanical characteristics of left bundle branch block: Potential implications for selection and response of cardiac resynchronization therapy. International Journal of Cardiology 2018;257:84-91. [DOI: 10.1016/j.ijcard.2017.10.055] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 2.8] [Reference Citation Analysis]
282 Zhao G. Significance of non-coding circular RNAs and micro RNAs in the pathogenesis of cardiovascular diseases. J Med Genet 2018;55:713-20. [PMID: 30177556 DOI: 10.1136/jmedgenet-2018-105387] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
283 Leite AR, Neves JS, Borges-Canha M, Vale C, von Hafe M, Carvalho D, Leite-Moreira A. Evaluation of Thyroid Function in Patients Hospitalized for Acute Heart Failure. Int J Endocrinol 2021;2021:6616681. [PMID: 33859686 DOI: 10.1155/2021/6616681] [Reference Citation Analysis]
284 Binder C, Poglitsch M, Duca F, Rettl R, Dachs TM, Dalos D, Schrutka L, Seirer B, Ligios LC, Capelle C, Eslam RB, Qin H, Hengstenberg C, Bonderman D. Renin Feedback Is an Independent Predictor of Outcome in HFpEF. J Pers Med 2021;11:370. [PMID: 34063595 DOI: 10.3390/jpm11050370] [Reference Citation Analysis]
285 Kurata Y, Muraki S, Hirota T, Araki H, Ieiri I. Reduced theophylline clearance due to hepatic congestion secondary to right heart failure - A population pharmacokinetic study. Drug Metab Pharmacokinet 2021;41:100403. [PMID: 34619548 DOI: 10.1016/j.dmpk.2021.100403] [Reference Citation Analysis]
286 Kapłon-Cieślicka A, Lund LH. Do we need a definition of acute heart failure with preserved ejection fraction? Ann Med 2021;53:1470-5. [PMID: 34431429 DOI: 10.1080/07853890.2021.1968028] [Reference Citation Analysis]
287 Bauersachs J, Veltmann C. Heart rate control in heart failure with reduced ejection fraction: the bright and the dark side of the moon. Eur J Heart Fail 2020;22:539-42. [DOI: 10.1002/ejhf.1733] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
288 Papoutsi C, A'Court C, Wherton J, Shaw S, Greenhalgh T. Explaining the mixed findings of a randomised controlled trial of telehealth with centralised remote support for heart failure: multi-site qualitative study using the NASSS framework. Trials 2020;21:891. [PMID: 33109254 DOI: 10.1186/s13063-020-04817-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
289 Aimo A, Valleggi A, Barison A, Salerni S, Emdin M, Aquaro GD. Morphologies and prognostic significance of left ventricular volume/time curves with cardiac magnetic resonance in patients with non-ischaemic heart failure and left bundle branch block. Int J Cardiovasc Imaging 2021;37:2245-55. [PMID: 33635416 DOI: 10.1007/s10554-021-02194-3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
290 Hage C, LÖfstrÖm U, Donal E, Oger E, KapŁon-CieŚlicka A, Daubert JC, Linde C, Lund LH. Do Patients With Acute Heart Failure and Preserved Ejection Fraction Have Heart Failure at Follow-Up: Implications of the Framingham Criteria. J Card Fail 2020;26:673-84. [PMID: 31035008 DOI: 10.1016/j.cardfail.2019.04.013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
291 Passantino A, Guida P, Parisi G, Iacoviello M, Scrutinio D. Critical Appraisal of Multivariable Prognostic Scores in Heart Failure: Development, Validation and Clinical Utility. Adv Exp Med Biol 2018;1067:387-403. [PMID: 29260415 DOI: 10.1007/5584_2017_135] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
292 Madelaire C, Gustafsson F, Kristensen SL, D’souza M, Stevenson LW, Kober L, Torp-pedersen C, Gislason G, Schou M. Burden and Causes of Hospital Admissions in Heart Failure During the Last Year of Life. JACC: Heart Failure 2019;7:561-70. [DOI: 10.1016/j.jchf.2019.03.018] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
293 Maymon SL, Moravsky G, Marcus G, Shuvy M, Pereg D, Epstein D, Litovchik I, Fuchs S, Minha S. Disparities in the characteristics and outcomes of patients hospitalized with acute decompensated heart failure admitted to internal medicine and cardiology departments: a single-centre, retrospective cohort study. ESC Heart Fail 2021;8:390-8. [PMID: 33232585 DOI: 10.1002/ehf2.13084] [Reference Citation Analysis]
294 Rusnak J, Behnes M, Schupp T, Weiß C, Nienaber C, Lang S, Reiser L, Bollow A, Taton G, Reichelt T, Ellguth D, Engelke N, Ansari U, El-Battrawy I, Bertsch T, Akin M, Mashayekhi K, Borggrefe M, Akin I. Comparable survival in ischemic and nonischemic cardiomyopathy secondary to ventricular tachyarrhythmias and aborted cardiac arrest. Coron Artery Dis 2019;30:303-11. [PMID: 30896453 DOI: 10.1097/MCA.0000000000000738] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
295 Lyon AR. Heart failure resulting from cancer treatment: still serious but an opportunity for prevention. Heart 2018;105:6-8. [DOI: 10.1136/heartjnl-2018-313493] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
296 Krueger K, Griese-mammen N, Schubert I, Kieble M, Botermann L, Laufs U, Kloft C, Schulz M. In search of a standard when analyzing medication adherence in patients with heart failure using claims data: a systematic review. Heart Fail Rev 2018;23:63-71. [DOI: 10.1007/s10741-017-9656-x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
297 Neuendorff NR, Loh KP, Mims AS, Christofyllakis K, Soo WK, Bölükbasi B, Oñoro-Algar C, Hundley WG, Klepin HD. Anthracycline-related cardiotoxicity in older patients with acute myeloid leukemia: a Young SIOG review paper. Blood Adv 2020;4:762-75. [PMID: 32097461 DOI: 10.1182/bloodadvances.2019000955] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
298 Fröhlich H, Rosenfeld N, Täger T, Goode K, Kazmi S, Hole T, Katus HA, Atar D, Cleland JGF, Agewall S, Clark AL, Frankenstein L, Grundtvig M. Epidemiology and long-term outcome in outpatients with chronic heart failure in Northwestern Europe. Heart 2019;105:1252-9. [PMID: 30792238 DOI: 10.1136/heartjnl-2018-314256] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
299 Sun J, Xu W, Hua H, Xiao Y, Chen X, Gao Z, Li S, Jing X, Du F, Sun G. Pharmacodynamic and pharmacokinetic effects of S086, a novel angiotensin receptor neprilysin inhibitor. Biomed Pharmacother 2020;129:110410. [PMID: 32570118 DOI: 10.1016/j.biopha.2020.110410] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
300 Chen J, Chen S, Zhang B, Liu J. SIRT3 as a potential therapeutic target for heart failure. Pharmacol Res 2021;165:105432. [PMID: 33508434 DOI: 10.1016/j.phrs.2021.105432] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
301 Jansen SMA, Huis In 't Veld AE, Jacobs W, Grotjohan HP, Waskowsky M, van der Maten J, van der Weerdt A, Hoekstra R, Overbeek MJ, Mollema SA, Tolen PHCG, Hassan El Bouazzaoui LH, Vriend JWJ, Roorda JMM, de Nooijer R, van der Lee I, Voogel BAJ, Peels K, Macken T, Aerts JM, Vonk Noordegraaf A, Handoko ML, de Man FS, Bogaard HJ. Noninvasive Prediction of Elevated Wedge Pressure in Pulmonary Hypertension Patients Without Clear Signs of Left-Sided Heart Disease: External Validation of the OPTICS Risk Score. J Am Heart Assoc 2020;9:e015992. [PMID: 32750312 DOI: 10.1161/JAHA.119.015992] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
302 Byrd JB, Newby DE, Anderson JA, Calverley PMA, Celli BR, Cowans NJ, Crim C, Martinez FJ, Vestbo J, Yates J, Brook RD; SUMMIT Investigators. Blood pressure, heart rate, and mortality in chronic obstructive pulmonary disease: the SUMMIT trial. Eur Heart J 2018;39:3128-34. [PMID: 30101300 DOI: 10.1093/eurheartj/ehy451] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
303 Ponikowski P, Alemayehu W, Oto A, Bahit MC, Noori E, Patel MJ, Butler J, Ezekowitz JA, Hernandez AF, Lam CSP, O'Connor CM, Pieske B, Roessig L, Voors AA, Westerhout C, Armstrong PW; VICTORIA Study Group. Vericiguat in patients with atrial fibrillation and heart failure with reduced ejection fraction: insights from the VICTORIA trial. Eur J Heart Fail 2021;23:1300-12. [PMID: 34191395 DOI: 10.1002/ejhf.2285] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
304 Tóth N, Soós A, Váradi A, Hegyi P, Tinusz B, Vágvölgyi A, Orosz A, Solymár M, Polyák A, Varró A, Farkas AS, Nagy N. Effect of ivabradine in heart failure: a meta-analysis of heart failure patients with reduced versus preserved ejection fraction. Can J Physiol Pharmacol 2021;99:1159-74. [PMID: 34636643 DOI: 10.1139/cjpp-2020-0700] [Reference Citation Analysis]
305 Cooper LB, Hernandez AF. Maximizing benefits and mitigating risks with mineralocorticoid receptor antagonist therapy: Editorial comment. Eur J Heart Fail 2018;20:1227-9. [DOI: 10.1002/ejhf.1221] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
306 Roura S, Rudilla F, Gastelurrutia P, Enrich E, Campos E, Lupón J, Santiago-Vacas E, Querol S, Bayés-Genís A. Determination of HLA-A, -B, -C, -DRB1 and -DQB1 allele and haplotype frequencies in heart failure patients. ESC Heart Fail 2019;6:388-95. [PMID: 30672659 DOI: 10.1002/ehf2.12406] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
307 Xin Y, Chen X, Zhao Y, Hu W. The impact of heart rate on patients diagnosed with heart failure with mid-range ejection fraction. Anatol J Cardiol 2019;21:68-74. [PMID: 30520426 DOI: 10.14744/AnatolJCardiol.2018.38364] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
308 Deka P, Almenar L, Pathak D, Klompstra L, López-Vilella R, Marques-Sule E. Depression mediates physical activity readiness and physical activity in patients with heart failure. ESC Heart Fail 2021. [PMID: 34523268 DOI: 10.1002/ehf2.13609] [Reference Citation Analysis]
309 Surkova E, Muraru D, Genovese D, Aruta P, Palermo C, Badano LP. Relative Prognostic Importance of Left and Right Ventricular Ejection Fraction in Patients With Cardiac Diseases. Journal of the American Society of Echocardiography 2019;32:1407-1415.e3. [DOI: 10.1016/j.echo.2019.06.009] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 5.7] [Reference Citation Analysis]
310 Campbell RT, Petrie MC, Mcmurray JJ. Redefining heart failure phenotypes based on ejection fraction. Eur J Heart Fail 2018;20:1634-5. [DOI: 10.1002/ejhf.1325] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
311 Lauritsen J, Gustafsson F, Abdulla J. Characteristics and long-term prognosis of patients with heart failure and mid-range ejection fraction compared with reduced and preserved ejection fraction: a systematic review and meta-analysis. ESC Heart Fail 2018;5:685-94. [PMID: 29660263 DOI: 10.1002/ehf2.12283] [Cited by in Crossref: 36] [Cited by in F6Publishing: 29] [Article Influence: 9.0] [Reference Citation Analysis]
312 Lemay S, Massot M, Philippon F, Belzile D, Turgeon PY, Beaudoin J, Laliberté C, Fortin S, Dion G, Milot J, Trottier M, Gosselin J, Charbonneau É, Birnie DH, Sénéchal M. Ten Questions Cardiologists Should Be Able to Answer About Cardiac Sarcoidosis: Case-Based Approach and Contemporary Review. CJC Open 2021;3:532-48. [PMID: 34027358 DOI: 10.1016/j.cjco.2020.11.022] [Reference Citation Analysis]
313 Lin S, Shi Q, Ge Z, Liu Y, Cao Y, Yang Y, Zhao Z, Bi Y, Hou Y, Wang S, Wang X, Mao J. Efficacy and Safety of Traditional Chinese Medicine Injections for Heart Failure With Reduced Ejection Fraction: A Bayesian Network Meta-Analysis of Randomized Controlled Trials. Front Pharmacol 2021;12:659707. [PMID: 34916929 DOI: 10.3389/fphar.2021.659707] [Reference Citation Analysis]
314 Fong MC, Chang HY, Wang CC, Feng AN, Lin WS, Wu YW, Sung SH, Huang JL, Kuo JY, Yin WH. The Characteristics and Outcomes of Patients with Heart Failure and Reduced Ejection Fraction: The Eligibility of Novel Heart Failure Medications. Acta Cardiol Sin 2021;37:394-403. [PMID: 34257489 DOI: 10.6515/ACS.202107_37(4).20201223A] [Reference Citation Analysis]
315 Kaye DM, Petrie MC, McKenzie S, Hasenfuβ G, Malek F, Post M, Doughty RN, Trochu JN, Gustafsson F, Lang I, Kolodziej A, Westenfeld R, Penicka M, Rosenberg M, Hausleiter J, Raake P, Jondeau G, Bergmann MW, Spelman T, Aytug H, Ponikowski P, Hayward C; REDUCE LAP-HF study investigators. Impact of an interatrial shunt device on survival and heart failure hospitalization in patients with preserved ejection fraction. ESC Heart Fail 2019;6:62-9. [PMID: 30311437 DOI: 10.1002/ehf2.12350] [Cited by in Crossref: 26] [Cited by in F6Publishing: 17] [Article Influence: 6.5] [Reference Citation Analysis]
316 Sarafidis PA, Memmos E, Alexandrou ME, Papagianni A. Mineralocorticoid Receptor Antagonists for Nephroprotection: Current Evidence and Future Perspectives. Curr Pharm Des 2018;24:5528-36. [PMID: 30848187 DOI: 10.2174/1381612825666190306162658] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
317 Soenarta AA, Buranakitjaroen P, Chia Y, Chen C, Nailes J, Hoshide S, Minh HV, Park S, Shin J, Siddique S, Sison J, Sogunuru GP, Sukonthasarn A, Tay JC, Teo BW, Turana Y, Verma N, Wang T, Zhang Y, Wang J, Kario K. An overview of hypertension and cardiac involvement in Asia: Focus on heart failure. J Clin Hypertens 2020;22:423-30. [DOI: 10.1111/jch.13753] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
318 Sica DA, Gehr TW, Frishman WH. Use of Diuretics in the Treatment of Heart Failure in Older Adults. Heart Failure Clinics 2017;13:503-12. [DOI: 10.1016/j.hfc.2017.02.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
319 Castiglione V, Aimo A, Vergaro G, Saccaro L, Passino C, Emdin M. Biomarkers for the diagnosis and management of heart failure. Heart Fail Rev 2021. [PMID: 33852110 DOI: 10.1007/s10741-021-10105-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
320 Lainscak M, Omersa D, Rosano G, Farkas J, Böhm M. Pharmacotherapy adherence in patients with heart failure: Easier said than done. Int J Cardiol 2021;332:135-7. [PMID: 33785392 DOI: 10.1016/j.ijcard.2021.03.051] [Reference Citation Analysis]
321 Hu J, Wan Q, Zhang Y, Zhou J, Li M, Jiang L, Yuan F. Efficacy and safety of early ultrafiltration in patients with acute decompensated heart failure with volume overload: a prospective, randomized, controlled clinical trial. BMC Cardiovasc Disord 2020;20:447. [PMID: 33054727 DOI: 10.1186/s12872-020-01733-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
322 Vuori MA, Laukkanen JA, Pietilä A, Havulinna AS, Kähönen M, Salomaa V, Niiranen TJ; FinnGen investigators. The validity of heart failure diagnoses in the Finnish Hospital Discharge Register. Scand J Public Health 2020;48:20-8. [PMID: 31068116 DOI: 10.1177/1403494819847051] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
323 Campodonico J, Piepoli M, Clemenza F, Bonomi A, Paolillo S, Salvioni E, Corrà U, Binno S, Veglia F, Lagioia R, Sinagra G, Cattadori G, Scardovi AB, Metra M, Senni M, Scrutinio D, Raimondo R, Emdin M, Magrì D, Parati G, Re F, Cicoira M, Minà C, Limongelli G, Correale M, Frigerio M, Bussotti M, Perna E, Battaia E, Guazzi M, Badagliacca R, Di Lenarda A, Maggioni A, Passino C, Sciomer S, Pacileo G, Mapelli M, Vignati C, Lombardi C, Filardi PP, Agostoni P. Dose-dependent efficacy of β-blocker in patients with chronic heart failure and atrial fibrillation. International Journal of Cardiology 2018;273:141-6. [DOI: 10.1016/j.ijcard.2018.08.012] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
324 Wang Y, Wang Y, Adi D, He X, Liu F, Abudesimu A, Fu Z, Ma Y. Dab2 gene variant is associated with increased coronary artery disease risk in Chinese Han population. Medicine (Baltimore) 2020;99:e20924. [PMID: 32629690 DOI: 10.1097/MD.0000000000020924] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
325 Pieske B, Tschöpe C, de Boer RA, Fraser AG, Anker SD, Donal E, Edelmann F, Fu M, Guazzi M, Lam CSP, Lancellotti P, Melenovsky V, Morris DA, Nagel E, Pieske-Kraigher E, Ponikowski P, Solomon SD, Vasan RS, Rutten FH, Voors AA, Ruschitzka F, Paulus WJ, Seferovic P, Filippatos G. How to diagnose heart failure with preserved ejection fraction: the HFA-PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). Eur J Heart Fail 2020;22:391-412. [PMID: 32133741 DOI: 10.1002/ejhf.1741] [Cited by in Crossref: 56] [Cited by in F6Publishing: 44] [Article Influence: 28.0] [Reference Citation Analysis]
326 Eggers KM, Lindahl B. Application of Cardiac Troponin in Cardiovascular Diseases Other Than Acute Coronary Syndrome. Clinical Chemistry 2017;63:223-35. [DOI: 10.1373/clinchem.2016.261495] [Cited by in Crossref: 41] [Cited by in F6Publishing: 38] [Article Influence: 8.2] [Reference Citation Analysis]
327 Musallam KM, Taher AT. Iron deficiency beyond erythropoiesis: should we be concerned? Current Medical Research and Opinion 2018;34:81-93. [DOI: 10.1080/03007995.2017.1394833] [Cited by in Crossref: 44] [Cited by in F6Publishing: 36] [Article Influence: 8.8] [Reference Citation Analysis]
328 Norton P, Araújo N, Pinho P, Costa Gomes J, Silva C, Gama C, Barbosa M, Ferreira P, Cunha S, Moreira S, Martins S, Faria S, Sousa S, Figueiras Alves N, Lunet N. Diagnosis, treatment, and work impact of iron deficiency anemia in a Portuguese urban community. Porto Biomed J 2020;5:e064. [PMID: 32734009 DOI: 10.1097/j.pbj.0000000000000064] [Reference Citation Analysis]
329 Shirakabe A, Hata N, Kobayashi N, Okazaki H, Matsushita M, Shibata Y, Uchiyama S, Sawatani T, Asai K, Shimizu W. Worsening renal failure in patients with acute heart failure: the importance of cardiac biomarkers. ESC Heart Fail 2019;6:416-27. [PMID: 30801997 DOI: 10.1002/ehf2.12414] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
330 Ren W, Gao S, Zhang H, Ren Y, Yu X, Lin W, Guo S, Zhu R, Wang W. Decomposing the Mechanism of Qishen Granules in the Treatment of Heart Failure by a Quantitative Pathway Analysis Method. Molecules 2018;23:E1829. [PMID: 30041436 DOI: 10.3390/molecules23071829] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
331 Delles C, Rankin NJ, Boachie C, McConnachie A, Ford I, Kangas A, Soininen P, Trompet S, Mooijaart SP, Jukema JW, Zannad F, Ala-Korpela M, Salomaa V, Havulinna AS, Welsh P, Würtz P, Sattar N. Nuclear magnetic resonance-based metabolomics identifies phenylalanine as a novel predictor of incident heart failure hospitalisation: results from PROSPER and FINRISK 1997. Eur J Heart Fail 2018;20:663-73. [PMID: 29226610 DOI: 10.1002/ejhf.1076] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 5.4] [Reference Citation Analysis]
332 Trenson S, Hermans H, Craps S, Pokreisz P, de Zeeuw P, Van Wauwe J, Gillijns H, Veltman D, Wei F, Caluwé E, Gijsbers R, Baatsen P, Staessen JA, Ghesquiere B, Carmeliet P, Rega F, Meuris B, Meyns B, Oosterlinck W, Duchenne J, Goetschalckx K, Voigt JU, Herregods MC, Herijgers P, Luttun A, Janssens S. Cardiac Microvascular Endothelial Cells in Pressure Overload-Induced Heart Disease. Circ Heart Fail 2021;14:e006979. [PMID: 33464950 DOI: 10.1161/CIRCHEARTFAILURE.120.006979] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
333 Delnoy PHM, Gutleben KJ, Bruun NE, Maier SKG, Oswald H, Stellbrink C, Johansen JB, Paule S, Søgaard P. Hemodynamic monitoring by intracardiac impedance measured by cardiac resynchronization defibrillators: Evaluation in a controlled clinical setting (BIO.Detect HF II study). Indian Pacing Electrophysiol J 2021;21:209-18. [PMID: 33866018 DOI: 10.1016/j.ipej.2021.04.003] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
334 Lund LH, Svennblad B, Dahlström U, Ståhlberg M. Effect of expanding evidence and evolving clinical guidelines on the prevalence of indication for cardiac resynchronization therapy in patients with heart failure. Eur J Heart Fail 2018;20:769-77. [PMID: 28949083 DOI: 10.1002/ejhf.929] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
335 Nakata M, Sakuma J, Takano M, Nagasaki S. Assessment of fetal cardiac function with echocardiography. J Obstet Gynaecol Res 2020;46:31-8. [PMID: 31595615 DOI: 10.1111/jog.14143] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
336 Berezin AA, Fushtey IM, Berezin AE. Discriminative Utility of Apelin-to-NT-Pro-Brain Natriuretic Peptide Ratio for Heart Failure with Preserved Ejection Fraction among Type 2 Diabetes Mellitus Patients. JCDD 2022;9:23. [DOI: 10.3390/jcdd9010023] [Reference Citation Analysis]
337 Santobuono VE, Guaricci AI, Carulli E, Bozza N, Pepe M, Ranauro A, Ranieri C, Carella MC, Loizzi F, Resta N, Favale S, Forleo C. Importance of clinical suspicion and multidisciplinary management for early diagnosis of a cardiac laminopathy patient: A case report. World J Clin Cases 2021; 9(25): 7472-7477 [PMID: 34616814 DOI: 10.12998/wjcc.v9.i25.7472] [Reference Citation Analysis]
338 Sokolski M, Gajewski P, Zymliński R, Biegus J, Berg JMT, Bor W, Braunschweig F, Caldeira D, Cuculi F, D'Elia E, Edes IF, Garus M, Greenwood JP, Halfwerk FR, Hindricks G, Knuuti J, Kristensen SD, Landmesser U, Lund LH, Lyon A, Mebazaa A, Merkely B, Nawrocka-Millward S, Pinto FJ, Ruschitzka F, Semedo E, Senni M, Sepehri Shamloo A, Sorensen J, Stengaard C, Thiele H, Toggweiler S, Tukiendorf A, Verhorst PM, Wright DJ, Zamorano P, Zuber M, Narula J, Bax JJ, Ponikowski P. Impact of Coronavirus Disease 2019 (COVID-19) Outbreak on Acute Admissions at the Emergency and Cardiology Departments Across Europe. Am J Med 2021;134:482-9. [PMID: 33010226 DOI: 10.1016/j.amjmed.2020.08.043] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
339 Boerman LM, Maass SW, van der Meer P, Gietema JA, Maduro JH, Hummel YM, Berger MY, de Bock GH, Berendsen AJ. Long-term outcome of cardiac function in a population-based cohort of breast cancer survivors: A cross-sectional study. European Journal of Cancer 2017;81:56-65. [DOI: 10.1016/j.ejca.2017.05.013] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 3.6] [Reference Citation Analysis]
340 Pathan F, Puntmann VO, Nagel E. Role of Cardiac Magnetic Resonance in Heart Failure with Preserved Ejection Fraction. Curr Cardiovasc Imaging Rep 2018;11. [DOI: 10.1007/s12410-018-9450-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
341 Farmakis D, Triposkiadis F, Lekakis J, Parissis J. Heart failure in haemoglobinopathies: pathophysiology, clinical phenotypes, and management. Eur J Heart Fail 2017;19:479-89. [PMID: 28000341 DOI: 10.1002/ejhf.708] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
342 Espriella R, Bayés-Genis A, Revuelta-LóPEZ E, Miñana G, Santas E, Llàcer P, García-Blas S, Fernández-Cisnal A, Bonanad C, Ventura S, Sánchez R, Bodí V, Cordero A, Fácila L, Mollar A, Sanchis J, Núñez J; IMPROVE-HF Investigators. Soluble ST2 and Diuretic Efficiency in Acute Heart Failure and Concomitant Renal Dysfunction. J Card Fail 2021;27:427-34. [PMID: 33038531 DOI: 10.1016/j.cardfail.2020.10.002] [Reference Citation Analysis]
343 Tschöpe C, Kherad B, Klein O, Lipp A, Blaschke F, Gutterman D, Burkhoff D, Hamdani N, Spillmann F, Van Linthout S. Cardiac contractility modulation: mechanisms of action in heart failure with reduced ejection fraction and beyond. Eur J Heart Fail 2019;21:14-22. [PMID: 30485591 DOI: 10.1002/ejhf.1349] [Cited by in Crossref: 31] [Cited by in F6Publishing: 24] [Article Influence: 7.8] [Reference Citation Analysis]
344 Harada D, Asanoi H, Noto T, Takagawa J. The Impact of Deep Y Descent on Hemodynamics in Patients With Heart Failure and Preserved Left Ventricular Systolic Function. Front Cardiovasc Med 2021;8:770923. [PMID: 34926620 DOI: 10.3389/fcvm.2021.770923] [Reference Citation Analysis]
345 Miranda-Silva D, Wüst RCI, Conceição G, Gonçalves-Rodrigues P, Gonçalves N, Gonçalves A, Kuster DWD, Leite-Moreira AF, van der Velden J, de Sousa Beleza JM, Magalhães J, Stienen GJM, Falcão-Pires I. Disturbed cardiac mitochondrial and cytosolic calcium handling in a metabolic risk-related rat model of heart failure with preserved ejection fraction. Acta Physiol (Oxf) 2020;228:e13378. [PMID: 31520455 DOI: 10.1111/apha.13378] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
346 Domínguez JM, Keller B, Moisés J, Spitaleri G, Farrero M, Casal J, Pérez-Villa F, Castel MA. Changes in Pulmonary Function in Patients With Advanced Heart Failure Listed for Heart Transplantation. Transplant Proc 2019;51:3424-7. [PMID: 31810509 DOI: 10.1016/j.transproceed.2019.09.003] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
347 Ma Z, Zhao L, Martin S, Zhang Y, Dong Y, Zhong JC, Yang XC. Lower Plasma Elabela Levels in Hypertensive Patients With Heart Failure Predict the Occurrence of Major Adverse Cardiac Events: A Preliminary Study. Front Cardiovasc Med 2021;8:638468. [PMID: 33738301 DOI: 10.3389/fcvm.2021.638468] [Reference Citation Analysis]
348 Llubani R, Vukadinović D, Werner C, Marx N, Zewinger S, Böhm M. Hyperkalaemia in Heart Failure-Pathophysiology, Implications and Therapeutic Perspectives. Curr Heart Fail Rep 2018;15:390-7. [PMID: 30421355 DOI: 10.1007/s11897-018-0413-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
349 Ginwalla M, Tofovic DS. Current Status of Inotropes in Heart Failure. Heart Fail Clin 2018;14:601-16. [PMID: 30266368 DOI: 10.1016/j.hfc.2018.06.010] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
350 Lewis LK, Raudsepp SD, Yandle TG, Prickett TC, Richards AM. Development of a BNP1-32 Immunoassay That Does Not Cross-React with proBNP. Clin Chem 2017;63:1110-7. [PMID: 28428353 DOI: 10.1373/clinchem.2016.269712] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
351 Nepomuceno E, Silva LN, Cunha DCPD, Furuya RK, Simões MV, Dantas RAS. Comparison of tools for assessing fatigue in patients with heart failure. Rev Bras Enferm 2018;71:2404-10. [DOI: 10.1590/0034-7167-2017-0083] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
352 Safarikova I, Bulava A, Hajek P. Remote monitoring of implantable cardioverters defibrillators: a comparison of acceptance between octogenarians and younger patients. J Geriatr Cardiol 2020;17:417-26. [PMID: 32863824 DOI: 10.11909/j.issn.1671-5411.2020.07.008] [Reference Citation Analysis]
353 Zhang Q, Guo D, Wang Y, Wang X, Wang Q, Wu Y, Li C, Wang W, Wang Y. Danqi Pill Protects Against Heart Failure Post-Acute Myocardial Infarction via HIF-1α/PGC-1α Mediated Glucose Metabolism Pathway. Front Pharmacol 2020;11:458. [PMID: 32372956 DOI: 10.3389/fphar.2020.00458] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
354 Khariton Y, Fonarow GC, Arnold SV, Hellkamp A, Nassif ME, Sharma PP, Butler J, Thomas L, Duffy CI, DeVore AD, Albert NM, Patterson JH, Williams FB, McCague K, Spertus JA. Association Between Sacubitril/Valsartan Initiation and Health Status Outcomes in Heart Failure With Reduced Ejection Fraction. JACC Heart Fail 2019;7:933-41. [PMID: 31521679 DOI: 10.1016/j.jchf.2019.05.016] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 5.3] [Reference Citation Analysis]
355 López-Vilella R, Marqués-Sulé E, Sánchez-Lázaro I, Laymito Quispe R, Martínez Dolz L, Almenar Bonet L. Creatinine and NT-ProBNP levels could predict the length of hospital stay of patients with decompensated heart failure. Acta Cardiol 2021;:1-8. [PMID: 33480331 DOI: 10.1080/00015385.2020.1871264] [Reference Citation Analysis]
356 Metra M. November 2017 at a glance: quality of care and disease management. Eur J Heart Fail 2017;19:1351-2. [PMID: 29143470 DOI: 10.1002/ejhf.1074] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
357 Sciatti E, Vizzardi E, Bonadei I, Fabbricatore D, Prati F, Pagnoni M, Metra M. Prognostic evaluation of the elastic properties of the ascending aorta in dilated cardiomyopathy. Eur J Clin Invest 2018;48:e12950. [PMID: 29754460 DOI: 10.1111/eci.12950] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
358 Kataoka H. Chloride in Heart Failure Syndrome: Its Pathophysiologic Role and Therapeutic Implication. Cardiol Ther 2021. [PMID: 34398440 DOI: 10.1007/s40119-021-00238-2] [Reference Citation Analysis]
359 Naseri MH, Madani H, Ahmadi Tafti SH, Moshkani Farahani M, Kazemi Saleh D, Hosseinnejad H, Hosseini S, Hekmat S, Hossein Ahmadi Z, Dehghani M, Saadat A, Mardpour S, Hosseini SE, Esmaeilzadeh M, Sadeghian H, Bahoush G, Bassi A, Amin A, Fazeli R, Sharafi Y, Arab L, Movahhed M, Davaran S, Ramezanzadeh N, Kouhkan A, Hezavehei A, Namiri M, Kashfi F, Akhlaghi A, Sotoodehnejadnematalahi F, Vosough Dizaji A, Gourabi H, Syedi N, Shahverdi AH, Baharvand H, Aghdami N. COMPARE CPM-RMI Trial: Intramyocardial Transplantation of Autologous Bone Marrow-Derived CD133+ Cells and MNCs during CABG in Patients with Recent MI: A Phase II/III, Multicenter, Placebo-Controlled, Randomized, Double-Blind Clinical Trial. Cell J 2018;20:267-77. [PMID: 29633605 DOI: 10.22074/cellj.2018.5197] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
360 Iborra-Egea O, Gálvez-Montón C, Roura S, Perea-Gil I, Prat-Vidal C, Soler-Botija C, Bayes-Genis A. Mechanisms of action of sacubitril/valsartan on cardiac remodeling: a systems biology approach. NPJ Syst Biol Appl 2017;3:12. [PMID: 28649439 DOI: 10.1038/s41540-017-0013-4] [Cited by in Crossref: 55] [Cited by in F6Publishing: 41] [Article Influence: 11.0] [Reference Citation Analysis]
361 Naruse H, Ishii J, Takahashi H, Kitagawa F, Sakaguchi E, Nishimura H, Kawai H, Muramatsu T, Harada M, Yamada A, Fujiwara W, Hayashi M, Motoyama S, Sarai M, Watanabe E, Ito H, Ozaki Y, Izawa H. Combined Assessment of D-Dimer with the Get with the Guidelines-Heart Failure Risk Score and N-Terminal Pro-B-Type Natriuretic Peptide in Patients with Acute Decompensated Heart Failure with Preserved and Reduced Ejection Fraction. J Clin Med 2021;10:3564. [PMID: 34441860 DOI: 10.3390/jcm10163564] [Reference Citation Analysis]
362 Lang NN, Dobbin SJH, Petrie MC. Vericiguat in worsening heart failure: agonising over, or celebrating, agonism in the VICTORIA trial. Cardiovasc Res 2020;116:e152-5. [PMID: 32980877 DOI: 10.1093/cvr/cvaa247] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
363 Vergaro G, Aimo A, Zareba W, Emdin M. The ST2-SCD score and the conundrum of sudden death prediction in heart failure. Int J Cardiol 2019;294:50-1. [PMID: 31421855 DOI: 10.1016/j.ijcard.2019.07.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
364 Zhou W, Brown JM, Bajaj NS, Chandra A, Divakaran S, Weber B, Bibbo CF, Hainer J, Taqueti VR, Dorbala S, Blankstein R, Adler D, O'Gara P, Di Carli MF. Hypertensive coronary microvascular dysfunction: a subclinical marker of end organ damage and heart failure. Eur Heart J 2020;41:2366-75. [PMID: 32221588 DOI: 10.1093/eurheartj/ehaa191] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 15.0] [Reference Citation Analysis]
365 Lindmark K, Boman K, Stålhammar J, Olofsson M, Lahoz R, Studer R, Proudfoot C, Corda S, Fonseca AF, Costa-Scharplatz M, Levine A, Törnblom M, Castelo-Branco A, Kopsida E, Wikström G. Recurrent heart failure hospitalizations increase the risk of cardiovascular and all-cause mortality in patients with heart failure in Sweden: a real-world study. ESC Heart Fail 2021;8:2144-53. [PMID: 33751806 DOI: 10.1002/ehf2.13296] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
366 Bayard G, Da Costa A, Pierrard R, Roméyer-Bouchard C, Guichard JB, Isaaz K. Impact of sacubitril/valsartan on echo parameters in heart failure patients with reduced ejection fraction a prospective evaluation. Int J Cardiol Heart Vasc 2019;25:100418. [PMID: 31517034 DOI: 10.1016/j.ijcha.2019.100418] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
367 Malavasi VL, Vitolo M, Colella J, Montagnolo F, Mantovani M, Proietti M, Potpara TS, Lip GYH, Boriani G. Rhythm- or rate-control strategies according to 4S-AF characterization scheme and long-term outcomes in atrial fibrillation patients: the FAMo (Fibrillazione Atriale in Modena) cohort. Intern Emerg Med 2021. [PMID: 34855117 DOI: 10.1007/s11739-021-02890-x] [Reference Citation Analysis]
368 Poglajen G, Zemljič G, Frljak S, Cerar A, Andročec V, Sever M, Černelč P. Stem Cell Therapy in Patients with Chronic Nonischemic Heart Failure. Stem Cells Int 2018;2018:6487812. [PMID: 29535775 DOI: 10.1155/2018/6487812] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
369 Duyan M, Ünal AY, Özturan İU, Günsoy E. Contribution of caval index and ejection fraction estimated by e-point septal separation measured by emergency physicians in the clinical diagnosis of acute heart failure. Turk J Emerg Med 2020;20:105-10. [PMID: 32832729 DOI: 10.4103/2452-2473.290065] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
370 Agostoni P, Paolillo S, Mapelli M, Gentile P, Salvioni E, Veglia F, Bonomi A, Corrà U, Lagioia R, Limongelli G, Sinagra G, Cattadori G, Scardovi AB, Metra M, Carubelli V, Scrutinio D, Raimondo R, Emdin M, Piepoli M, Magrì D, Parati G, Caravita S, Re F, Cicoira M, Minà C, Correale M, Frigerio M, Bussotti M, Oliva F, Battaia E, Belardinelli R, Mezzani A, Pastormerlo L, Guazzi M, Badagliacca R, Di Lenarda A, Passino C, Sciomer S, Zambon E, Pacileo G, Ricci R, Apostolo A, Palermo P, Contini M, Clemenza F, Marchese G, Gargiulo P, Binno S, Lombardi C, Passantino A, Filardi PP. Multiparametric prognostic scores in chronic heart failure with reduced ejection fraction: a long-term comparison. Eur J Heart Fail 2018;20:700-10. [PMID: 28949086 DOI: 10.1002/ejhf.989] [Cited by in Crossref: 45] [Cited by in F6Publishing: 35] [Article Influence: 9.0] [Reference Citation Analysis]
371 Parajuli DR, Kourbelis C, Franzon J, Newman P, Mckinnon RA, Shakib S, Whitehead D, Clark RA. Effectiveness of the Pharmacist-Involved Multidisciplinary Management of Heart Failure to Improve Hospitalizations and Mortality Rates in 4630 Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Journal of Cardiac Failure 2019;25:744-56. [DOI: 10.1016/j.cardfail.2019.07.455] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]
372 Katsi V, Georgiopoulos G, Laina A, Koutli E, Parissis J, Tsioufis C, Nihoyannopoulos P, Tousoulis D. Left ventricular ejection fraction as therapeutic target: is it the ideal marker? Heart Fail Rev 2017;22:641-55. [PMID: 28601914 DOI: 10.1007/s10741-017-9624-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 2.8] [Reference Citation Analysis]
373 Butler J, Anker SD, Siddiqi TJ, Coats AJS, Dorigotti F, Filippatos G, Friede T, Göhring UM, Kosiborod MN, Lund LH, Metra M, Moreno Quinn C, Piña IL, Pinto FJ, Rossignol P, Szecsödy P, Van Der Meer P, Weir M, Pitt B. Patiromer for the management of hyperkalaemia in patients receiving renin-angiotensin-aldosterone system inhibitors for heart failure: design and rationale of the DIAMOND trial. Eur J Heart Fail 2021. [PMID: 34800079 DOI: 10.1002/ejhf.2386] [Reference Citation Analysis]
374 Han X, Zhou Y, Liu W. Precision cardio-oncology: understanding the cardiotoxicity of cancer therapy. NPJ Precis Oncol 2017;1:31. [PMID: 29872712 DOI: 10.1038/s41698-017-0034-x] [Cited by in Crossref: 55] [Cited by in F6Publishing: 45] [Article Influence: 11.0] [Reference Citation Analysis]
375 Meyer S, Teerlink JR, Metra M, Ponikowski P, Cotter G, Davison BA, Felker GM, Filippatos G, Greenberg BH, Hua TA, Severin T, Qian M, Voors AA. Sex differences in early dyspnea relief between men and women hospitalized for acute heart failure: insights from the RELAX-AHF study. Clin Res Cardiol 2017;106:280-92. [PMID: 27838739 DOI: 10.1007/s00392-016-1051-4] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
376 Karakoyun I, Colak A, Arslan FD, Hasturk AG, Duman C. Anemia considerations when assessing natriuretic peptide levels in ED patients. Am J Emerg Med 2017;35:1677-81. [PMID: 28587950 DOI: 10.1016/j.ajem.2017.05.048] [Cited by in Crossref: 5] [Article Influence: 1.0] [Reference Citation Analysis]
377 Almuwaqqat Z, O'Neal WT, Norby FL, Lutsey PL, Selvin E, Soliman EZ, Chen LY, Alonso A. Joint Associations of Obesity and NT-proBNP With the Incidence of Atrial Fibrillation in the ARIC Study. J Am Heart Assoc 2019;8:e013294. [PMID: 31564186 DOI: 10.1161/JAHA.119.013294] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
378 Metra M. March 2018 at a glance: clinical trials, co-morbidities and treatment of mitral regurgitation. Eur J Heart Fail 2018;20:411-2. [PMID: 29575434 DOI: 10.1002/ejhf.998] [Reference Citation Analysis]
379 Garcimartín P, Comín-Colet J, Pardo-Cladellas Y, Badosa N, Linas A, Rosenfeld L, Faraudo M, Valero O, Hidalgo E, Cainzos-Achirica M, Ruiz S, Delgado-Hito P. Validation of the Spanish version of the questionnaire on Patient Empowerment in Long-Term Conditions. PLoS One 2020;15:e0233338. [PMID: 32530951 DOI: 10.1371/journal.pone.0233338] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
380 Salzano A, D'Assante R, Lander M, Arcopinto M, Bossone E, Suzuki T, Cittadini A. Hormonal Replacement Therapy in Heart Failure: Focus on Growth Hormone and Testosterone. Heart Fail Clin 2019;15:377-91. [PMID: 31079696 DOI: 10.1016/j.hfc.2019.02.007] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
381 Gastl M, Gotschy A, Polacin M, Vishnevskiy V, Meyer D, Sokolska J, Tanner FC, Alkadhi H, Kozerke S, Manka R. Determinants of myocardial function characterized by CMR-derived strain parameters in left ventricular non-compaction cardiomyopathy. Sci Rep 2019;9:15882. [PMID: 31685845 DOI: 10.1038/s41598-019-52161-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
382 Sucato V, Galassi AR, Novo S, Saladino A, Evola S, Novo G. Correlation between longitudinal strain analysis and coronary microvascular dysfunction in patients with heart failure with preserved ejection fraction. Microcirculation 2020;27. [DOI: 10.1111/micc.12605] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
383 Miró Ò, García Sarasola A, Fuenzalida C, Calderón S, Jacob J, Aguirre A, Wu DM, Rizzi MA, Malchair P, Haro A, Herrera S, Gil V, Martín-Sánchez FJ, Llorens P, Herrero Puente P, Bueno H, Domínguez Rodríguez A, Müller CE, Mebazaa A, Chioncel O, Alquézar-Arbé A; ICA-SEMES Research Group. Departments involved during the first episode of acute heart failure and subsequent emergency department revisits and rehospitalisations: an outlook through the NOVICA cohort. Eur J Heart Fail 2019;21:1231-44. [PMID: 31389111 DOI: 10.1002/ejhf.1567] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 4.7] [Reference Citation Analysis]
384 Lindgren MP, PirouziFard M, Smith JG, Sundquist J, Sundquist K, Zöller B. A Swedish Nationwide Adoption Study of the Heritability of Heart Failure. JAMA Cardiol 2018;3:703-10. [PMID: 29998296 DOI: 10.1001/jamacardio.2018.1919] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 7.7] [Reference Citation Analysis]
385 Mann JA, Abraham WT. Cardiac Contractility Modulation and Baroreflex Activation Therapy in Heart Failure Patients. Curr Heart Fail Rep 2019;16:38-46. [DOI: 10.1007/s11897-019-0422-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
386 Gallagher J, McDonald K, Ledwidge M, Watson CJ. Heart Failure in Sub-Saharan Africa. Card Fail Rev 2018;4:21-4. [PMID: 29892471 DOI: 10.15420/cfr.2018:4:1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
387 Fitzsimons D, Doherty LC, Murphy M, Dixon L, Donnelly P, Mcdonald K, Mcilfatrick S. Inadequate Communication Exacerbates the Support Needs of Current and Bereaved Caregivers in Advanced Heart Failure and Impedes Shared Decision-making. J Cardiovasc Nurs 2019;34:11-9. [DOI: 10.1097/jcn.0000000000000516] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 2.7] [Reference Citation Analysis]
388 Terlizzese P, Losurdo F, Iacoviello M, Aspromonte N. Heart failure risk and major cardiovascular events in diabetes: an overview of within-group differences in non-insulin antidiabetic treatment. Heart Fail Rev 2018;23:469-79. [DOI: 10.1007/s10741-017-9667-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
389 Asakawa N, Uchida K, Sakakibara M, Omote K, Noguchi K, Tokuda Y, Kamiya K, Hatanaka KC, Matsuno Y, Yamada S, Asakawa K, Fukasawa Y, Nagai T, Anzai T, Ikeda Y, Ishibashi-Ueda H, Hirota M, Orii M, Akasaka T, Uto K, Shingu Y, Matsui Y, Morimoto SI, Tsutsui H, Eishi Y. Immunohistochemical identification of Propionibacterium acnes in granuloma and inflammatory cells of myocardial tissues obtained from cardiac sarcoidosis patients. PLoS One 2017;12:e0179980. [PMID: 28686683 DOI: 10.1371/journal.pone.0179980] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 4.2] [Reference Citation Analysis]
390 Van Der Linden L, Hias J, Walgraeve K, Loyens S, Flamaing J, Spriet I, Tournoy J. Factors associated with the number of clinical pharmacy recommendations: findings from an observational study in geriatric inpatients. Acta Clin Belg 2021;76:119-26. [PMID: 31642397 DOI: 10.1080/17843286.2019.1683128] [Reference Citation Analysis]
391 Mebazaa A, Motiejunaite J, Gayat E, Crespo-Leiro MG, Lund LH, Maggioni AP, Chioncel O, Akiyama E, Harjola VP, Seferovic P, Laroche C, Julve MS, Roig E, Ruschitzka F, Filippatos G; ESC Heart Failure Long-Term Registry Investigators. Long-term safety of intravenous cardiovascular agents in acute heart failure: results from the European Society of Cardiology Heart Failure Long-Term Registry. Eur J Heart Fail 2018;20:332-41. [PMID: 28990358 DOI: 10.1002/ejhf.991] [Cited by in Crossref: 44] [Cited by in F6Publishing: 33] [Article Influence: 8.8] [Reference Citation Analysis]
392 Liao WI, Wang JC, Lin CS, Yang CJ, Hsu CC, Chu SJ, Chu CM, Tsai SH. Elevated Glycemic Gap Predicts Acute Respiratory Failure and In-hospital Mortality in Acute Heart Failure Patients with Diabetes. Sci Rep 2019;9:6279. [PMID: 31000758 DOI: 10.1038/s41598-019-42666-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
393 Hiemstra YL, Debonnaire P, Bootsma M, Schalij MJ, Bax JJ, Delgado V, Marsan NA. Prevalence and Prognostic Implications of Right Ventricular Dysfunction in Patients With Hypertrophic Cardiomyopathy. The American Journal of Cardiology 2019;124:604-12. [DOI: 10.1016/j.amjcard.2019.05.021] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
394 Biasillo G, Cipolla CM, Cardinale D. Cardio-oncology: Gaps in Knowledge, Goals, Advances, and Educational Efforts. Curr Oncol Rep 2017;19. [DOI: 10.1007/s11912-017-0610-9] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
395 Bencivenga L, Komici K, Nocella P, Grieco FV, Spezzano A, Puzone B, Cannavo A, Cittadini A, Corbi G, Ferrara N, Rengo G. Atrial fibrillation in the elderly: a risk factor beyond stroke. Ageing Research Reviews 2020;61:101092. [DOI: 10.1016/j.arr.2020.101092] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
396 Ioannou A, Papageorgiou N, Barber H, Falconer D, Barra S, Babu G, Ahsan S, Rowland E, Hunter R, Lowe M, Schilling R, Lambiase P, Chow A, Providencia R. Impact of an Age-Adjusted Co-morbidity Index on Survival of Patients With Heart Failure Implanted With Cardiac Resynchronization Therapy Devices. The American Journal of Cardiology 2017;120:1158-65. [DOI: 10.1016/j.amjcard.2017.06.056] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
397 Metra M, Carubelli V, Ravera A, Stewart Coats AJ. Heart failure 2016: still more questions than answers. Int J Cardiol 2017;227:766-77. [PMID: 27838123 DOI: 10.1016/j.ijcard.2016.10.060] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
398 Kasahara S, Sakata Y, Nochioka K, Tay WT, Claggett BL, Abe R, Oikawa T, Sato M, Aoyanagi H, Miura M, Shiroto T, Takahashi J, Sugimura K, Teng TK, Miyata S, Shimokawa H. The 3A3B score: The simple risk score for heart failure with preserved ejection fraction - A report from the CHART-2 Study. Int J Cardiol 2019;284:42-9. [PMID: 30413304 DOI: 10.1016/j.ijcard.2018.10.076] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
399 Heckman GA, Hirdes JP, Hébert P, Costa A, Onder G, Declercq A, Nova A, Chen J, McKelvie RS. Assessments of heart failure and frailty-related health instability provide complementary and useful information for home care planning and prognosis. Can J Cardiol 2021:S0828-282X(21)00374-3. [PMID: 34303783 DOI: 10.1016/j.cjca.2021.07.009] [Reference Citation Analysis]
400 Ouwerkerk W, Teng TK, Tromp J, Tay WT, Cleland JG, Veldhuisen DJ, Dickstein K, Ng LL, Lang CC, Anker SD, Zannad F, Hung C, Sawhney JP, Naik A, Shimizu W, Hagiwara N, Wander GS, Anand I, Richards AM, Voors AA, Lam CS. Effects of combined renin–angiotensin–aldosterone system inhibitor and beta‐blocker treatment on outcomes in heart failure with reduced ejection fraction: insights from BIOSTAT‐CHF and ASIAN‐HF registries. Eur J Heart Fail 2020;22:1472-82. [DOI: 10.1002/ejhf.1869] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
401 Huusko J, Tuominen S, Studer R, Corda S, Proudfoot C, Lassenius M, Ukkonen H. Recurrent hospitalizations are associated with increased mortality across the ejection fraction range in heart failure. ESC Heart Fail 2020;7:2406-17. [PMID: 32667143 DOI: 10.1002/ehf2.12792] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
402 Stojanovic D, Mitic V, Stojanovic M, Petrovic D, Ignjatovic A, Milojkovic M, Dunjic O, Milenkovic J, Bojanic V, Deljanin Ilic M. The Discriminatory Ability of Renalase and Biomarkers of Cardiac Remodeling for the Prediction of Ischemia in Chronic Heart Failure Patients With the Regard to the Ejection Fraction. Front Cardiovasc Med 2021;8:691513. [PMID: 34395559 DOI: 10.3389/fcvm.2021.691513] [Reference Citation Analysis]
403 Jobs A, Schwind J, Katalinic A, Babaev V, Tilz RR, Rausch S, Thiele H, Eitel I, Eitel C. Prognostic significance of atrial fibrillation in acute decompensated heart failure with reduced versus preserved ejection fraction. Clin Res Cardiol 2019;108:74-82. [PMID: 29987595 DOI: 10.1007/s00392-018-1321-4] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
404 Scalvini S, Grossetti F, Paganoni AM, Teresa La Rovere M, Pedretti RF, Frigerio M. Impact of in-hospital cardiac rehabilitation on mortality and readmissions in heart failure: A population study in Lombardy, Italy, from 2005 to 2012. Eur J Prev Cardiolog 2019;26:808-17. [DOI: 10.1177/2047487319833512] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 5.3] [Reference Citation Analysis]
405 Wussler D, Kozhuharov N, Tavares Oliveira M, Bossa A, Sabti Z, Nowak A, Murray K, du Fay de Lavallaz J, Badertscher P, Twerenbold R, Shrestha S, Flores D, Nestelberger T, Walter J, Boeddinghaus J, Zimmermann T, Koechlin L, von Eckardstein A, Breidthardt T, Mueller C. Clinical Utility of Procalcitonin in the Diagnosis of Pneumonia. Clin Chem 2019;65:1532-42. [PMID: 31615771 DOI: 10.1373/clinchem.2019.306787] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 3.7] [Reference Citation Analysis]
406 Liu Y, Li CP, Lu PJ, Wang XY, Xiao JY, Gao MD, Wang JX, Li XW, Zhang N, Li CJ, Ma J, Gao J. Percutaneous coronary intervention assisted by invasive mechanical ventilation and intra-aortic balloon pump for acute myocardial infarction with cardiogenic shock: Retrospective cohort study and meta-analyses. Bosn J Basic Med Sci 2020;20:514-23. [PMID: 31782697 DOI: 10.17305/bjbms.2019.4500] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
407 Al-Wakeel-Marquard N, Degener F, Herbst C, Kühnisch J, Dartsch J, Schmitt B, Kuehne T, Messroghli D, Berger F, Klaassen S. RIKADA Study Reveals Risk Factors in Pediatric Primary Cardiomyopathy. J Am Heart Assoc 2019;8:e012531. [PMID: 31333075 DOI: 10.1161/JAHA.119.012531] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
408 Wu J, Ye Y, Li C, Zhou W, Chang R. Correlation of Inhaled Long-Acting Bronchodilators With Adverse Cardiovascular Outcomes in Patients With Stable COPD: A Bayesian Network Meta-Analysis of Randomized Controlled Trials. J Cardiovasc Pharmacol 2019;74:255-65. [PMID: 31306366 DOI: 10.1097/FJC.0000000000000705] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
409 Tsigkas G, Apostolos A, Despotopoulos S, Vasilagkos G, Papageorgiou A, Kallergis E, Leventopoulos G, Mplani V, Koniari I, Velissaris D, Parissis J. Anticoagulation for atrial fibrillation in heart failure patients: balancing between Scylla and Charybdis. J Geriatr Cardiol 2021;18:352-61. [PMID: 34149824 DOI: 10.11909/j.issn.1671-5411.2021.05.006] [Reference Citation Analysis]
410 Farmakis D, Papingiotis G, Parissis J, Filippatos G. Ups and downs in heart failure: the case of proteomics: Editorial comment. Eur J Heart Fail 2018;20:63-6. [DOI: 10.1002/ejhf.1065] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
411 Sharp TE 3rd, Lefer DJ. Renal Denervation to Treat Heart Failure. Annu Rev Physiol 2021;83:39-58. [PMID: 33074771 DOI: 10.1146/annurev-physiol-031620-093431] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
412 Parlakpinar H, Ozhan O, Ermis N, Vardi N, Cigremis Y, Tanriverdi LH, Colak C, Acet A. Acute and Subacute Effects of Low Versus High Doses of Standardized Panax ginseng Extract on the Heart: An Experimental Study. Cardiovasc Toxicol 2019;19:306-20. [DOI: 10.1007/s12012-019-09512-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
413 Barandiarán Aizpurua A, Sanders-van Wijk S, Brunner-La Rocca HP, Henkens M, Heymans S, Beussink-Nelson L, Shah SJ, van Empel VPM. Validation of the HFA-PEFF score for the diagnosis of heart failure with preserved ejection fraction. Eur J Heart Fail 2020;22:413-21. [PMID: 31472035 DOI: 10.1002/ejhf.1614] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 11.7] [Reference Citation Analysis]
414 Sokolski M, Zymliński R, Biegus J, Siwołowski P, Nawrocka-Millward S, Todd J, Yerramilli MR, Estis J, Jankowska EA, Banasiak W, Ponikowski P. Urinary levels of novel kidney biomarkers and risk of true worsening renal function and mortality in patients with acute heart failure. Eur J Heart Fail 2017;19:760-7. [PMID: 28133864 DOI: 10.1002/ejhf.746] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 6.6] [Reference Citation Analysis]
415 Palazzuoli A, Ruocco G, Paolillo S, Perrone Filardi P. The use of diuretics in heart failure with congestion: we can't judge a book by its cover. ESC Heart Fail 2019;6:1222-5. [PMID: 31617332 DOI: 10.1002/ehf2.12515] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
416 Rechenberg K, Cousin L, Redwine L. Mindfulness, Anxiety Symptoms, and Quality of Life in Heart Failure. J Cardiovasc Nurs 2020;35:358-63. [PMID: 31904692 DOI: 10.1097/JCN.0000000000000630] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
417 Chioncel O, Parissis J, Mebazaa A, Thiele H, Desch S, Bauersachs J, Harjola V, Antohi E, Arrigo M, Gal TB, Celutkiene J, Collins SP, Debacker D, Iliescu VA, Jankowska E, Jaarsma T, Keramida K, Lainscak M, Lund LH, Lyon AR, Masip J, Metra M, Miro O, Mortara A, Mueller C, Mullens W, Nikolaou M, Piepoli M, Price S, Rosano G, Vieillard‐baron A, Weinstein JM, Anker SD, Filippatos G, Ruschitzka F, Coats AJ, Seferovic P. Epidemiology, pathophysiology and contemporary management of cardiogenic shock – a position statement from the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 2020;22:1315-41. [DOI: 10.1002/ejhf.1922] [Cited by in Crossref: 42] [Cited by in F6Publishing: 35] [Article Influence: 21.0] [Reference Citation Analysis]
418 Scalvini S, Bernocchi P, Villa S, Paganoni AM, La Rovere MT, Frigerio M. Treatment prescription, adherence, and persistence after the first hospitalization for heart failure: A population-based retrospective study on 100785 patients. Int J Cardiol 2021;330:106-11. [PMID: 33582198 DOI: 10.1016/j.ijcard.2021.02.016] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
419 Wang S, Ma W, Wang SM, Yi X. Regular Physical Activities and Related Factors among Middle-Aged and Older Adults in Jinan, China: A Cross-Sectional Study. Int J Environ Res Public Health 2021;18:10362. [PMID: 34639662 DOI: 10.3390/ijerph181910362] [Reference Citation Analysis]
420 Tavazzi L, Borer JS, Tavazzi G. Use and Disuse of Observational Research: The Case of Remote Monitoring in Heart Failure. Cardiology 2017;137:14-9. [DOI: 10.1159/000453655] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
421 Uz İ, Kiyan GS, ÖzÇete E, YalÇinli S, Korgan MB, Altunci YA, Ersel M, Akarca FK, Yavuzgİl O. Is the flow-safe disposable continuous positive airway pressure (CPAP) system as effective as non-invasive mechanical ventilation (NIMV) in the treatment of acute cardiogenic pulmonary Oedema? Am J Emerg Med 2021;39:109-13. [PMID: 31983599 DOI: 10.1016/j.ajem.2020.01.034] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
422 Chunbin W, Han W, Lin C. Efficacy of Vitamin D on Chronic Heart Failure Among Adults: A Meta-analysis of Randomized Controlled Trials. International Journal for Vitamin and Nutrition Research 2020;90:49-58. [DOI: 10.1024/0300-9831/a000487] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
423 Tavares-Silva M, Saraiva F, Pinto R, Amorim S, Silva JC, Leite-Moreira AF, Maciel MJ, Lourenço AP. Comparison of levosimendan, NO, and inhaled iloprost for pulmonary hypertension reversibility assessment in heart transplant candidates. ESC Heart Fail 2021;8:908-17. [PMID: 33621427 DOI: 10.1002/ehf2.13168] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
424 Abumayyaleh M, Pilsinger C, El-Battrawy I, Kummer M, Kuschyk J, Borggrefe M, Mügge A, Aweimer A, Akin I. Clinical Outcomes in Patients with Ischemic versus Non-Ischemic Cardiomyopathy after Angiotensin-Neprilysin Inhibition Therapy. J Clin Med 2021;10:4989. [PMID: 34768510 DOI: 10.3390/jcm10214989] [Reference Citation Analysis]
425 Abdin A, Böhm M. Renal function and vericiguat in heart failure patients: light at the end of the tunnel! Eur J Heart Fail 2021;23:1322-4. [PMID: 34173701 DOI: 10.1002/ejhf.2280] [Reference Citation Analysis]
426 Li XQ. Effects of high-quality nursing care on psychological outcomes in patients with chronic heart failure. Medicine (Baltimore) 2019;98:e17351. [PMID: 31593085 DOI: 10.1097/MD.0000000000017351] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
427 Maeda M, Omori T, Kagawa S, Uno G, Rader F, Siegel RJ, Shiota T. Impact of Systolic Blood Pressure on Heart Failure Symptoms With Moderate Aortic Stenosis. Am J Cardiol 2021;155:96-102. [PMID: 34315571 DOI: 10.1016/j.amjcard.2021.06.018] [Reference Citation Analysis]
428 Chera HH, Al-Sadawi M, Michelakis N, Spinelli M. Optimizer Smart System for the treatment of chronic heart failure: Overview of its safety and efficacy. Expert Rev Med Devices 2021;18:505-12. [PMID: 34323128 DOI: 10.1080/17434440.2021.1923478] [Reference Citation Analysis]
429 Lewis LK, Raudsepp SD, Prickett TCR, Yandle TG, Doughty RN, Frampton CM, Pemberton CJ, Richards AM. ProBNP That Is Not Glycosylated at Threonine 71 Is Decreased with Obesity in Patients with Heart Failure. Clin Chem 2019;65:1115-24. [PMID: 31092393 DOI: 10.1373/clinchem.2019.302547] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
430 Ferreira JP, Mentz RJ, Pizard A, Pitt B, Zannad F. Tailoring mineralocorticoid receptor antagonist therapy in heart failure patients: are we moving towards a personalized approach?: MRA therapy in heart failure patients. Eur J Heart Fail 2017;19:974-86. [DOI: 10.1002/ejhf.814] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 4.4] [Reference Citation Analysis]
431 Lalem T, Zhang L, Scholz M, Burkhardt R, Saccheti V, Teren A, Thiery J, Devaux Y. Cyclin dependent kinase inhibitor 1 C is a female-specific marker of left ventricular function after acute myocardial infarction. International Journal of Cardiology 2019;274:319-25. [DOI: 10.1016/j.ijcard.2018.07.042] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
432 Metra M. December 2017 at a glance: left ventricular ejection fraction, exercise capacity, peripartum cardiomyopathy. Eur J Heart Fail 2017;19:1562-3. [PMID: 29271589 DOI: 10.1002/ejhf.1095] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
433 Hu J, Wu Y, Zhou X, Wang X, Jiang W, Huo J, Shan Q. Beneficial Effects of Sacubitril/Valsartan at Low Doses in an Asian Real-World Heart Failure Population. J Cardiovasc Pharmacol 2020;76:445-51. [PMID: 33030857 DOI: 10.1097/FJC.0000000000000873] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
434 Javaloyes P, Miró Ò, Gil V, Martín-Sánchez FJ, Jacob J, Herrero P, Takagi K, Alquézar-Arbé A, López Díez MP, Martín E, Bibiano C, Escoda R, Gil C, Fuentes M, Llopis García G, Álvarez Pérez JM, Jerez A, Tost J, Llauger L, Romero R, Garrido JM, Rodríguez-Adrada E, Sánchez C, Rossello X, Parissis J, Mebazaa A, Chioncel O, Llorens P; ICA-SEMES Research Group. Clinical phenotypes of acute heart failure based on signs and symptoms of perfusion and congestion at emergency department presentation and their relationship with patient management and outcomes. Eur J Heart Fail 2019;21:1353-65. [PMID: 31127677 DOI: 10.1002/ejhf.1502] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 6.7] [Reference Citation Analysis]
435 Rao VS, Ivey-Miranda JB, Cox ZL, Riello R, Griffin M, Fleming J, Soucier R, Sangkachand P, O'Brien M, LoRusso F, D'Ambrosi J, Churchwell K, Mahoney D, Bellumkonda L, Asher JL, Maulion C, Turner JM, Wilson FP, Collins SP, Testani JM. Natriuretic Equation to Predict Loop Diuretic Response in Patients With Heart Failure. J Am Coll Cardiol 2021;77:695-708. [PMID: 33573739 DOI: 10.1016/j.jacc.2020.12.022] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
436 Packer M. Kicking the tyres of a heart failure trial: physician response to the approval of sacubitril/valsartan in the USA. Eur J Heart Fail 2016;18:1211-9. [PMID: 27510447 DOI: 10.1002/ejhf.623] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
437 Huang Y, Wang Y, Huang Y, Zhai M, Zhou Q, Zhao X, Tian P, Ji S, Zhang C, Zhang Y, Zhang J. Prognostic value of sleep apnea and nocturnal hypoxemia in patients with decompensated heart failure. Clin Cardiol 2020;43:329-37. [PMID: 31967668 DOI: 10.1002/clc.23319] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
438 Yao Y, Zhang R, Zhang Q, Zhao X, Zhang J. Does higher SBP at discharge explain better outcomes in non-heart failure with reduced ejection fraction patients? Insights from Fuwai Hospital. J Hypertens 2021;39:356-66. [PMID: 33031173 DOI: 10.1097/HJH.0000000000002633] [Reference Citation Analysis]
439 Monitillo F, Di Terlizzi V, Gioia MI, Barone R, Grande D, Parisi G, Brunetti ND, Iacoviello M. Right Ventricular Function in Chronic Heart Failure: From the Diagnosis to the Therapeutic Approach. J Cardiovasc Dev Dis 2020;7:E12. [PMID: 32283619 DOI: 10.3390/jcdd7020012] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
440 Boban M, Zulj M, Pesa V, Persic V, Trbusic M, Vcev A. Ratio of End-Systolic Volume to Left Atrial Area Is a Solid Benchmark of Systolic Dysfunction in Non-Ischemic Cardiomyopathies. Med Sci Monit 2018;24:9144-50. [PMID: 30555151 DOI: 10.12659/MSM.911586] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
441 Stewart Coats AJ. Early abnormalities of cerebral blood flow in mild non-ischaemic heart failure: part of a whole-body response? Eur J Heart Fail 2017;19:269-70. [PMID: 28157270 DOI: 10.1002/ejhf.713] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
442 Savarese G, Carrero JJ, Pitt B, Anker SD, Rosano GMC, Dahlström U, Lund LH. Factors associated with underuse of mineralocorticoid receptor antagonists in heart failure with reduced ejection fraction: an analysis of 11 215 patients from the Swedish Heart Failure Registry. Eur J Heart Fail 2018;20:1326-34. [PMID: 29578280 DOI: 10.1002/ejhf.1182] [Cited by in Crossref: 72] [Cited by in F6Publishing: 63] [Article Influence: 18.0] [Reference Citation Analysis]
443 Grossman SM, Pravda NS, Orvin K, Hamdan A, Vaturi M, Bengal T, Kornowski R, Weissler-Snir A. Characterization and long-term outcomes of patients with myocarditis: a retrospective observational study. Postepy Kardiol Interwencyjnej 2021;17:60-7. [PMID: 33868419 DOI: 10.5114/aic.2021.104770] [Reference Citation Analysis]
444 Malik J, Valerianova A, Tuka V, Trachta P, Bednarova V, Hruskova Z, Slavikova M, Rosner MH, Tesar V. The effect of high-flow arteriovenous fistulas on systemic haemodynamics and brain oxygenation. ESC Heart Fail 2021;8:2165-71. [PMID: 33755355 DOI: 10.1002/ehf2.13305] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
445 Allemann H, Strömberg A, Thylén I. Perceived Social Support in Persons With Heart Failure Living With an Implantable Cardioverter Defibrillator: A Cross-sectional Explorative Study. J Cardiovasc Nurs 2018;33:E1-8. [DOI: 10.1097/jcn.0000000000000523] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
446 Abraham WT, Ponikowski P, Brueckmann M, Zeller C, Macesic H, Peil B, Brun M, Ustyugova A, Jamal W, Salsali A, Lindenfeld J, Anker SD; EMPERIAL Investigators and National Coordinators. Rationale and design of the EMPERIAL-Preserved and EMPERIAL-Reduced trials of empagliflozin in patients with chronic heart failure. Eur J Heart Fail 2019;21:932-42. [PMID: 31218819 DOI: 10.1002/ejhf.1486] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 7.3] [Reference Citation Analysis]
447 Heggermont WA, Goethals M, Dierckx R, Verstreken S, Bartunek J, Vanderheyden M. Should MRAs be at the front row in heart failure? A plea for the early use of mineralocorticoid receptor antagonists in medical therapy for heart failure based on clinical experience. Heart Fail Rev 2016;21:699-701. [PMID: 27620301 DOI: 10.1007/s10741-016-9583-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
448 Huttin O, Fraser AG, Lund LH, Donal E, Linde C, Kobayashi M, Erdei T, Machu JL, Duarte K, Rossignol P, Paulus W, Zannad F, Girerd N; MEDIA and KaRen investigators. Risk stratification with echocardiographic biomarkers in heart failure with preserved ejection fraction: the media echo score. ESC Heart Fail 2021;8:1827-39. [PMID: 33656803 DOI: 10.1002/ehf2.13251] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
449 Su A, Al'Aref SJ, Beecy AN, Min JK, Karas MG. Clinical and Socioeconomic Predictors of Heart Failure Readmissions: A Review of Contemporary Literature. Mayo Clin Proc 2019;94:1304-20. [PMID: 31272573 DOI: 10.1016/j.mayocp.2019.01.017] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
450 Knuiman P, Straw S, Gierula J, Koshy A, Roberts LD, Witte KK, Ferguson C, Bowen TS. Quantifying the relationship and contribution of mitochondrial respiration to systemic exercise limitation in heart failure. ESC Heart Fail 2021;8:898-907. [PMID: 33609003 DOI: 10.1002/ehf2.13272] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
451 Tsigkou V, Siasos G, Bletsa E, Panoilia M, Papastavrou A, Kokosias G, Oikonomou E, Papageorgiou N, Zaromitidou M, Marinos G, Vavuranakis M, Stefanadis C, Papavassiliou AG, Tousoulis D. The Predictive Role for ST2 in Patients with Acute Coronary Syndromes and Heart Failure. CMC 2020;27:4479-93. [DOI: 10.2174/0929867326666191016121630] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
452 Tanriverdi A, Kahraman BO, Ozsoy I, Acar S, Senturk B, Ozpelit E, Akdeniz B, Savci S. Balance performance in patients with heart failure. Heart Lung 2020;49:458-62. [PMID: 32434700 DOI: 10.1016/j.hrtlng.2020.04.004] [Reference Citation Analysis]
453 Hage C, Löfgren L, Michopoulos F, Nilsson R, Davidsson P, Kumar C, Ekström M, Eriksson MJ, Lyngå P, Persson B, Wallén H, Gan LM, Persson H, Linde C. Metabolomic Profile in HFpEF vs HFrEF Patients. J Card Fail 2020;26:1050-9. [PMID: 32750486 DOI: 10.1016/j.cardfail.2020.07.010] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
454 Saposnik G, Saposnik F, Saposnik P. Rethinking adherence to home care in heart failure: the lessons learned from Diego Maradona's death. Home Health Care Serv Q 2021;:1-12. [PMID: 34284687 DOI: 10.1080/01621424.2021.1945519] [Reference Citation Analysis]
455 Feijen M, Egorova AD, Beeres SLMA, Treskes RW. Early Detection of Fluid Retention in Patients with Advanced Heart Failure: A Review of a Novel Multisensory Algorithm, HeartLogicTM. Sensors (Basel) 2021;21:1361. [PMID: 33671930 DOI: 10.3390/s21041361] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
456 Koehler J, Stengel A, Hofmann T, Wegscheider K, Koehler K, Sehner S, Rose M, Deckwart O, Anker SD, Koehler F, Laufs U. Telemonitoring in patients with chronic heart failure and moderate depressed symptoms: results of the Telemedical Interventional Monitoring in Heart Failure (TIM-HF) study. Eur J Heart Fail 2021;23:186-94. [PMID: 33063412 DOI: 10.1002/ejhf.2025] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
457 Pagliaro BR, Cannata F, Stefanini GG, Bolognese L. Myocardial ischemia and coronary disease in heart failure. Heart Fail Rev 2020;25:53-65. [PMID: 31332663 DOI: 10.1007/s10741-019-09831-z] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 10.5] [Reference Citation Analysis]
458 Karataş MB, Çanga Y, Yelgeç NS, Zengin A, Güzelburç Ö, Eren S, Emre A. Modified SAMe-TT2R2 score for predicting the therapeutic range of digoxin. Herz 2021;46:359-66. [PMID: 32632549 DOI: 10.1007/s00059-020-04965-5] [Reference Citation Analysis]
459 Gu J, Pan JA, Fan YQ, Zhang HL, Zhang JF, Wang CQ. Prognostic impact of HbA1c variability on long-term outcomes in patients with heart failure and type 2 diabetes mellitus. Cardiovasc Diabetol 2018;17:96. [PMID: 29960591 DOI: 10.1186/s12933-018-0739-3] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 6.3] [Reference Citation Analysis]
460 Silva-Cardoso J, Andrade A, Brito D, Ferreira J, Fonseca C, Peres M, Franco F, Moura B. SGLT-2 inhibitors: A step forward in the treatment of heart failure with reduced ejection fraction. Rev Port Cardiol (Engl Ed) 2021;40:687-93. [PMID: 34503709 DOI: 10.1016/j.repce.2021.02.006] [Reference Citation Analysis]
461 Guzman M, Gomez R, Romero SP, Aranda R, Andrey JL, Pedrosa MJ, Egido J, Gomez F. Prognosis of heart failure treated with digoxin or with ivabradine: A cohort study in the community. Int J Clin Pract 2018;72:e13217. [PMID: 30248211 DOI: 10.1111/ijcp.13217] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
462 Deek H, Newton PJ, Kabbani S, Hassouna B, Macdonald PS, Davidson PM. The Lebanese Heart Failure Snapshot: A National Presentation of Acute Heart Failure Admissions. Journal of Nursing Scholarship 2020;52:506-14. [DOI: 10.1111/jnu.12583] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
463 Park CS, Yang HM, Ki YJ, Kang J, Han JK, Park KW, Kang HJ, Koo BK, Kim CJ, Cho MC, Kim YJ, Chae SC, Jeong MH, Kim HS; KAMIR-NIH Registry. Left Ventricular Ejection Fraction 1 Year After Acute Myocardial Infarction Identifies the Benefits of the Long-Term Use of β-Blockers: Analysis of Data From the KAMIR-NIH Registry. Circ Cardiovasc Interv 2021;14:e010159. [PMID: 33877862 DOI: 10.1161/CIRCINTERVENTIONS.120.010159] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
464 Biffi M, Loforte A, Folesani G, Ziacchi M, Attinà D, Niro F, Pasquale F, Pacini D. Hybrid transcatheter left ventricular reconstruction for the treatment of ischemic cardiomyopathy. Cardiovasc Diagn Ther 2021;11:183-92. [PMID: 33708491 DOI: 10.21037/cdt-20-265] [Reference Citation Analysis]
465 Ichikawa K, Sakuragi S, Nishihara T, Tsuji M, Mori A, Yokohama F, Wada T, Hasegawa D, Kawamoto K, Tanakaya M, Katayama Y, Ito H. Influence of arterial stiffness on cardiovascular outcome in patients without high blood pressure. Heart 2018;104:318-23. [DOI: 10.1136/heartjnl-2017-311751] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
466 Murphy KM, Rosenthal JL. Progress in the Presence of Failure: Updates in Chronic Systolic Heart Failure Management. Curr Treat Options Cardio Med 2017;19. [DOI: 10.1007/s11936-017-0552-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
467 Camman M, Joanne P, Agbulut O, Hélary C. 3D models of dilated cardiomyopathy: Shaping the chemical, physical and topographical properties of biomaterials to mimic the cardiac extracellular matrix. Bioact Mater 2022;7:275-91. [PMID: 34466733 DOI: 10.1016/j.bioactmat.2021.05.040] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
468 Iwata Y, Wakabayashi S, Ito S, Kitakaze M. Production of TRPV2-targeting functional antibody ameliorating dilated cardiomyopathy and muscular dystrophy in animal models. Lab Invest 2020;100:324-37. [PMID: 31896817 DOI: 10.1038/s41374-019-0363-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
469 Gori M, Lam CSP, D’elia E, Iorio AM, Calabrese A, Canova P, Cioffi G, De Maria R, Ghirardi A, Iacovoni A, Grosu A, Fontana A, Ferrari P, Parati G, Gavazzi A, Senni M. Integrating natriuretic peptides and diastolic dysfunction to predict adverse events in high-risk asymptomatic subjects. European Journal of Preventive Cardiology 2021;28:937-45. [DOI: 10.1177/2047487319899618] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
470 Koshy AO, Swoboda PPP, Gierula J, Witte KK. Cardiac magnetic resonance in patients with cardiac resynchronization therapy: is it time to scan with resynchronization on? Europace 2019;21:554-62. [PMID: 30608530 DOI: 10.1093/europace/euy299] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
471 Müller-Tasch T, Löwe B, Lossnitzer N, Frankenstein L, Täger T, Haass M, Katus H, Schultz JH, Herzog W. Anxiety and self-care behaviour in patients with chronic systolic heart failure: A multivariate model. Eur J Cardiovasc Nurs 2018;17:170-7. [PMID: 28718661 DOI: 10.1177/1474515117722255] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 5.0] [Reference Citation Analysis]
472 Noordali H, Loudon BL, Frenneaux MP, Madhani M. Cardiac metabolism - A promising therapeutic target for heart failure. Pharmacol Ther 2018;182:95-114. [PMID: 28821397 DOI: 10.1016/j.pharmthera.2017.08.001] [Cited by in Crossref: 39] [Cited by in F6Publishing: 33] [Article Influence: 7.8] [Reference Citation Analysis]
473 Halliday BP, Cleland JG, Goldberger JJ, Prasad SK. Personalizing Risk Stratification for Sudden Death in Dilated Cardiomyopathy: The Past, Present, and Future. Circulation 2017;136:215-31. [DOI: 10.1161/circulationaha.116.027134] [Cited by in Crossref: 105] [Cited by in F6Publishing: 41] [Article Influence: 21.0] [Reference Citation Analysis]
474 Bayés-genís A, Núñez J, Lupón J. Soluble ST2 for Prognosis and Monitoring in Heart Failure. Journal of the American College of Cardiology 2017;70:2389-92. [DOI: 10.1016/j.jacc.2017.09.031] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 5.2] [Reference Citation Analysis]
475 Ghafourian K, Chang H, Ardehali H. Intravenous iron therapy in heart failure: a different perspective. Eur J Heart Fail 2019;21:703-14. [DOI: 10.1002/ejhf.1434] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
476 Pradhan A, Vohra S, Sethi R. Eplerenone: The Multifaceted Drug in Cardiovascular Pharmacology. J Pharm Bioallied Sci 2020;12:381-90. [PMID: 33679083 DOI: 10.4103/jpbs.JPBS_338_19] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
477 Huet F, Dupuy AM, Duflos C, Reis CA, Kuster N, Aguilhon S, Cristol JP, Roubille F. Soluble urokinase-type plasminogen activator receptor strongly predicts global mortality in acute heart failure patients: insight from the STADE-HF registry. Future Sci OA 2021;7:FSO697. [PMID: 34046195 DOI: 10.2144/fsoa-2020-0197] [Reference Citation Analysis]
478 Sattler K, El-Battrawy I, Gietzen T, Kummer M, Lang S, Zhou XB, Behnes M, Borggrefe M, Akin I. Improved Outcome of Cardiogenic Shock Triggered by Takotsubo Syndrome Compared With Myocardial Infarction. Can J Cardiol. 2020;36:860-867. [PMID: 32249068 DOI: 10.1016/j.cjca.2019.10.012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
479 Cosentino E. Sacubitril/Valsartan in Clinical Practice: A Report of 2 Cases. Cardiology 2017;138 Suppl 1:7-10. [PMID: 29262399 DOI: 10.1159/000484874] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
480 Chen X, Jiang X, Cheng C, Chen J, Huang S, Xu M, Liu S. Berberine Attenuates Cardiac Hypertrophy Through Inhibition of mTOR Signaling Pathway. Cardiovasc Drugs Ther 2020;34:463-73. [PMID: 32394178 DOI: 10.1007/s10557-020-06977-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
481 Min D, Park JS, Choi EY, Ahn JA. Comparison of learning needs priorities between healthcare providers and patients with heart failure. PLoS One 2020;15:e0239656. [PMID: 32970770 DOI: 10.1371/journal.pone.0239656] [Reference Citation Analysis]
482 Kosir G, Jug B, Novakovic M, Mijovski MB, Ksela J. Endocan Is an Independent Predictor of Heart Failure-Related Mortality and Hospitalizations in Patients with Chronic Stable Heart Failure. Dis Markers 2019;2019:9134096. [PMID: 31089401 DOI: 10.1155/2019/9134096] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
483 Di Lorenzo A, Iannuzzo G, Parlato A, Cuomo G, Testa C, Coppola M, D'Ambrosio G, Oliviero DA, Sarullo S, Vitale G, Nugara C, Sarullo FM, Giallauria F. Clinical Evidence for Q10 Coenzyme Supplementation in Heart Failure: From Energetics to Functional Improvement. J Clin Med 2020;9:E1266. [PMID: 32349341 DOI: 10.3390/jcm9051266] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
484 Richards AM. Future biomarkers in cardiology: my favourites. European Heart Journal Supplements 2018;20:G37-44. [DOI: 10.1093/eurheartj/suy023] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
485 Sunayama T, Yatsu S, Matsue Y, Dotare T, Maeda D, Ishiwata S, Nakamura Y, Suda S, Kato T, Hiki M, Kasai T, Minamino T. Urinary liver-type fatty acid-binding protein as a prognostic marker in patients with acute heart failure. ESC Heart Fail 2021. [PMID: 34921522 DOI: 10.1002/ehf2.13730] [Reference Citation Analysis]
486 Zhao J, Xu T, Zhou Y, Zhou Y, Xia Y, Li D. B-type natriuretic peptide and its role in altering Ca2+-regulatory proteins in heart failure-mechanistic insights. Heart Fail Rev 2020;25:861-71. [PMID: 31820203 DOI: 10.1007/s10741-019-09883-1] [Reference Citation Analysis]
487 Zoppini G, Bergamini C, Bonapace S, Trombetta M, Mantovani A, Toffalini A, Lanzoni L, Bertolini L, Zenari L, Bonora E, Targher G, Rossi A. Left ventricular chamber dilation and filling pressure may help to categorise patients with type 2 diabetes. BMJ Open Diabetes Res Care 2018;6:e000529. [PMID: 29942525 DOI: 10.1136/bmjdrc-2018-000529] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
488 Bayes-Genis A. Highlights of the 2016 European Society of Cardiology Guidelines on Heart Failure. Eur Cardiol 2017;12:76-7. [PMID: 30416556 DOI: 10.15420/ecr.2017:5:2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
489 Motiejunaite J, Chouihed T, Mebazaa A. Upcoming Challenges in Multidisciplinary Heart Failure Management: Active Role of Future Clinical Pharmacists. Clin Pharmacol Ther 2017;102:180-2. [PMID: 28581206 DOI: 10.1002/cpt.728] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
490 Kuschyk J, Nägele H, Heinz-kuck K, Butter C, Lawo T, Wietholt D, Roeger S, Gutterman D, Burkhoff D, Rousso B, Borggrefe M. Cardiac contractility modulation treatment in patients with symptomatic heart failure despite optimal medical therapy and cardiac resynchronization therapy (CRT). International Journal of Cardiology 2019;277:173-7. [DOI: 10.1016/j.ijcard.2018.10.086] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
491 Mihos CG, Santana O, Yucel E, Capoulade R, Upadhyay GA, Orencole MP, Singh JP, Picard MH. The effects of cardiac resynchronization therapy on left ventricular and mitral valve geometry and secondary mitral regurgitation in patients with left bundle branch block. Echocardiography 2019;36:1450-8. [DOI: 10.1111/echo.14444] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
492 Correale M, Tarantino N, Petrucci R, Tricarico L, Laonigro I, Di Biase M, Brunetti ND. Liver disease and heart failure: Back and forth. European Journal of Internal Medicine 2018;48:25-34. [DOI: 10.1016/j.ejim.2017.10.016] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 3.8] [Reference Citation Analysis]
493 Pan Y, Li D, Ma J, Shan L, Wei M. NT-proBNP test with improved accuracy for the diagnosis of chronic heart failure. Medicine (Baltimore) 2017;96:e9181. [PMID: 29390456 DOI: 10.1097/MD.0000000000009181] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
494 Angermann CE, Rosenkranz S. [Telemonitoring and pulmonary artery pressure-guided treatment of heart failure]. Internist (Berl) 2018;59:1041-53. [PMID: 30238134 DOI: 10.1007/s00108-018-0495-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
495 Lakhani I, Leung KSK, Tse G, Lee APW. Novel Mechanisms in Heart Failure With Preserved, Midrange, and Reduced Ejection Fraction. Front Physiol 2019;10:874. [PMID: 31333505 DOI: 10.3389/fphys.2019.00874] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
496 Doshi R, Patel K, Gupta N, Gupta R, Meraj P. Characteristics and in-hospital outcomes of hospitalisations with heart failure with reduced or preserved ejection fraction undergoing percutaneous coronary intervention. Ir J Med Sci 2019;188:791-9. [PMID: 30328085 DOI: 10.1007/s11845-018-1910-2] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
497 Rossignol P, Zannad F. Hypo- and hyperkalaemia in heart failure. Navigating between Scylla and Charybdis. Eur J Heart Fail 2020;22:1399-401. [PMID: 32167654 DOI: 10.1002/ejhf.1791] [Reference Citation Analysis]
498 Cotter G, Davison BA. Unmodifiable events, heart failure research, and ‘risk‐based monitoring’ in large studies—the unholy triumvirate. Eur J Heart Fail 2018;20:1639-44. [DOI: 10.1002/ejhf.1282] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
499 Edvinsson ML, Stenberg A, Åström-Olsson K. Improved outcome with standardized plan for clinical management of acute decompensated chronic heart failure. J Geriatr Cardiol 2019;16:12-8. [PMID: 30800146 DOI: 10.11909/j.issn.1671-5411.2019.01.002] [Reference Citation Analysis]
500 Wang S, Zhou J, Yang J, Wang X, Chen X, Ji L, Yang L. Clinical features and prognostic factors of acute kidney injury caused by adult secondary hemophagocytic lymphohistiocytosis. J Nephrol. [DOI: 10.1007/s40620-021-01147-2] [Reference Citation Analysis]
501 Magkoutis N, Mantzaraki V, Farmakis D, Spathis A, Foukas P, Bistola V, Bakosis G, Konstantoudakis S, Trogkanis E, Papingiotis G, Hatziagelaki E, Ikonomidis I, Karavidas A, Filippatos G, Parissis J. Effects of functional electrical stimulation of lower limb muscles on circulating endothelial progenitor cells, CD34+ cells and vascular endothelial growth factor-A in heart failure with reduced ejection fraction: Effects of functional electrical stimulation of lower limb muscles on circulating endothelial progenitor cells, CD34+ cells and vascular endothelial g. Eur J Heart Fail 2018;20:1162-3. [DOI: 10.1002/ejhf.1176] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
502 Hirose S, Nakajima T, Nozawa N, Katayanagi S, Ishizaka H, Mizushima Y, Matsumoto K, Nishikawa K, Toyama Y, Takahashi R, Arakawa T, Yasuda T, Haruyama A, Yazawa H, Yamaguchi S, Toyoda S, Shibasaki I, Mizushima T, Fukuda H, Inoue T. Phase Angle as an Indicator of Sarcopenia, Malnutrition, and Cachexia in Inpatients with Cardiovascular Diseases. J Clin Med 2020;9:E2554. [PMID: 32781732 DOI: 10.3390/jcm9082554] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
503 Jorsal A, Wiggers H, Mcmurray JJ. Heart Failure. Endocrinology and Metabolism Clinics of North America 2018;47:117-35. [DOI: 10.1016/j.ecl.2017.10.007] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
504 Čelutkienė J, Lainscak M, Anderson L, Gayat E, Grapsa J, Harjola VP, Manka R, Nihoyannopoulos P, Filardi PP, Vrettou R, Anker SD, Filippatos G, Mebazaa A, Metra M, Piepoli M, Ruschitzka F, Zamorano JL, Rosano G, Seferovic P. Imaging in patients with suspected acute heart failure: timeline approach position statement on behalf of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 2020;22:181-95. [PMID: 31815347 DOI: 10.1002/ejhf.1678] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 7.3] [Reference Citation Analysis]
505 Wei D, Li J, Janszky I, Chen H, Fang F, Ljung R, László KD. Death of a child and the risk of heart failure: a population-based cohort study from Denmark and Sweden. Eur J Heart Fail 2021. [PMID: 34693593 DOI: 10.1002/ejhf.2372] [Reference Citation Analysis]
506 Teng HC, Yeh ML, Wang MH. Walking with controlled breathing improves exercise tolerance, anxiety, and quality of life in heart failure patients: A randomized controlled trial. Eur J Cardiovasc Nurs 2018;17:717-27. [PMID: 29775076 DOI: 10.1177/1474515118778453] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
507 Tschöpe C, Birner C, Böhm M, Bruder O, Frantz S, Luchner A, Maier L, Störk S, Kherad B, Laufs U. Heart failure with preserved ejection fraction: current management and future strategies : Expert opinion on the behalf of the Nucleus of the "Heart Failure Working Group" of the German Society of Cardiology (DKG). Clin Res Cardiol 2018;107:1-19. [PMID: 29018938 DOI: 10.1007/s00392-017-1170-6] [Cited by in Crossref: 52] [Cited by in F6Publishing: 46] [Article Influence: 10.4] [Reference Citation Analysis]
508 von Haehling S, Doehner W, Anker SD. The evolving obesity paradigm story: from heart failure to atrial fibrillation. Eur Heart J 2019;40:1550-2. [PMID: 31009055 DOI: 10.1093/eurheartj/ehz082] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
509 Legrand M, Futier E, Leone M, Deniau B, Mebazaa A, Plaud B, Coriat P, Rossignol P, Vicaut E, Gayat E; STOP-OR-NOT study investigators. Impact of renin-angiotensin system inhibitors continuation versus discontinuation on outcome after major surgery: protocol of a multicenter randomized, controlled trial (STOP-or-NOT trial). Trials 2019;20:160. [PMID: 30836981 DOI: 10.1186/s13063-019-3247-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.7] [Reference Citation Analysis]
510 Knudsen MSS, Eismark F, Goetze JP, Gustafsson F, Wolsk E. The contribution of cardiac and extracardiac factors to NT-proBNP concentrations in patients with advanced heart failure before and after left ventricular assist device implantation. Peptides 2021;135:170420. [PMID: 33058962 DOI: 10.1016/j.peptides.2020.170420] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
511 van Veldhuisen DJ, van Woerden G, Gorter TM, van Empel VPM, Manintveld OC, Tieleman RG, Maass AH, Vernooy K, Westenbrink BD, van Gelder IC, Rienstra M. Ventricular tachyarrhythmia detection by implantable loop recording in patients with heart failure and preserved ejection fraction: the VIP-HF study. Eur J Heart Fail 2020;22:1923-9. [PMID: 32683763 DOI: 10.1002/ejhf.1970] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
512 Johansson I, Dahlström U, Edner M, Näsman P, Rydén L, Norhammar A. Type 2 diabetes and heart failure: Characteristics and prognosis in preserved, mid-range and reduced ventricular function. Diab Vasc Dis Res 2018;15:494-503. [PMID: 30176743 DOI: 10.1177/1479164118794619] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 4.8] [Reference Citation Analysis]
513 Del Vecchio L, Ekart R, Ferro CJ, Malyszko J, Mark PB, Ortiz A, Sarafidis P, Valdivielso JM, Mallamaci F; ERA-EDTA European Renal and Cardiovascular Medicine Working (EURECA-m) Group. Intravenous iron therapy and the cardiovascular system: risks and benefits. Clin Kidney J 2021;14:1067-76. [PMID: 34188903 DOI: 10.1093/ckj/sfaa212] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
514 Son YJ, Oh S, Kim EY. Patients' needs and perspectives for using mobile phone interventions to improve heart failure self-care: A qualitative study. J Adv Nurs 2020;76:2380-90. [PMID: 32672374 DOI: 10.1111/jan.14455] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
515 Semenov AG, Katrukha AG. A View on the Interrelationship between Obesity and Natriuretic Peptide Measurements: Can Dysregulation in pro-B-type Natriuretic Peptide Glycosylation Explain Decreased B-type Natriuretic Peptide Concentrations in Obese Heart Failure Patients? Clin Chem 2019;65:1070-2. [PMID: 31235540 DOI: 10.1373/clinchem.2019.306175] [Reference Citation Analysis]
516 Shin S, Claggett B, Pfeffer MA, Skali H, Liu J, Aguilar D, Diaz R, Dickstein K, Gerstein HC, Køber LV, Lawson FC, Lewis EF, Maggioni AP, Mcmurray JJ, Probstfield JL, Riddle MC, Tardif J, Solomon SD; for the ELIXA Investigators. Hyperglycaemia, ejection fraction and the risk of heart failure or cardiovascular death in patients with type 2 diabetes and a recent acute coronary syndrome. Eur J Heart Fail 2020;22:1133-43. [DOI: 10.1002/ejhf.1790] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
517 Miller RJH, Howlett JG. Untying the Gordian knot of sex and heart failure therapy. Eur J Heart Fail 2021. [PMID: 34263968 DOI: 10.1002/ejhf.2299] [Reference Citation Analysis]
518 Matsue Y, Damman K, Voors AA, Kagiyama N, Yamaguchi T, Kuroda S, Okumura T, Kida K, Mizuno A, Oishi S, Inuzuka Y, Akiyama E, Matsukawa R, Kato K, Suzuki S, Naruke T, Yoshioka K, Miyoshi T, Baba Y, Yamamoto M, Murai K, Mizutani K, Yoshida K, Kitai T. Time-to-Furosemide Treatment and Mortality in Patients Hospitalized With Acute Heart Failure. J Am Coll Cardiol 2017;69:3042-51. [PMID: 28641794 DOI: 10.1016/j.jacc.2017.04.042] [Cited by in Crossref: 136] [Cited by in F6Publishing: 92] [Article Influence: 27.2] [Reference Citation Analysis]
519 Boban M, Pesa V, Persic V, Zulj M, Malcic I, Beck N, Vcev A. Overlapping Phenotypes and Degree of Ventricular Dilatation Are Associated with Severity of Systolic Impairment and Late Gadolinium Enhancement in Non-Ischemic Cardiomyopathies. Med Sci Monit 2018;24:5084-92. [PMID: 30032158 DOI: 10.12659/MSM.909172] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
520 Aimo A, Barison A, Castiglione V, Emdin M. The unbearable underreporting of comorbidities in heart failure clinical trials. Eur J Heart Fail 2020;22:1043-4. [DOI: 10.1002/ejhf.1846] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
521 Traversi E, Rossi D, Maestri R, Olmetti F, La Rovere MT, Pinna GD. The reduction of central sleep apnoea severity in the left lateral position is not due to an improvement in cardiac haemodynamics in patients with chronic heart failure. Sleep Medicine 2017;34:30-2. [DOI: 10.1016/j.sleep.2017.02.023] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
522 Fischer-Rasokat U, Renker M, Liebetrau C, Weferling M, Rolf A, Doss M, Möllmann H, Walther T, Hamm CW, Kim WK. Outcome of patients with heart failure after transcatheter aortic valve implantation. PLoS One 2019;14:e0225473. [PMID: 31770401 DOI: 10.1371/journal.pone.0225473] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
523 Bourke JP, Bueser T, Quinlivan R. Interventions for preventing and treating cardiac complications in Duchenne and Becker muscular dystrophy and X-linked dilated cardiomyopathy. Cochrane Database Syst Rev 2018;10:CD009068. [PMID: 30326162 DOI: 10.1002/14651858.CD009068.pub3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
524 Bertero E, Ameri P, Maack C. Bidirectional Relationship Between Cancer and Heart Failure: Old and New Issues in Cardio-oncology. Card Fail Rev 2019;5:106-11. [PMID: 31179021 DOI: 10.15420/cfr.2019.1.2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
525 Peterson TE, Baker JV, Wong LY, Rupert A, Ntusi NAB, Esmail H, Wilkinson R, Sereti I, Meintjes G, Ntsekhe M, Thienemann F. Elevated N-terminal prohormone of brain natriuretic peptide among persons living with HIV in a South African peri-urban township. ESC Heart Fail 2020;7:3246-51. [PMID: 32585776 DOI: 10.1002/ehf2.12849] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
526 Marra AM, Sherman AE, Salzano A, Guazzi M, Saggar R, Squire IB, Cittadini A, Channick R, Bossone E. Right Heart Pulmonary Circulation Unit Involvement in Left-Sided Heart Failure: Diagnostic, Prognostic, and Therapeutic Implications. Chest 2021:S0012-3692(21)04062-9. [PMID: 34592320 DOI: 10.1016/j.chest.2021.09.023] [Reference Citation Analysis]
527 Anker MS, von Haehling S, Landmesser U, Coats AJS, Anker SD. Cancer and heart failure-more than meets the eye: common risk factors and co-morbidities. Eur J Heart Fail 2018;20:1382-4. [PMID: 29943887 DOI: 10.1002/ejhf.1252] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 6.3] [Reference Citation Analysis]
528 Gastl M, Peereboom SM, Gotschy A, Fuetterer M, von Deuster C, Boenner F, Kelm M, Schwotzer R, Flammer AJ, Manka R, Kozerke S. Myocardial triglycerides in cardiac amyloidosis assessed by proton cardiovascular magnetic resonance spectroscopy. J Cardiovasc Magn Reson 2019;21:10. [PMID: 30700314 DOI: 10.1186/s12968-019-0519-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
529 Raafs AG, Linssen GCM, Brugts JJ, Erol-Yilmaz A, Plomp J, Smits JPP, Nagelsmit MJ, Oortman RM, Hoes AW, Brunner-LaRocca HP. Contemporary use of devices in chronic heart failure in the Netherlands. ESC Heart Fail 2020;7:1771-80. [PMID: 32395914 DOI: 10.1002/ehf2.12740] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
530 Veenis JF, Brunner-La Rocca HP, Linssen GC, Geerlings PR, Van Gent MW, Aksoy I, Oosterom L, Moons AH, Hoes AW, Brugts JJ; CHECK-HF investigators. Age differences in contemporary treatment of patients with chronic heart failure and reduced ejection fraction. Eur J Prev Cardiol 2019;26:1399-407. [PMID: 30866680 DOI: 10.1177/2047487319835042] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
531 Böhm M, Coats AJS, Kindermann I, Spoletini I, Rosano G. Physiological monitoring in the complex multimorbid heart failure patient - Conclusions. Eur Heart J Suppl 2019;21:M68-71. [PMID: 31908622 DOI: 10.1093/eurheartj/suz232] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
532 Voors AA, Kremer D, Geven C, Ter Maaten JM, Struck J, Bergmann A, Pickkers P, Metra M, Mebazaa A, Düngen HD, Butler J. Adrenomedullin in heart failure: pathophysiology and therapeutic application. Eur J Heart Fail 2019;21:163-71. [PMID: 30592365 DOI: 10.1002/ejhf.1366] [Cited by in Crossref: 55] [Cited by in F6Publishing: 45] [Article Influence: 13.8] [Reference Citation Analysis]
533 Ren L, Guan H, Dai G, Gao W, Su J. Efficacy and safety of Shenfuqiangxin pills in complementary treatment of chronic heart failure: A protocol for systematic review and meta-analysis. Medicine (Baltimore) 2021;100:e24531. [PMID: 33847608 DOI: 10.1097/MD.0000000000024531] [Reference Citation Analysis]
534 Liu JJ, Liu S, Wang J, Lee J, Tang JI, Gurung RL, Ang K, Shao YM, Tavintharan S, Tang WE, Sum CF, Lim SC. Risk of incident heart failure in individuals with early-onset type 2 diabetes. J Clin Endocrinol Metab 2021:dgab620. [PMID: 34415993 DOI: 10.1210/clinem/dgab620] [Reference Citation Analysis]
535 Emami A, Saitoh M, Valentova M, Sandek A, Evertz R, Ebner N, Loncar G, Springer J, Doehner W, Lainscak M, Hasenfuß G, Anker SD, von Haehling S. Comparison of sarcopenia and cachexia in men with chronic heart failure: results from the Studies Investigating Co-morbidities Aggravating Heart Failure (SICA-HF). Eur J Heart Fail 2018;20:1580-7. [PMID: 30160804 DOI: 10.1002/ejhf.1304] [Cited by in Crossref: 61] [Cited by in F6Publishing: 59] [Article Influence: 15.3] [Reference Citation Analysis]
536 Kario K, Ito S, Itoh H, Rakugi H, Okuda Y, Yamakawa S. Effect of esaxerenone on nocturnal blood pressure and natriuretic peptide in different dipping phenotypes. Hypertens Res 2022;45:97-105. [PMID: 34650195 DOI: 10.1038/s41440-021-00756-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
537 Heckman GA, Hirdes JP, Hébert PC, Morinville A, Amaral ACKB, Costa A, McKelvie RS. Predicting Future Health Transitions Among Newly Admitted Nursing Home Residents With Heart Failure. J Am Med Dir Assoc 2019;20:438-43. [PMID: 30573437 DOI: 10.1016/j.jamda.2018.10.031] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
538 Lainscak M, Laviano A. ACT-ONE - ACTION at last on cancer cachexia by adapting a novel action beta-blocker. J Cachexia Sarcopenia Muscle 2016;7:400-2. [PMID: 27625919 DOI: 10.1002/jcsm.12136] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 3.3] [Reference Citation Analysis]
539 Josa-laorden C, Sola A, Giménez-lópez I, Rubio-gracia J, Garcés-horna V, Pérez-calvo J. Valor pronóstico de la ratio urea / creatinina en la insuficiencia cardiaca descompensada y su relación con el daño renal agudo. Revista Clínica Española 2018;218:232-40. [DOI: 10.1016/j.rce.2018.03.009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
540 Mishra S, Mohan JC, Nair T, Chopra VK, Harikrishnan S, Guha S, Ramakrishnan S, Ray S, Sethi R, Samal UC, Sarat Chandra K, Hiremath MS, Banerjee AK, Kumar S, Das MK, Deb PK, Bahl VK. Management protocols for chronic heart failure in India. Indian Heart J 2018;70:105-27. [PMID: 29455764 DOI: 10.1016/j.ihj.2017.11.015] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 2.2] [Reference Citation Analysis]
541 Waddingham PH, Lambiase P, Muthumala A, Rowland E, Chow AW. Fusion Pacing with Biventricular, Left Ventricular-only and Multipoint Pacing in Cardiac Resynchronisation Therapy: Latest Evidence and Strategies for Use. Arrhythm Electrophysiol Rev 2021;10:91-100. [PMID: 34401181 DOI: 10.15420/aer.2020.49] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
542 Koudstaal S, Pujades-Rodriguez M, Denaxas S, Gho JMIH, Shah AD, Yu N, Patel RS, Gale CP, Hoes AW, Cleland JG, Asselbergs FW, Hemingway H. Prognostic burden of heart failure recorded in primary care, acute hospital admissions, or both: a population-based linked electronic health record cohort study in 2.1 million people. Eur J Heart Fail 2017;19:1119-27. [PMID: 28008698 DOI: 10.1002/ejhf.709] [Cited by in Crossref: 55] [Cited by in F6Publishing: 43] [Article Influence: 9.2] [Reference Citation Analysis]
543 Pieske B, Tschöpe C, de Boer RA, Fraser AG, Anker SD, Donal E, Edelmann F, Fu M, Guazzi M, Lam CSP, Lancellotti P, Melenovsky V, Morris DA, Nagel E, Pieske-Kraigher E, Ponikowski P, Solomon SD, Vasan RS, Rutten FH, Voors AA, Ruschitzka F, Paulus WJ, Seferovic P, Filippatos G. How to diagnose heart failure with preserved ejection fraction: the HFA-PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). Eur Heart J 2019;40:3297-317. [PMID: 31504452 DOI: 10.1093/eurheartj/ehz641] [Cited by in Crossref: 268] [Cited by in F6Publishing: 199] [Article Influence: 134.0] [Reference Citation Analysis]
544 Lund LH, Carrero J, Farahmand B, Henriksson KM, Jonsson Å, Jernberg T, Dahlström U. Association between enrolment in a heart failure quality registry and subsequent mortality-a nationwide cohort study: Quality registry and mortality in heart failure. Eur J Heart Fail 2017;19:1107-16. [DOI: 10.1002/ejhf.762] [Cited by in Crossref: 48] [Cited by in F6Publishing: 37] [Article Influence: 9.6] [Reference Citation Analysis]
545 Grabska J, Schlöglhofer T, Gross C, Maw M, Dimitrov K, Wiedemann D, Zimpfer D, Schima H, Moscato F. Early Detection of Pump Thrombosis in Patients With Left Ventricular Assist Device. ASAIO J 2020;66:348-54. [PMID: 31294721 DOI: 10.1097/MAT.0000000000001015] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
546 Balmain BN, Sabapathy S, Jay O, Adsett J, Stewart GM, Jayasinghe R, Morris NR. Heart Failure and Thermoregulatory Control: Can Patients With Heart Failure Handle the Heat? Journal of Cardiac Failure 2017;23:621-7. [DOI: 10.1016/j.cardfail.2017.04.003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
547 Michalska-Kasiczak M, Bielecka-Dabrowa A, von Haehling S, Anker SD, Rysz J, Banach M. Biomarkers, myocardial fibrosis and co-morbidities in heart failure with preserved ejection fraction: an overview. Arch Med Sci 2018;14:890-909. [PMID: 30002709 DOI: 10.5114/aoms.2018.76279] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 6.0] [Reference Citation Analysis]
548 Sharma A, Kuppachi S, Subramani S, Walia A, Thomas J, Ramakrishna H. Loop Diuretics-Analysis of Efficacy Data for the Perioperative Clinician. J Cardiothorac Vasc Anesth 2020;34:2253-9. [PMID: 31879151 DOI: 10.1053/j.jvca.2019.10.035] [Reference Citation Analysis]
549 Ahmad T, Testani JM. Haemoconcentration as a treatment goal in heart failure: ready for prime time? Eur J Heart Fail 2017;19:237-40. [PMID: 28157266 DOI: 10.1002/ejhf.715] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
550 Iwata Y, Ito S, Wakabayashi S, Kitakaze M. TRPV2 channel as a possible drug target for the treatment of heart failure. Lab Invest 2020;100:207-17. [PMID: 31857697 DOI: 10.1038/s41374-019-0349-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
551 Shah ASV, Sandoval Y, Noaman A, Sexter A, Vaswani A, Smith SW, Gibbins M, Griffiths M, Chapman AR, Strachan FE, Anand A, Denvir MA, Adamson PD, D'Souza MS, Gray AJ, McAllister DA, Newby DE, Apple FS, Mills NL. Patient selection for high sensitivity cardiac troponin testing and diagnosis of myocardial infarction: prospective cohort study. BMJ 2017;359:j4788. [PMID: 29114078 DOI: 10.1136/bmj.j4788] [Cited by in Crossref: 61] [Cited by in F6Publishing: 44] [Article Influence: 12.2] [Reference Citation Analysis]
552 Galves R, Da Costa A, Pierrard R, Bayard G, Guichard JB, Isaaz K. Impact of β-blocker therapy on right ventricular function in heart failure patients with reduced ejection fraction. A prospective evaluation. Echocardiography 2020;37:1392-8. [PMID: 32815195 DOI: 10.1111/echo.14813] [Reference Citation Analysis]
553 Cafagna G, Seghieri C, Vainieri M, Nuti S. A turnaround strategy: improving equity in order to achieve quality of care and financial sustainability in Italy. Int J Equity Health 2018;17:169. [PMID: 30454018 DOI: 10.1186/s12939-018-0878-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
554 Wang Z, Dong Y, Gao Q, Zhang Q, Jiang H. The role of acute heart failure index (AHFI) combined with emergency heart failure mortality risk grade (EHMRG) in the evaluation of clinical outcomes and prognosis in patients with acute heart failure. Acta Cardiol 2021;:1-6. [PMID: 34338593 DOI: 10.1080/00015385.2021.1955482] [Reference Citation Analysis]
555 Palau P, Domínguez E, Núñez J. Sex differences on peak oxygen uptake in heart failure. ESC Heart Fail 2019;6:921-6. [PMID: 31325239 DOI: 10.1002/ehf2.12483] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
556 Qian H, Tang C, Yan G. Predictive value of blood urea nitrogen/creatinine ratio in the long-term prognosis of patients with acute myocardial infarction complicated with acute heart failure. Medicine (Baltimore) 2019;98:e14845. [PMID: 30882678 DOI: 10.1097/MD.0000000000014845] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
557 Woldman S. Heart failure management-time to change our script on prognosis?: Viewpoint. Eur J Heart Fail 2018;20:837-8. [DOI: 10.1002/ejhf.1157] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
558 Zhang J, Lenarczyk R, Marin F, Malaczynska-Rajpold K, Kosiuk J, Doehner W, Van Gelder IC, Lee G, Hendriks JM, Lip GYH, Potpara TS. The interpretation of CHA2DS2-VASc score components in clinical practice: a joint survey by the European Heart Rhythm Association (EHRA) Scientific Initiatives Committee, the EHRA Young Electrophysiologists, the Association of Cardiovascular Nursing and Allied Professionals, and the European Society of Cardiology Council on Stroke. Europace 2021;23:314-22. [PMID: 33554259 DOI: 10.1093/europace/euaa358] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
559 Liguori I, Russo G, Curcio F, Sasso G, Della-Morte D, Gargiulo G, Pirozzi F, Cacciatore F, Bonaduce D, Abete P, Testa G. Depression and chronic heart failure in the elderly: an intriguing relationship. J Geriatr Cardiol 2018;15:451-9. [PMID: 30108618 DOI: 10.11909/j.issn.1671-5411.2018.06.014] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
560 Clerico A, Passino C, Emdin M. The paradox of low B-type natriuretic peptide levels in obesity revisited: does sex matter?: Editorial comment. Eur J Heart Fail 2018;20:1215-6. [DOI: 10.1002/ejhf.1226] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
561 Sakata Y, Tsuji K, Nochioka K, Shimokawa H. Transition of Left Ventricular Ejection Fraction in Heart Failure. In: Islam MS, editor. Heart Failure: From Research to Clinical Practice. Cham: Springer International Publishing; 2018. pp. 5-15. [DOI: 10.1007/5584_2018_178] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
562 Kanda T, Uematsu M, Fujita M, Iida O, Masuda M, Okamoto S, Ishihara T, Nanto K, Tsujimura T, Matsuda Y, Okuno S, Mano T. A novel predictor of clinical outcomes in patients with heart failure with preserved left-ventricular ejection fraction: a pilot study. Heart Vessels 2018;33:1490-5. [PMID: 29934800 DOI: 10.1007/s00380-018-1211-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
563 Linde C. Pace and ablate better than drugs in patients with heart failure and atrial fibrillation: lessons from the APAF-CRT mortality trial. Eur Heart J 2021;42:4740-2. [PMID: 34613382 DOI: 10.1093/eurheartj/ehab695] [Reference Citation Analysis]
564 Schauer A, Draskowski R, Jannasch A, Kirchhoff V, Goto K, Männel A, Barthel P, Augstein A, Winzer E, Tugtekin M, Labeit S, Linke A, Adams V. ZSF1 rat as animal model for HFpEF: Development of reduced diastolic function and skeletal muscle dysfunction. ESC Heart Fail 2020;7:2123-34. [PMID: 32710530 DOI: 10.1002/ehf2.12915] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
565 Aldaas OM, Malladi CL, Mylavarapu PS, Lupercio F, Darden D, Han FT, Hoffmayer KS, Krummen D, Ho G, Raissi F, Feld GK, Hsu JC. Comparison of Outcomes After Ablation of Atrial Fibrillation in Patients With Heart Failure With Preserved Versus Reduced Ejection Fraction. Am J Cardiol 2020;136:62-70. [PMID: 32941815 DOI: 10.1016/j.amjcard.2020.09.018] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
566 Chinwong S, Doungsong K, Channaina P, Phrommintikul A, Chinwong D. Association between medication adherence and cardiovascular outcomes among acute coronary syndrome patients. Res Social Adm Pharm 2021;17:1631-5. [PMID: 33455883 DOI: 10.1016/j.sapharm.2021.01.003] [Reference Citation Analysis]
567 Vicent L, Nuñez Olarte JM, Puente-Maestu L, Oliva A, López JC, Postigo A, Martín I, Luna R, Fernández-Avilés F, Martínez-Sellés M. Degree of dyspnoea at admission and discharge in patients with heart failure and respiratory diseases. BMC Palliat Care 2017;16:35. [PMID: 28532487 DOI: 10.1186/s12904-017-0208-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
568 Maggioni AP. Appropriate prescriptions mean better outcomes: how can we improve ourselves? Eur J Heart Fail 2019;21:930-1. [PMID: 31099172 DOI: 10.1002/ejhf.1476] [Reference Citation Analysis]
569 Núñez J, Miñana G, Cardells I, Palau P, Llàcer P, Fácila L, Almenar L, López-Lereu MP, Monmeneu JV, Amiguet M, González J, Serrano A, Montagud V, López-Vilella R, Valero E, García-Blas S, Bodí V, de la Espriella-Juan R, Lupón J, Navarro J, Górriz JL, Sanchis J, Chorro FJ, Comín-Colet J, Bayés-Genís A; Myocardial‐IRON Investigators* †. Noninvasive Imaging Estimation of Myocardial Iron Repletion Following Administration of Intravenous Iron: The Myocardial-IRON Trial. J Am Heart Assoc 2020;9:e014254. [PMID: 32067585 DOI: 10.1161/JAHA.119.014254] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
570 Mert GÖ, Dural M, Mert KU. Comparison of acute management of atrial fibrillation in heart failure with unequal sized groups. Am J Emerg Med 2018;36:1693. [PMID: 29941321 DOI: 10.1016/j.ajem.2018.06.046] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
571 González-Islas D, Arámbula-Garza E, Orea-Tejeda A, Castillo-Martínez L, Keirns-Davies C, Salgado-Fernández F, Hernández-Urquieta L, Hernández-López S, Pilotzi-Montiel Y. Body composition changes assessment by bioelectrical impedance vectorial analysis in right heart failure and left heart failure. Heart Lung 2020;49:42-7. [PMID: 31421949 DOI: 10.1016/j.hrtlng.2019.07.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
572 Wang Y, Zhou R, Lu C, Chen Q, Xu T, Li D. Effects of the Angiotensin-Receptor Neprilysin Inhibitor on Cardiac Reverse Remodeling: Meta-Analysis. J Am Heart Assoc 2019;8:e012272. [PMID: 31240976 DOI: 10.1161/JAHA.119.012272] [Cited by in Crossref: 33] [Cited by in F6Publishing: 14] [Article Influence: 11.0] [Reference Citation Analysis]
573 Simonovic D, Coiro S, Deljanin-Ilic M, Kobayashi M, Carluccio E, Girerd N, Ambrosio G. Exercise-induced B-lines in heart failure with preserved ejection fraction occur along with diastolic function worsening. ESC Heart Fail 2021. [PMID: 34655174 DOI: 10.1002/ehf2.13575] [Reference Citation Analysis]
574 Hage C, Bjerre M, Frystyk J, Gu HF, Brismar K, Donal E, Daubert JC, Linde C, Lund LH. Comparison of Prognostic Usefulness of Serum Insulin-Like Growth Factor-Binding Protein 7 in Patients With Heart Failure and Preserved Versus Reduced Left Ventricular Ejection Fraction. Am J Cardiol 2018;121:1558-66. [PMID: 29622288 DOI: 10.1016/j.amjcard.2018.02.041] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
575 Boerma E, Singer M. Beta-blockers in sepsis: time to reconsider current constraints? British Journal of Anaesthesia 2017;119:560-1. [DOI: 10.1093/bja/aex266] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
576 Cho J, Park IB, Lee K, Ahn TH, Park WB, Kim JH, Ahn Y, Jeong MH, Lee DH; Other Korea Acute Myocardial Infarction Registry (KAMIR) and Korea Working Group on Myocardial Infarction (KorMI) Investigators. Statin has more protective effects in AMI patients with higher plasma BNP or NT-proBNP level, but not with lower left ventricular ejection fraction. J Cardiol 2018;71:375-81. [PMID: 29158023 DOI: 10.1016/j.jjcc.2017.10.009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
577 Li N, Zhu Y, Zeng J. Clinical value of pulmonary congestion detection by lung ultrasound in patients with chronic heart failure. Clin Cardiol 2021;44:1488-96. [PMID: 34599512 DOI: 10.1002/clc.23738] [Reference Citation Analysis]
578 Bazoukis G, Naka KK, Alsheikh-Ali A, Tse G, Letsas KP, Korantzopoulos P, Liu T, Yeung C, Efremidis M, Tsioufis K, Baranchuk A, Stavrakis S. Association of QRS narrowing with response to cardiac resynchronization therapy-a systematic review and meta-analysis of observational studies. Heart Fail Rev 2020;25:745-56. [PMID: 31392534 DOI: 10.1007/s10741-019-09839-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
579 Amin A, von Haehling S. Updates in heart failure: Highlights from the Iranian Joint Cardiovascular Congress Tehran, Iran, 1-4 March 2016. Int J Cardiol 2017;235:179-82. [PMID: 28284507 DOI: 10.1016/j.ijcard.2017.02.088] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
580 Janssen DJA, Johnson MJ, Spruit MA. Palliative care needs assessment in chronic heart failure. Curr Opin Support Palliat Care 2018;12:25-31. [PMID: 29206704 DOI: 10.1097/SPC.0000000000000317] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
581 Esposito D, Pasquali D, Johannsson G. Primary Adrenal Insufficiency: Managing Mineralocorticoid Replacement Therapy. J Clin Endocrinol Metab 2018;103:376-87. [PMID: 29156052 DOI: 10.1210/jc.2017-01928] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 4.8] [Reference Citation Analysis]
582 Furer A, Wessler J, Burkhoff D. Hemodynamics of Cardiogenic Shock. Interv Cardiol Clin 2017;6:359-71. [PMID: 28600090 DOI: 10.1016/j.iccl.2017.03.006] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
583 Nakano I, Tsuda M, Kinugawa S, Fukushima A, Kakutani N, Takada S, Yokota T. Loop diuretic use is associated with skeletal muscle wasting in patients with heart failure. J Cardiol 2020;76:109-14. [PMID: 32001074 DOI: 10.1016/j.jjcc.2020.01.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
584 Giannitsi S, Bougiakli M, Bechlioulis A, Naka K. Endothelial dysfunction and heart failure: A review of the existing bibliography with emphasis on flow mediated dilation. JRSM Cardiovasc Dis 2019;8:2048004019843047. [PMID: 31007907 DOI: 10.1177/2048004019843047] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 6.7] [Reference Citation Analysis]
585 MacKenzie M, Hall R. Pharmacogenomics and pharmacogenetics for the intensive care unit: a narrative review. Can J Anaesth 2017;64:45-64. [PMID: 27752976 DOI: 10.1007/s12630-016-0748-1] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 3.7] [Reference Citation Analysis]
586 Boşnak Güçlü M, Barği G, Katayifçi N, Şen F. Comparison of functional and maximal exercise capacity, respiratory and peripheral muscle strength, dyspnea, and fatigue in patients with heart failure with pacemakers and healthy controls: a cross-sectional study. Physiother Theory Pract 2021;37:295-306. [PMID: 31204872 DOI: 10.1080/09593985.2019.1630878] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
587 Cohen LP, Vittinghoff E, Pletcher MJ, Allen NB, Shah SJ, Wilkins JT, Chang PP, Ndumele CE, Newman AB, Ives D, Maurer MS, Oelsner EC, Moran AE, Zhang Y. Association of Midlife Cardiovascular Risk Factors With the Risk of Heart Failure Subtypes Later in Life. J Card Fail 2021;27:435-44. [PMID: 33238139 DOI: 10.1016/j.cardfail.2020.11.008] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
588 Yoshihisa A, Ishibashi S, Matsuda M, Yamadera Y, Ichijo Y, Sato Y, Yokokawa T, Misaka T, Oikawa M, Kobayashi A, Yamaki T, Kunii H, Takeishi Y. Clinical Implications of Hepatic Hemodynamic Evaluation by Abdominal Ultrasonographic Imaging in Patients With Heart Failure. J Am Heart Assoc 2020;9:e016689. [PMID: 32750309 DOI: 10.1161/JAHA.120.016689] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
589 Turri-Silva N, Vale-Lira A, Verboven K, Quaglioti Durigan JL, Hansen D, Cipriano G Jr. High-intensity interval training versus progressive high-intensity circuit resistance training on endothelial function and cardiorespiratory fitness in heart failure: A preliminary randomized controlled trial. PLoS One 2021;16:e0257607. [PMID: 34597330 DOI: 10.1371/journal.pone.0257607] [Reference Citation Analysis]
590 Kamon D, Sugawara Y, Soeda T, Okamura A, Nakada Y, Hashimoto Y, Ueda T, Nishida T, Onoue K, Okayama S, Watanabe M, Kawakami R, Saito Y. Predominant subtype of heart failure after acute myocardial infarction is heart failure with non-reduced ejection fraction. ESC Heart Fail 2021;8:317-25. [PMID: 33295115 DOI: 10.1002/ehf2.13070] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
591 Sessa M, Mascolo A, Mortensen RN, Andersen MP, Rosano GMC, Capuano A, Rossi F, Gislason G, Enghusen-Poulsen H, Torp-Pedersen C. Relationship between heart failure, concurrent chronic obstructive pulmonary disease and beta-blocker use: a Danish nationwide cohort study. Eur J Heart Fail 2018;20:548-56. [PMID: 29159953 DOI: 10.1002/ejhf.1045] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 5.6] [Reference Citation Analysis]
592 Paolini C, Mugnai G, Dalla Valle C, Volpiana A, Ferraglia A, Frigo AC, Bilato C. Effects and clinical implications of sacubitril/valsartan on left ventricular reverse remodeling in patients affected by chronic heart failure: A 24-month follow-up. Int J Cardiol Heart Vasc 2021;35:100821. [PMID: 34179333 DOI: 10.1016/j.ijcha.2021.100821] [Reference Citation Analysis]
593 Onyemelukwe OU, Oyati AI, Danbauchi SS, Obasohan A. B-Type Natriuretic Peptides (BNP) and Tissue Doppler E/e´ Before and After 4 Weeks Standard Treatment of African Heart Failure Subjects: The ABU-BNP Longitudinal Survey. Vasc Health Risk Manag 2019;15:559-69. [PMID: 31908467 DOI: 10.2147/VHRM.S211498] [Reference Citation Analysis]
594 Murakami T, Takeda A. Aortic Reservoir Function has a Strong Impact on the Cardiac Blood Supply-Workload Balance in Children. Pediatr Cardiol 2018;39:660-4. [PMID: 29288317 DOI: 10.1007/s00246-017-1803-6] [Reference Citation Analysis]
595 Abdu FA, Liu L, Mohammed AQ, Yin G, Xu B, Zhang W, Xu S, Lv X, Fan R, Feng C, Shi T, Huo Y, Xu Y, Che W. Prognostic impact of coronary microvascular dysfunction in patients with myocardial infarction with non-obstructive coronary arteries. Eur J Intern Med 2021:S0953-6205(21)00186-2. [PMID: 34092485 DOI: 10.1016/j.ejim.2021.05.027] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
596 Tilea I, Varga A, Georgescu AM, Grigorescu BL. Critical Care Management of Decompensated Right Heart Failure in Pulmonary Arterial Hypertension Patients - An Ongoing Approach. J Crit Care Med (Targu Mures) 2021;7:170-83. [PMID: 34722920 DOI: 10.2478/jccm-2021-0020] [Reference Citation Analysis]
597 Lapinskas T, Kelle S, Grune J, Foryst-Ludwig A, Meyborg H, Jeuthe S, Wellnhofer E, Elsanhoury A, Pieske B, Gebker R, Kintscher U, Stawowy P. Serelaxin Improves Regional Myocardial Function in Experimental Heart Failure: An In Vivo Cardiac Magnetic Resonance Study. J Am Heart Assoc 2020;9:e013702. [PMID: 32000566 DOI: 10.1161/JAHA.119.013702] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
598 Silva Lopes B, Craveiro N, Firmino-Machado J, Ribeiro P, Castelo-Branco M. Hemodynamic differences among hypertensive patients with and without heart failure using impedance cardiography. Ther Adv Cardiovasc Dis 2019;13:1753944719876517. [PMID: 31554488 DOI: 10.1177/1753944719876517] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
599 Poulidakis E, Aggeli C, Sideris S, Sfendouraki E, Koutagiar I, Katsaros A, Giannoulis E, Koukos M, Margioula E, Lagoudakou S, Gatzoulis K, Dilaveris P, Kallikazaros I, Couloheri S, Stefanadis C, Tousoulis D. Echocardiography for prediction of 6-month and late response to cardiac resynchronization therapy: implementation of stress echocardiography and comparative assessment along with widely used dyssynchrony indices. Int J Cardiovasc Imaging 2019;35:285-94. [PMID: 30623352 DOI: 10.1007/s10554-018-01520-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.7] [Reference Citation Analysis]
600 Michels da Silva D, Langer H, Graf T. Inflammatory and Molecular Pathways in Heart Failure—Ischemia, HFpEF and Transthyretin Cardiac Amyloidosis. IJMS 2019;20:2322. [DOI: 10.3390/ijms20092322] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 5.7] [Reference Citation Analysis]
601 Gao WQ, Meng XD, Sun Z. Efficacy of tolvaptan for chronic heart failure: Study protocol for a systematic review of randomized controlled trial. Medicine (Baltimore) 2019;98:e14540. [PMID: 30762795 DOI: 10.1097/MD.0000000000014540] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
602 Tamargo J, Caballero R, Delpón E. New drugs in preclinical and early stage clinical development in the treatment of heart failure. Expert Opinion on Investigational Drugs 2019;28:51-71. [DOI: 10.1080/13543784.2019.1551357] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
603 D'Amario D, Migliaro S, Borovac JA, Restivo A, Vergallo R, Galli M, Leone AM, Montone RA, Niccoli G, Aspromonte N, Crea F. Microvascular Dysfunction in Heart Failure With Preserved Ejection Fraction. Front Physiol. 2019;10:1347. [PMID: 31749710 DOI: 10.3389/fphys.2019.01347] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 8.0] [Reference Citation Analysis]
604 Han X, Zhang S, Chen Z, Adhikari BK, Zhang Y, Zhang J, Sun J, Wang Y. Cardiac biomarkers of heart failure in chronic kidney disease. Clin Chim Acta 2020;510:298-310. [PMID: 32710942 DOI: 10.1016/j.cca.2020.07.040] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
605 Bjarnason-wehrens B, Predel H. Inspiratory muscle training – an inspiration for more effective cardiac rehabilitation in heart failure patients? Eur J Prev Cardiolog 2018;25:1687-90. [DOI: 10.1177/2047487318798917] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
606 Papadimitriou L, Hamo CE, Butler J. Heart Failure Guidelines on Pharmacotherapy. Handb Exp Pharmacol 2017;243:109-29. [PMID: 28451824 DOI: 10.1007/164_2017_24] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
607 Lee TC, Qian M, Mu L, Di Tullio MR, Graham S, Mann DL, Nakanishi K, Teerlink JR, Lip GYH, Freudenberger RS, Sacco RL, Mohr JP, Labovitz AJ, Ponikowski P, Lok DJ, Estol C, Anker SD, Pullicino PM, Buchsbaum R, Levin B, Thompson JLP, Homma S, Ye S; WARCEF Investigators. Association between mortality and implantable cardioverter-defibrillators by aetiology of heart failure: a propensity-matched analysis of the WARCEF trial. ESC Heart Fail 2019;6:297-307. [PMID: 30816013 DOI: 10.1002/ehf2.12407] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
608 Novák J, Macháčková T, Krejčí J, Bienertová-Vašků J, Slabý O. MicroRNAs as theranostic markers in cardiac allograft transplantation: from murine models to clinical practice. Theranostics 2021;11:6058-73. [PMID: 33897899 DOI: 10.7150/thno.56327] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
609 Gundersen GH, Norekvål TM, Graven T, Haug HH, Skjetne K, Kleinau JO, Gustad LT, Dalen H. Patient-reported outcomes and associations with pleural effusion in outpatients with heart failure: an observational cohort study. BMJ Open 2017;7:e013734. [PMID: 28320791 DOI: 10.1136/bmjopen-2016-013734] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
610 Sciatti E, Dallapellegrina L, Metra M, Lombardi CM. New drugs for the treatment of chronic heart failure with a reduced ejection fraction: What the future may hold. Journal of Cardiovascular Medicine 2019;20:650-9. [DOI: 10.2459/jcm.0000000000000850] [Cited by in Crossref: 7] [Article Influence: 2.3] [Reference Citation Analysis]
611 Díez-Villanueva P, Jiménez-Méndez C, Alfonso F. Heart failure in the elderly. J Geriatr Cardiol 2021;18:219-32. [PMID: 33907552 DOI: 10.11909/j.issn.1671-5411.2021.03.009] [Reference Citation Analysis]
612 Berezin AE, Berezin AA. Adverse Cardiac Remodelling after Acute Myocardial Infarction: Old and New Biomarkers. Dis Markers 2020;2020:1215802. [PMID: 32626540 DOI: 10.1155/2020/1215802] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
613 Sanfilippo F, Knight JB, Scolletta S, Santonocito C, Pastore F, Lorini FL, Tritapepe L, Morelli A, Arcadipane A. Levosimendan for patients with severely reduced left ventricular systolic function and/or low cardiac output syndrome undergoing cardiac surgery: a systematic review and meta-analysis. Crit Care 2017;21:252. [PMID: 29047417 DOI: 10.1186/s13054-017-1849-0] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 5.4] [Reference Citation Analysis]
614 van den Berge JC, van Vark LC, Postmus D, Utens EMWJ, Hillege HL, Boersma E, Lesman-Leegte I, Akkerhuis KM. Determinants of quality of life in acute heart failure patients with and without comorbidities: a prospective, observational study. Eur J Cardiovasc Nurs 2021:zvab061. [PMID: 34392355 DOI: 10.1093/eurjcn/zvab061] [Reference Citation Analysis]
615 Salzano A, Marra AM, Arcopinto M, D'Assante R, Triggiani V, Coscioni E, Pasquali D, Rengo G, Suzuki T, Bossone E, Cittadini A. Combined effects of growth hormone and testosterone replacement treatment in heart failure. ESC Heart Fail 2019;6:1216-21. [PMID: 31696666 DOI: 10.1002/ehf2.12520] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
616 Frankenstein L, Seide S, Täger T, Jensen K, Fröhlich H, Clark AL, Seiz M, Katus HA, Nee P, Uhlmann L, Naci H, Atar D. Relative Efficacy of Spironolactone, Eplerenone, and cAnRenone in patients with Chronic Heart failure (RESEARCH): a systematic review and network meta-analysis of randomized controlled trials. Heart Fail Rev 2020;25:161-71. [PMID: 31364027 DOI: 10.1007/s10741-019-09832-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
617 Nikolovska Vukadinović A, Vukadinović D, Borer J, Cowie M, Komajda M, Lainscak M, Swedberg K, Böhm M. Heart rate and its reduction in chronic heart failure and beyond: Heart rate and its reduction in chronic heart failure and beyond. Eur J Heart Fail 2017;19:1230-41. [DOI: 10.1002/ejhf.902] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 4.2] [Reference Citation Analysis]
618 Rørth R, Fosbøl EL, Mogensen UM, Kragholm K, Jhund PS, Petrie MC, Schou M, Gislason GH, McMurray JJV, Torp-Pedersen C, Køber L, Kristensen SL. Evidence-Based Therapy and Its Association With Workforce Detachment After First Hospitalization for Heart Failure. JACC Heart Fail 2018;6:41-8. [PMID: 29226811 DOI: 10.1016/j.jchf.2017.09.019] [Reference Citation Analysis]
619 Martens P, Dupont M, Dauw J, Somers F, Herbots L, Timmermans P, Verwerft J, Mullens W. Rationale and design of the IRON-CRT trial: effect of intravenous ferric carboxymaltose on reverse remodelling following cardiac resynchronization therapy. ESC Heart Fail 2019;6:1208-15. [PMID: 31562751 DOI: 10.1002/ehf2.12503] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
620 Colom G, Salvador JP, Acosta G, Albericio F, Royo M, Marco MP. Competitive ELISA for N-terminal pro-brain natriuretic peptide (NT-proBNP) determination in human plasma. Analyst 2020;145:6719-27. [PMID: 32815928 DOI: 10.1039/d0an00650e] [Reference Citation Analysis]
621 Piek A, Suthahar N, Voors AA, de Boer RA, Silljé HHW. A combined bioinformatics, experimental and clinical approach to identify novel cardiac-specific heart failure biomarkers: is Dickkopf-3 (DKK3) a possible candidate? Eur J Heart Fail 2020;22:2065-74. [PMID: 32809235 DOI: 10.1002/ejhf.1988] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
622 Palau P, Domínguez E, López L, Ramón JM, Heredia R, González J, Santas E, Bodí V, Miñana G, Valero E, Mollar A, Bertomeu González V, Chorro FJ, Sanchis J, Lupón J, Bayés-genís A, Núñez J. Entrenamiento de la musculatura inspiratoria y la electroestimulación muscular funcional en el tratamiento de la insuficiencia cardiaca con función sistólica conservada: estudio TRAINING-HF. Revista Española de Cardiología 2019;72:288-97. [DOI: 10.1016/j.recesp.2018.01.024] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 3.7] [Reference Citation Analysis]
623 Galderisi M, Cosyns B, Edvardsen T, Cardim N, Delgado V, Di Salvo G, Donal E, Sade LE, Ernande L, Garbi M, Grapsa J, Hagendorff A, Kamp O, Magne J, Santoro C, Stefanidis A, Lancellotti P, Popescu B, Habib G; 2016–2018 EACVI Scientific Documents Committee., 2016–2018 EACVI Scientific Documents Committee. Standardization of adult transthoracic echocardiography reporting in agreement with recent chamber quantification, diastolic function, and heart valve disease recommendations: an expert consensus document of the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 2017;18:1301-10. [PMID: 29045589 DOI: 10.1093/ehjci/jex244] [Cited by in Crossref: 176] [Cited by in F6Publishing: 141] [Article Influence: 44.0] [Reference Citation Analysis]
624 Komajda M, Isnard R, Cohen-Solal A, Metra M, Pieske B, Ponikowski P, Voors AA, Dominjon F, Henon-Goburdhun C, Pannaux M, Böhm M; prEserveD left ventricular ejectIon fraction chronic heart Failure with ivabradine studY (EDIFY) Investigators. Effect of ivabradine in patients with heart failure with preserved ejection fraction: the EDIFY randomized placebo-controlled trial. Eur J Heart Fail 2017;19:1495-503. [PMID: 28462519 DOI: 10.1002/ejhf.876] [Cited by in Crossref: 98] [Cited by in F6Publishing: 83] [Article Influence: 19.6] [Reference Citation Analysis]
625 Katsi V, Marketou M, Antonopoulos AS, Vrachatis D, Parthenakis F, Tousoulis D. B-type natriuretic peptide levels and benign adiposity in obese heart failure patients. Heart Fail Rev 2019;24:219-26. [DOI: 10.1007/s10741-018-9739-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
626 Guo X, Gu X, Jiang J, Li H, Duan R, Zhang Y, Sun L, Bao Z, Shen J, Chen F. A Hospital-Community-Family-Based Telehealth Program for Patients With Chronic Heart Failure: Single-Arm, Prospective Feasibility Study. JMIR Mhealth Uhealth 2019;7:e13229. [PMID: 31833835 DOI: 10.2196/13229] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
627 Yue M, Zhang L, Lu Y, Jin C. Translation and psychometric evaluation of the Chinese version of the Heart Failure-Specific Health Literacy Scale. International Journal of Nursing Sciences 2016;3:342-6. [DOI: 10.1016/j.ijnss.2016.11.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
628 Sun J, Qiu Y, Guo H, Hua Y, Shao B, Qiao Y, Guo J, Ding H, Zhang Z, Miao L, Wang N, Zhang Y, Chen Y, Lu J, Dai M, Zhang C, Wang R. A method to screen left ventricular dysfunction through ECG based on convolutional neural network. J Cardiovasc Electrophysiol 2021;32:1095-102. [DOI: 10.1111/jce.14936] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
629 Choi HJ, Seo EJ, Choi JS, Oh SJ, Son YJ. Perioperative risk factors for new-onset postoperative atrial fibrillation among patients after isolated coronary artery bypass grafting: A retrospective study. J Adv Nurs 2021. [PMID: 34519375 DOI: 10.1111/jan.15045] [Reference Citation Analysis]
630 Dellafiore F, Buck HG, Pucciarelli G, Barbaranelli C, Paturzo M, Alvaro R, Vellone E. Psychometric characteristics of the mutuality scale in heart failure patients and caregivers. Heart & Lung 2018;47:553-61. [DOI: 10.1016/j.hrtlng.2018.05.018] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
631 Lee H, Park G, Lee KS, Jin H, Chun KJ, Kim JH. Knowledge, Adherence to Lifestyle Recommendations, and Quality of Life Among Koreans With Heart Failure. J Cardiovasc Pharmacol Ther 2020;25:324-31. [PMID: 32233801 DOI: 10.1177/1074248420916324] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
632 Kaur N, Pruthvi CR, Rohit M. Will introduction of ARNI reduce the need of device therapy in heart failure with reduced ejection fraction? Egypt Heart J 2021;73:26. [PMID: 33725186 DOI: 10.1186/s43044-021-00152-x] [Reference Citation Analysis]
633 S SK, Desai N, Gona OJ, K VK, B M. Impact of Updated 2016 ASE/EACVI VIS-À-VIS 2009 ASE Recommendation on the Prevalence of Diastolic Dysfunction and LV Filling Pressures in Patients with Preserved Ejection Fraction. J Cardiovasc Imaging 2021;29:31-43. [PMID: 33511798 DOI: 10.4250/jcvi.2020.0117] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
634 Dalal HM, Taylor RS, Wingham J, Greaves CJ, Jolly K, Lang CC, Davis RC, Smith KM, Doherty PJ, Miles J, van Lingen R, Warren FC, Sadler S, Abraham C, Britten N, Frost J, Hillsdon M, Singh S, Hayward C, Eyre V, Paul K. A facilitated home-based cardiac rehabilitation intervention for people with heart failure and their caregivers: a research programme including the REACH-HF RCT. Programme Grants Appl Res 2021;9:1-100. [DOI: 10.3310/pgfar09010] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
635 Turcato G, Cervellin G, Bonora A, Prati D, Zorzi E, Ricci G, Salvagno GL, Maccagnani A, Lippi G. Red Blood Cell Distribution Width Improves Reclassification of Patients Admitted to the Emergency Department with Acute Decompensated Heart Failure. J Med Biochem 2018;37:299-306. [PMID: 30598626 DOI: 10.1515/jomb-2017-0054] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
636 Takei M, Kohsaka S, Shiraishi Y, Goda A, Nagatomo Y, Mizuno A, Suzino Y, Kohno T, Fukuda K, Yoshikawa T. Heart Failure With Midrange Ejection Fraction in Patients Admitted for Acute Decompensation: A Report from the Japanese Multicenter Registry. J Card Fail 2019;25:666-73. [PMID: 31129270 DOI: 10.1016/j.cardfail.2019.05.010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
637 Tolppanen H, Rivas-Lasarte M, Lassus J, Sans-Roselló J, Hartmann O, Lindholm M, Arrigo M, Tarvasmäki T, Köber L, Thiele H, Pulkki K, Spinar J, Parissis J, Banaszewski M, Silva-Cardoso J, Carubelli V, Sionis A, Harjola VP, Mebazaa A. Adrenomedullin: a marker of impaired hemodynamics, organ dysfunction, and poor prognosis in cardiogenic shock. Ann Intensive Care 2017;7:6. [PMID: 28050899 DOI: 10.1186/s13613-016-0229-2] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 5.4] [Reference Citation Analysis]
638 Logeart D, Berthelot E, Bihry N, Eschalier R, Salvat M, Garcon P, Eicher JC, Cohen A, Tartiere JM, Samadi A, Donal E, deGroote P, Mewton N, Mansencal N, Raphael P, Ghanem N, Seronde MF, Chavelas C, Rosamel Y, Beauvais F, Kevorkian JP, Diallo A, Vicaut E, Isnard R. Early and short-term intensive management after discharge for patients hospitalized with acute heart failure: a randomized study (ECAD-HF). Eur J Heart Fail 2021. [PMID: 34628697 DOI: 10.1002/ejhf.2357] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
639 Vijiiac A, Onciul S, Guzu C, Scarlatescu A, Petre I, Zamfir D, Onut R, Deaconu S, Dorobantu M. Forgotten No More-The Role of Right Ventricular Dysfunction in Heart Failure with Reduced Ejection Fraction: An Echocardiographic Perspective. Diagnostics (Basel) 2021;11:548. [PMID: 33808566 DOI: 10.3390/diagnostics11030548] [Reference Citation Analysis]
640 Klimiuk A, Zalewska A, Sawicki R, Knapp M, Maciejczyk M. Salivary Oxidative Stress Increases With the Progression of Chronic Heart Failure. J Clin Med 2020;9:E769. [PMID: 32178375 DOI: 10.3390/jcm9030769] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 13.5] [Reference Citation Analysis]
641 Suutari AM, Thor J, Nordin AMM, Kjellström S, Areskoug Josefsson K. Improving Health for People Living With Heart Failure: Focus Group Study of Preconditions for Co-Production of Health and Care. J Particip Med 2021;13:e27125. [PMID: 33973859 DOI: 10.2196/27125] [Reference Citation Analysis]
642 Saito H, Matsue Y, Suzuki M, Kamiya K, Hasegawa Y, Endo Y, Negishi Y, Hirano M, Takanashi K, Iizuka H, Matsumura A, Hashimoto Y. Discordance between subjective and objective evaluations of cognitive function in old Japanese patients with heart failure. Australas J Ageing 2018;38:57-9. [DOI: 10.1111/ajag.12591] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
643 Targher G, Dauriz M, Laroche C, Temporelli PL, Hassanein M, Seferovic PM, Drozdz J, Ferrari R, Anker S, Coats A, Filippatos G, Crespo‐leiro MG, Mebazaa A, Piepoli MF, Maggioni AP, Tavazzi L, Crespo‐leiro M, Anker S, Coats A, Ferrari R, Filippatos G, Maggioni A, Mebazaa A, Piepoli M, Amir O, Chioncel O, Dahlström U, Jimenez JD, Drozdz J, Erglis A, Fazlibegovic E, Fonseca C, Fruhwald F, Gatzov P, Goncalvesova E, Hassanein M, Hradec J, Kavoliuniene A, Lainscak M, Logeart D, Merkely B, Metra M, Otljanska M, Seferovic P, Kostovska ES, Temizhan A, Tousoulis D, Andarala M, Ferreira T, Fiorucci E, Gracia G, Laroche C, Pommier C, Taylor C, Cuculici A, Gaulhofer C, Casado EP, Szymczyk E, Ramani F, Mulak G, Schou I, Semenka J, Stojkovic J, Mehanna R, Mizarienne V, Auer J, Ablasser K, Fruhwald F, Dolze T, Brandner K, Gstrein S, Poelzl G, Moertl D, Reiter S, Podczeck‐schweighofer A, Muslibegovic A, Vasilj M, Fazlibegovic E, Cesko M, Zelenika D, Palic B, Pravdic D, Cuk D, Vitlianova K, Katova T, Velikov T, Kurteva T, Gatzov P, Kamenova D, Antova M, Sirakova V, Krejci J, Mikolaskova M, Spinar J, Krupicka J, Malek F, Hegarova M, Lazarova M, Monhart Z, Hassanein M, Sobhy M, El Messiry F, El Shazly A, Elrakshy Y, Youssef A, Moneim A, Noamany M, Reda A, Dayem TA, Farag N, Halawa SI, Hamid MA, Said K, Saleh A, Ebeid H, Hanna R, Aziz R, Louis O, Enen M, Ibrahim B, Nasr G, Elbahry A, Sobhy H, Ashmawy M, Gouda M, Aboleineen W, Bernard Y, Luporsi P, Meneveau N, Pillot M, Morel M, Seronde M, Schiele F, Briand F, Delahaye F, Damy T, Eicher J, Groote P, Fertin M, Lamblin N, Isnard R, Lefol C, Thevenin S, Hagege A, Jondeau G, Logeart D, Le Marcis V, Ly J, Coisne D, Lequeux B, Le Moal V, Mascle S, Lotton P, Behar N, Donal E, Thebault C, Ridard C, Reynaud A, Basquin A, Bauer F, Codjia R, Galinier M, Tourikis P, Stavroula M, Tousoulis D, Stefanadis C, Chrysohoou C, Kotrogiannis I, Matzaraki V, Dimitroula T, Karavidas A, Tsitsinakis G, Kapelios C, Nanas J, Kampouri H, Nana E, Kaldara E, Eugenidou A, Vardas P, Saloustros I, Patrianakos A, Tsaknakis T, Evangelou S, Nikoloulis N, Tziourganou H, Tsaroucha A, Papadopoulou A, Douras A, Polgar L, Merkely B, Kosztin A, Nyolczas N, Nagy AC, Halmosi R, Elber J, Alony I, Shotan A, Fuhrmann AV, Amir O, Romano S, Marcon S, Penco M, Di Mauro M, Lemme E, Carubelli V, Rovetta R, Metra M, Bulgari M, Quinzani F, Lombardi C, Bosi S, Schiavina G, Squeri A, Barbieri A, Di Tano G, Pirelli S, Ferrari R, Fucili A, Passero T, Musio S, Di Biase M, Correale M, Salvemini G, Brognoli S, Zanelli E, Giordano A, Agostoni P, Italiano G, Salvioni E, Copelli S, Modena M, Reggianini L, Valenti C, Olaru A, Bandino S, Deidda M, Mercuro G, Dessalvi CC, Marino P, Di Ruocco M, Sartori C, Piccinino C, Parrinello G, Licata G, Torres D, Giambanco S, Busalacchi S, Arrotti S, Novo S, Inciardi R, Pieri P, Chirco P, Galifi MA, Teresi G, Buccheri D, Minacapelli A, Veniani M, Frisinghelli A, Priori S, Cattaneo S, Opasich C, Gualco A, Pagliaro M, Mancone M, Fedele F, Cinque A, Vellini M, Scarfo I, Romeo F, Ferraiuolo F, Sergi D, Anselmi M, Melandri F, Leci E, Iori E, Bovolo V, Pidello S, Frea S, Bergerone S, Botta M, Canavosio F, Gaita F, Merlo M, Cinquetti M, Sinagra G, Ramani F, Fabris E, Stolfo D, Artico J, Miani D, Fresco C, Daneluzzi C, Proclemer A, Cicoira M, Zanolla L, Marchese G, Torelli F, Vassanelli C, Voronina N, Erglis A, Tamakauskas V, Smalinskas V, Karaliute R, Petraskiene I, Kazakauskaite E, Rumbinaite E, Kavoliuniene A, Vysniauskas V, Brazyte‐ramanauskiene R, Petraskiene D, Stankala S, Switala P, Juszczyk Z, Sinkiewicz W, Gilewski W, Pietrzak J, Orzel T, Kasztelowicz P, Kardaszewicz P, Lazorko‐piega M, Gabryel J, Mosakowska K, Bellwon J, Rynkiewicz A, Raczak G, Lewicka E, Dabrowska‐kugacka A, Bartkowiak R, Sosnowska‐pasiarska B, Wozakowska‐kaplon B, Krzeminski A, Zabojszcz M, Mirek‐bryniarska E, Grzegorzko A, Bury K, Nessler J, Zalewski J, Furman A, Broncel M, Poliwczak A, Bala A, Zycinski P, Rudzinska M, Jankowski L, Kasprzak J, Michalak L, Soska KW, Drozdz J, Huziuk I, Retwinski A, Flis P, Weglarz J, Bodys A, Grajek S, Kaluzna‐oleksy M, Straburzynska‐migaj E, Dankowski R, Szymanowska K, Grabia J, Szyszka A, Nowicka A, Samcik M, Wolniewicz L, Baczynska K, Komorowska K, Poprawa I, Komorowska E, Sajnaga D, Zolbach A, Dudzik‐plocica A, Abdulkarim A, Lauko‐rachocka A, Kaminski L, Kostka A, Cichy A, Ruszkowski P, Splawski M, Fitas G, Szymczyk A, Serwicka A, Fiega A, Zysko D, Krysiak W, Szabowski S, Skorek E, Pruszczyk P, Bienias P, Ciurzynski M, Welnicki M, Mamcarz A, Folga A, Zielinski T, Rywik T, Leszek P, Sobieszczanska‐malek M, Piotrowska M, Kozar‐kaminska K, Komuda K, Wisniewska J, Tarnowska A, Balsam P, Marchel M, Opolski G, Kaplon‐cieslicka A, Gil R, Mozenska O, Byczkowska K, Gil K, Pawlak A, Michalek A, Krzesinski P, Piotrowicz K, Uzieblo‐zyczkowska B, Stanczyk A, Skrobowski A, Ponikowski P, Jankowska E, Rozentryt P, Polonski L, Gadula‐gacek E, Nowalany‐kozielska E, Kuczaj A, Kalarus Z, Szulik M, Przybylska K, Klys J, Prokop‐lewicka G, Kleinrok A, Aguiar CT, Ventosa A, Pereira S, Faria R, Chin J, De Jesus I, Santos R, Silva P, Moreno N, Queirós C, Lourenço C, Pereira A, Castro A, Andrade A, Guimaraes TO, Martins S, Placido R, Lima G, Brito D, Francisco A, Cardiga R, Proenca M, Araujo I, Marques F, Fonseca C, Moura B, Leite S, Campelo M, Silva‐cardoso J, Rodrigues J, Rangel I, Martins E, Correia AS, Peres M, Marta L, Silva GF, Severino D, Durao D, Leao S, Magalhaes P, Moreira I, Cordeiro AF, Ferreira C, Araujo C, Ferreira A, Baptista A, Radoi M, Bicescu G, Vinereanu D, Sinescu C, Macarie C, Popescu R, Daha I, Dan G, Stanescu C, Dan A, Craiu E, Nechita E, Aursulesei V, Christodorescu R, Otasevic P, Seferovic P, Simeunovic D, Ristic A, Celic V, Pavlovic‐kleut M, Lazic JS, Stojcevski B, Pencic B, Stevanovic A, Andric A, Iric‐cupic V, Jovic M, Davidovic G, Milanov S, Mitic V, Atanaskovic V, Antic S, Pavlovic M, Stanojevic D, Stoickov V, Ilic S, Ilic MD, Petrovic D, Stojsic S, Kecojevic S, Dodic S, Adic NC, Cankovic M, Stojiljkovic J, Mihajlovic B, Radin A, Radovanovic S, Krotin M, Klabnik A, Goncalvesova E, Pernicky M, Murin J, Kovar F, Kmec J, Semjanova H, Strasek M, Iskra MS, Ravnikar T, Suligoj NC, Komel J, Fras Z, Jug B, Glavic T, Losic R, Bombek M, Krajnc I, Krunic B, Horvat S, Kovac D, Rajtman D, Cencic V, Letonja M, Winkler R, Valentincic M, Melihen‐bartolic C, Bartolic A, Vrckovnik MP, Kladnik M, Pusnik CS, Marolt A, Klen J, Drnovsek B, Leskovar B, Anguita MF, Page JG, Martinez FS, Andres J, Genis A, Mirabet S, Mendez A, Garcia‐cosio L, Roig E, Leon V, Gonzalez‐costello J, Muntane G, Garay A, Alcade‐martinez V, Fernandez SL, Rivera‐lopez R, Puga‐martinez M, Fernandez‐alvarez M, Serrano‐martinez J, Crespo‐leiro M, Grille‐cancela Z, Marzoa‐rivas R, Blanco‐canosa P, Paniagua‐martin M, Barge‐caballero E, Cerdena IL, Baldomero IFH, Padron AL, Rosillo SO, Gonzalez‐gallarza RD, Montanes OS, Manjavacas AI, Conde AC, Araujo A, Soria T, Garcia‐pavia P, Gomez‐bueno M, Cobo‐marcos M, Alonso‐pulpon L, Cubero JS, Sayago I, Gonzalez‐segovia A, Briceno A, Subias PE, Hernandez MV, Cano MR, Sanchez MG, Jimenez JD, Garrido‐lestache EB, Pinilla JG, Villa BG, Sahuquillo A, Marques RB, Calvo FT, Perez‐martinez M, Gracia‐rodenas M, Garrido‐bravo IP, Pastor‐perez F, Pascual‐figal D, Molina BD, Orus J, Gonzalo FE, Bertomeu V, Valero R, Martinez‐abellan R, Quiles J, Rodrigez‐ortega J, Mateo I, Elamrani A, Fernandez‐vivancos C, Valero DB, Almenar‐bonet L, Sanchez‐lazaro I, Marques‐sule E, Facila‐rubio L, Perez‐silvestre J, Garcia‐gonzalez P, Ridocci‐soriano F, Garcia‐escriva D, Pellicer‐cabo A, Fuente Galan L, Diaz JL, Platero AR, Arias J, Blasco‐peiro T, Julve MS, Sanchez‐insa E, Aured‐guallar C, Portoles‐ocampo A, Melin M, Hägglund E, Stenberg A, Lindahl I, Asserlund B, Olsson L, Dahlström U, Afzelius M, Karlström P, Tengvall L, Wiklund P, Olsson B, Kalayci S, Temizhan A, Cavusoglu Y, Gencer E, Yilmaz M, Gunes H; ESC‐HFA HF Long‐Term Registry investigators. In‐hospital and 1‐year mortality associated with diabetes in patients with acute heart failure: results from the ESC‐HFA Heart Failure Long‐Term Registry. Eur J Heart Fail 2017;19:54-65. [DOI: 10.1002/ejhf.679] [Cited by in Crossref: 76] [Cited by in F6Publishing: 66] [Article Influence: 12.7] [Reference Citation Analysis]
644 Zhang N, Zhao Y, Liu Y, Tang N, Zheng W, Mao M, Liu Q, Shen L, Deng B. A double-blinded, placebo-controlled randomized trial evaluating the efficacy and safety of Zhigancao Tang granules for treating HFpEF: study protocol for a randomized controlled trial. Trials 2021;22:293. [PMID: 33879223 DOI: 10.1186/s13063-021-05232-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
645 Sen J, Chung E, McGill D. Tolvaptan for Heart Failure in Chronic Kidney Disease Patients: A Systematic Review and Meta-Analysis. Heart Lung Circ 2018;27:928-39. [PMID: 29602756 DOI: 10.1016/j.hlc.2017.12.013] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
646 Nagueh SF. Heart failure with preserved ejection fraction: insights into diagnosis and pathophysiology. Cardiovasc Res 2021;117:999-1014. [PMID: 32717061 DOI: 10.1093/cvr/cvaa228] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
647 Inciardi RM, Rossi A. Left atrium: a forgotten biomarker and a potential target in cardiovascular medicine. Journal of Cardiovascular Medicine 2019;20:797-808. [DOI: 10.2459/jcm.0000000000000886] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
648 Eiringhaus J, Wünsche CM, Tirilomis P, Herting J, Bork N, Nikolaev VO, Hasenfuss G, Sossalla S, Fischer TH. Sacubitrilat reduces pro-arrhythmogenic sarcoplasmic reticulum Ca2+ leak in human ventricular cardiomyocytes of patients with end-stage heart failure. ESC Heart Fail 2020;7:2992-3002. [PMID: 32710603 DOI: 10.1002/ehf2.12918] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
649 Tymińska A, Kapłon-Cieślicka A, Ozierański K, Budnik M, Wancerz A, Sypień P, Peller M, Balsam P, Opolski G, Filipiak KJ. Association of Galectin-3 and Soluble ST2, and Their Changes, with Echocardiographic Parameters and Development of Heart Failure after ST-Segment Elevation Myocardial Infarction. Dis Markers 2019;2019:9529053. [PMID: 31687050 DOI: 10.1155/2019/9529053] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
650 Piotrowski J, Timler M, Kozłowski R, Stasiak A, Stasiak J, Bissinger A, Timler D, Timler W, Marczak M, Załuska R, Piotrowski G. Clinical Characteristics, Treatment, and Short-Term Outcome in Patients with Heart Failure and Cancer. Clin Pract 2021;11:933-41. [PMID: 34940006 DOI: 10.3390/clinpract11040107] [Reference Citation Analysis]
651 Gould J, Sieniewicz B, Porter B, Sidhu B, Rinaldi CA. Chronic Right Ventricular Pacing in the Heart Failure Population. Curr Heart Fail Rep 2018;15:61-9. [PMID: 29435789 DOI: 10.1007/s11897-018-0376-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
652 Crespo-leiro MG, Metra M, Lund LH, Milicic D, Costanzo MR, Filippatos G, Gustafsson F, Tsui S, Barge-caballero E, De Jonge N, Frigerio M, Hamdan R, Hasin T, Hülsmann M, Nalbantgil S, Potena L, Bauersachs J, Gkouziouta A, Ruhparwar A, Ristic AD, Straburzynska-migaj E, Mcdonagh T, Seferovic P, Ruschitzka F. Advanced heart failure: a position statement of the Heart Failure Association of the European Society of Cardiology: Advanced heart failure: HFA position statement. Eur J Heart Fail 2018;20:1505-35. [DOI: 10.1002/ejhf.1236] [Cited by in Crossref: 217] [Cited by in F6Publishing: 145] [Article Influence: 54.3] [Reference Citation Analysis]
653 Voors AA, Tamby JF, Cleland JG, Koren M, Forgosh LB, Gupta D, Lund LH, Camacho A, Karra R, Swart HP, Pellicori P, Wagner F, Hershberger RE, Prasad N, Anderson R, Anto A, Bell K, Edelberg JM, Fang L, Henze M, Kelly C, Kurio G, Li W, Wells K, Yang C, Teichman SL, Del Rio CL, Solomon SD. Effects of danicamtiv, a novel cardiac myosin activator, in heart failure with reduced ejection fraction: experimental data and clinical results from a phase 2a trial. Eur J Heart Fail 2020;22:1649-58. [PMID: 32558989 DOI: 10.1002/ejhf.1933] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
654 Russell-Hallinan A, Neary R, Watson CJ, Baugh JA. Repurposing From Oncology to Cardiology: Low-Dose 5-Azacytidine Attenuates Pathological Cardiac Remodeling in Response to Pressure Overload Injury. J Cardiovasc Pharmacol Ther 2021;26:375-85. [PMID: 33264040 DOI: 10.1177/1074248420979235] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
655 DeFilippis EM, Butler J, Vaduganathan M. Waiting Period Before Implantable Cardioverter-Defibrillator Implantation in Newly Diagnosed Heart Failure With Reduced Ejection Fraction: A Window of Opportunity. Circ Heart Fail 2017;10:e004478. [PMID: 29138249 DOI: 10.1161/CIRCHEARTFAILURE.117.004478] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
656 Shah M, Zimmer R, Kollefrath M, Khandwalla R. Digital Technologies in Heart Failure Management. Curr Cardiovasc Risk Rep 2020;14. [DOI: 10.1007/s12170-020-00643-7] [Reference Citation Analysis]
657 Brynildsen J, Petäjä L, Pettilä V, Nygård S, Vaara ST, Linko R, Okkonen M, Hagve TA, Soininen L, Suojaranta-Ylinen R, Lyngbakken MN, Omland T, Røsjø H. The predictive value of NT-proBNP and hs-TnT for risk of death in cardiac surgical patients. Clin Biochem 2018;53:65-71. [PMID: 29371002 DOI: 10.1016/j.clinbiochem.2018.01.012] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 2.8] [Reference Citation Analysis]
658 Manuel AM, Almeida J, Fonseca P, Monteiro J, Guerreiro C, Barbosa AR, Teixeira P, Ribeiro J, Santos E, Rosas F, Ribeiro J, Dias A, Caeiro D, Sousa O, Teixeira M, Oliveira M, Gonçalves H, Primo J, Braga P. Long-term outcomes after radiofrequency catheter ablation of the atrioventricular node: The experience of a Portuguese tertiary center. Rev Port Cardiol (Engl Ed) 2021;40:95-103. [PMID: 33422375 DOI: 10.1016/j.repc.2020.05.016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
659 Roalfe AK, Taylor CJ, Kelder JC, Hoes AW, Hobbs FDR. Diagnosing heart failure in primary care: individual patient data meta-analysis of two European prospective studies. ESC Heart Fail 2021;8:2193-201. [PMID: 33755352 DOI: 10.1002/ehf2.13311] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
660 Novo G, Santoro C, Manno G, Di Lisi D, Esposito R, Mandoli GE, Evola V, Pastore MC, Sperlongano S, D'Andrea A, Cameli M, Galderisi M. Usefulness of Stress Echocardiography in the Management of Patients Treated with Anticancer Drugs. J Am Soc Echocardiogr 2021;34:107-16. [PMID: 33223357 DOI: 10.1016/j.echo.2020.10.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
661 Lin X, Fang L. Pharmaceutical Treatment for Heart Failure. Adv Exp Med Biol 2020;1177:269-95. [PMID: 32246448 DOI: 10.1007/978-981-15-2517-9_7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
662 Hashemi D, Blum M, Mende M, Störk S, Angermann CE, Pankuweit S, Tahirovic E, Wachter R, Pieske B, Edelmann F, Düngen HD; German Competence Network for Heart Failure. Syncopes and clinical outcome in heart failure: results from prospective clinical study data in Germany. ESC Heart Fail 2020;7:942-52. [PMID: 32003157 DOI: 10.1002/ehf2.12605] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
663 Kassianides X, Bhandari S. Hypophosphataemia, fibroblast growth factor 23 and third-generation intravenous iron compounds: a narrative review. Drugs Context 2021;10:2020-11-3. [PMID: 33519940 DOI: 10.7573/dic.2020-11-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
664 Pascual-Figal D, Bayes-Genis A. The misperception of 'stable' heart failure. Eur J Heart Fail 2018;20:1375-8. [PMID: 29943884 DOI: 10.1002/ejhf.1248] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Article Influence: 2.3] [Reference Citation Analysis]
665 Weinmann K, Werner J, Koenig W, Rottbauer W, Walcher D, Keßler M. Add-on Immunoadsorption Shortly-after Optimal Medical Treatment Further Significantly and Persistently Improves Cardiac Function and Symptoms in Recent-Onset Heart Failure-A Single Center Experience. Biomolecules 2018;8:E133. [PMID: 30400209 DOI: 10.3390/biom8040133] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
666 Ishikawa Y, Sattler ELP. Nutrition as Treatment Modality in Heart Failure. Curr Atheroscler Rep 2021;23:13. [PMID: 33594492 DOI: 10.1007/s11883-021-00908-5] [Reference Citation Analysis]
667 Al-Jarallah M, Rajan R, Al-Zakwani I, Dashti R, Bulbanat B, Sulaiman K, Alsheikh-Ali AA, Panduranga P, AlHabib KF, Al Suwaidi J, Al-Mahmeed W, AlFaleh H, Elasfar A, Al-Motarreb A, Ridha M, Bazargani N, Asaad N, Amin H. Incidence and impact of cardiorenal anaemia syndrome on all-cause mortality in acute heart failure patients stratified by left ventricular ejection fraction in the Middle East. ESC Heart Fail 2019;6:103-10. [PMID: 30315634 DOI: 10.1002/ehf2.12351] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
668 Bose CN, Saboonchi F, Persson H, Björling G, Elfström ML. Adaptation of Coping Effectiveness Training for Patients With Heart Failure and Patient-Reported Experience of the Intervention. J Patient Exp 2020;7:1054-61. [PMID: 33457545 DOI: 10.1177/2374373520916012] [Reference Citation Analysis]
669 Tromp J, Ouwerkerk W, Demissei BG, Anker SD, Cleland JG, Dickstein K, Filippatos G, van der Harst P, Hillege HL, Lang CC, Metra M, Ng LL, Ponikowski P, Samani NJ, van Veldhuisen DJ, Zannad F, Zwinderman AH, Voors AA, van der Meer P. Novel endotypes in heart failure: effects on guideline-directed medical therapy. European Heart Journal 2018;39:4269-76. [DOI: 10.1093/eurheartj/ehy712] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 6.3] [Reference Citation Analysis]
670 Alhakak AS, Teerlink JR, Lindenfeld J, Böhm M, Rosano GMC, Biering-Sørensen T. The significance of left ventricular ejection time in heart failure with reduced ejection fraction. Eur J Heart Fail 2021;23:541-51. [PMID: 33590579 DOI: 10.1002/ejhf.2125] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
671 Bauersachs J, Arrigo M, Hilfiker-kleiner D, Veltmann C, Coats AJ, Crespo-leiro MG, De Boer RA, van der Meer P, Maack C, Mouquet F, Petrie MC, Piepoli MF, Regitz-zagrosek V, Schaufelberger M, Seferovic P, Tavazzi L, Ruschitzka F, Mebazaa A, Sliwa K. Current management of patients with severe acute peripartum cardiomyopathy: practical guidance from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy: Current management of patients with severe acute peripartum cardiomyopathy. Eur J Heart Fail 2016;18:1096-105. [DOI: 10.1002/ejhf.586] [Cited by in Crossref: 113] [Cited by in F6Publishing: 86] [Article Influence: 18.8] [Reference Citation Analysis]
672 Weir MR, Bushinsky DA, Benton WW, Woods SD, Mayo MR, Arthur SP, Pitt B, Bakris GL. Effect of Patiromer on Hyperkalemia Recurrence in Older Chronic Kidney Disease Patients Taking RAAS Inhibitors. The American Journal of Medicine 2018;131:555-564.e3. [DOI: 10.1016/j.amjmed.2017.11.011] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 6.3] [Reference Citation Analysis]
673 Rachwan RJ, Butler J, Collins SP, Cotter G, Davison BA, Senger S, Ezekowitz JA, Filippatos G, Levy PD, Metra M, Ponikowski P, Teerlink JR, Voors AA, de Boer RA, Soergel DG, Felker GM, Pang PS. Is plasma renin activity associated with worse outcomes in acute heart failure? A secondary analysis from the BLAST-AHF trial. Eur J Heart Fail 2019;21:1561-70. [PMID: 31646707 DOI: 10.1002/ejhf.1607] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
674 Grabczak EM, Stec S, Dabrowska M, Plevkova J, Krenke R. Cough as a Cause and Consequence of Heart Dysfunction - Current State of Art. Physiol Res 2020;69:S105-21. [PMID: 32228016 DOI: 10.33549/physiolres.934408] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
675 van den Berge JC, Vroegindewey MM, Veenis JF, Brugts JJ, Caliskan K, Manintveld OC, Akkerhuis KM, Boersma E, Deckers JW, Constantinescu AA. Left ventricular remodelling and prognosis after discharge in new-onset acute heart failure with reduced ejection fraction. ESC Heart Fail 2021;8:2679-89. [PMID: 33934556 DOI: 10.1002/ehf2.13299] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
676 Sidhu BS, Gould J, Sieniewicz BJ, Porter B, Rinaldi CA. Complications associated with cardiac resynchronization therapy upgrades versus de novo implantations. Expert Rev Cardiovasc Ther 2018;16:607-15. [PMID: 29985076 DOI: 10.1080/14779072.2018.1498783] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
677 Shrivastava A, Haase T, Zeller T, Schulte C. Biomarkers for Heart Failure Prognosis: Proteins, Genetic Scores and Non-coding RNAs. Front Cardiovasc Med 2020;7:601364. [PMID: 33330662 DOI: 10.3389/fcvm.2020.601364] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
678 Lu X, Zhao M, Tian C, Wei H, Gao M, Yang X, Zhang X, Li X. Prognostic value of ventricular mechanical dyssynchrony in patients with left ventricular aneurysm: A comparative study of medical and surgical treatment. J Nucl Cardiol 2020. [PMID: 32909240 DOI: 10.1007/s12350-020-02343-6] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
679 Şener YZ, Okşul M, Bölek EÇ. Iron deficiency and heart failure. Acta Cardiol 2021;76:107. [PMID: 31920152 DOI: 10.1080/00015385.2019.1707433] [Reference Citation Analysis]
680 Park JJ, Choi H, Hwang I, Park J, Park J, Cho G. Myocardial Strain for Identification of β-Blocker Responders in Heart Failure with Preserved Ejection Fraction. Journal of the American Society of Echocardiography 2019;32:1462-1469.e8. [DOI: 10.1016/j.echo.2019.06.017] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
681 Xiangli S, Lan L, Libiya Z, Jun M, Shubin J. Effect of levosimendan combined with recombinant human brain natriuretic peptide on diuretic resistance. Libyan J Med 2021;16:1973762. [PMID: 34493175 DOI: 10.1080/19932820.2021.1973762] [Reference Citation Analysis]
682 Nikolaidou T, Samuel NA, Marincowitz C, Fox DJ, Cleland JGF, Clark AL. Electrocardiographic characteristics in patients with heart failure and normal ejection fraction: A systematic review and meta-analysis. Ann Noninvasive Electrocardiol 2020;25:e12710. [PMID: 31603593 DOI: 10.1111/anec.12710] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
683 Carubelli V, Zhang Y, Metra M, Lombardi C, Felker GM, Filippatos G, O'Connor CM, Teerlink JR, Simmons P, Segal R, Malfatto G, La Rovere MT, Li D, Han X, Yuan Z, Yao Y, Li B, Lau LF, Bianchi G, Zhang J; Istaroxime ADHF Trial Group. Treatment with 24 hour istaroxime infusion in patients hospitalised for acute heart failure: a randomised, placebo-controlled trial. Eur J Heart Fail 2020;22:1684-93. [PMID: 31975496 DOI: 10.1002/ejhf.1743] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 6.5] [Reference Citation Analysis]
684 McCullough PA, Uhlig K, Neylan JF, Pergola PE, Fishbane S. Usefulness of Oral Ferric Citrate in Patients With Iron-Deficiency Anemia and Chronic Kidney Disease With or Without Heart Failure. Am J Cardiol 2018;122:683-8. [PMID: 29961562 DOI: 10.1016/j.amjcard.2018.04.062] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
685 Tschöpe C, Ammirati E, Bozkurt B, Caforio ALP, Cooper LT, Felix SB, Hare JM, Heidecker B, Heymans S, Hübner N, Kelle S, Klingel K, Maatz H, Parwani AS, Spillmann F, Starling RC, Tsutsui H, Seferovic P, Van Linthout S. Myocarditis and inflammatory cardiomyopathy: current evidence and future directions. Nat Rev Cardiol 2021;18:169-93. [PMID: 33046850 DOI: 10.1038/s41569-020-00435-x] [Cited by in Crossref: 57] [Cited by in F6Publishing: 56] [Article Influence: 28.5] [Reference Citation Analysis]
686 Ueda T, Kawakami R, Nakada Y, Nakano T, Nakagawa H, Matsui M, Nishida T, Onoue K, Soeda T, Okayama S, Watanabe M, Okura H, Saito Y. Differences in blood pressure riser pattern in patients with acute heart failure with reduced mid-range and preserved ejection fraction. ESC Heart Fail 2019;6:1057-67. [PMID: 31325235 DOI: 10.1002/ehf2.12500] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
687 Kakoullis L, Giannopoulou E, Papachristodoulou E, Pantzaris ND, Karamouzos V, Kounis NG, Koniari I, Velissaris D. The utility of brain natriuretic peptides in septic shock as markers for mortality and cardiac dysfunction: A systematic review. Int J Clin Pract 2019;73:e13374. [PMID: 31111653 DOI: 10.1111/ijcp.13374] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
688 Bunu DM, Timofte CE, Ciocoiu M, Floria M, Tarniceriu CC, Barboi OB, Tanase DM. Cardiovascular Manifestations of Inflammatory Bowel Disease: Pathogenesis, Diagnosis, and Preventive Strategies. Gastroenterol Res Pract 2019;2019:3012509. [PMID: 30733802 DOI: 10.1155/2019/3012509] [Cited by in Crossref: 26] [Cited by in F6Publishing: 11] [Article Influence: 8.7] [Reference Citation Analysis]
689 Hagsund T, Olsson SE, Smith JG, Madsen Hardig B, Wagner H. β-blockers after myocardial infarction and 1-year clinical outcome - a retrospective study. BMC Cardiovasc Disord 2020;20:165. [PMID: 32272880 DOI: 10.1186/s12872-020-01441-0] [Reference Citation Analysis]
690 Mütze T, Glimm E, Schmidli H, Friede T. Group sequential designs with robust semiparametric recurrent event models. Stat Methods Med Res 2018;28:2385-403. [DOI: 10.1177/0962280218780538] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
691 Ter Maaten JM, Rao VS, Hanberg JS, Perry Wilson F, Bellumkonda L, Assefa M, Sam Broughton J, D'Ambrosi J, Wilson Tang WH, Damman K, Voors AA, Ellison DH, Testani JM. Renal tubular resistance is the primary driver for loop diuretic resistance in acute heart failure. Eur J Heart Fail 2017;19:1014-22. [PMID: 28105769 DOI: 10.1002/ejhf.757] [Cited by in Crossref: 48] [Cited by in F6Publishing: 32] [Article Influence: 9.6] [Reference Citation Analysis]
692 Jones TL, Tan MC, Nguyen V, Kearney KE, Maynard CC, Anderson E, Mahr C, McCabe JM. Outcome differences in acute vs. acute on chronic heart failure and cardiogenic shock. ESC Heart Fail 2020;7:1118-24. [PMID: 32160418 DOI: 10.1002/ehf2.12670] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
693 Sbolli M, Fiuzat M, Cani D, O'connor CM. Depression and heart failure: the lonely comorbidity. Eur J Heart Fail 2020;22:2007-17. [DOI: 10.1002/ejhf.1865] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
694 Leitao Filho FS, Choi L, Sin DD. Beta-blockers in chronic obstructive pulmonary disease: the good, the bad and the ugly. Curr Opin Pulm Med 2021;27:125-31. [PMID: 33332878 DOI: 10.1097/MCP.0000000000000748] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
695 Maltês S, Rocha BML, Cunha GJL, Brízido C, Strong C, Tralhão A, Weigert A, Duarte JS, Aguiar C, Mendes M, Neves JP. Challenges of Organ Shortage for Heart Transplant: Surviving Amidst the Chaos of Long Waiting Times. Transplant Direct 2021;7:e671. [PMID: 34113713 DOI: 10.1097/TXD.0000000000001122] [Reference Citation Analysis]
696 Amar M, Lam SW, Faulkenberg K, Perez A, Tang WHW, Williams JB. Captopril Versus Hydralazine-Isosorbide Dinitrate Vasodilator Protocols in Patients With Acute Decompensated Heart Failure Transitioning From Sodium Nitroprusside. J Card Fail 2021:S1071-9164(21)00197-4. [PMID: 34051349 DOI: 10.1016/j.cardfail.2021.05.007] [Reference Citation Analysis]
697 Schuster AK, Leuschner A, Feretos C, Blumenstein P, Troebs SO, Schwuchow S, Schulz A, Nickels S, Mirshahi A, Blettner M, Beutel ME, Lackner KJ, Münzel T, Pfeiffer N, Wild PS. Choroidal thickness is associated with cardiovascular risk factors and cardiac health: the Gutenberg Health Study. Clin Res Cardiol 2020;109:172-82. [PMID: 31168641 DOI: 10.1007/s00392-019-01498-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
698 Dulai R, Chilmeran A, Hassan M, Veasey RA, Furniss S, Patel NR, Sulke N. How many patients with heart failure are eligible for cardiac contractility modulation therapy? Int J Clin Pract 2021;75:e13646. [PMID: 32757431 DOI: 10.1111/ijcp.13646] [Reference Citation Analysis]
699 Pearson MJ, Smart NA. Effect of exercise training on endothelial function in heart failure patients: A systematic review meta-analysis. Int J Cardiol 2017;231:234-43. [PMID: 28089145 DOI: 10.1016/j.ijcard.2016.12.145] [Cited by in Crossref: 40] [Cited by in F6Publishing: 39] [Article Influence: 6.7] [Reference Citation Analysis]
700 Vaz HA, Guimaraes RB, Dutra O. Challenges in high-sensitive troponin assay interpretation for intensive therapy. Rev Bras Ter Intensiva 2019;31:93-105. [PMID: 30843948 DOI: 10.5935/0103-507X.20190001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
701 Hamada T, Kubo T, Kawai K, Nakaoka Y, Yabe T, Furuno T, Yamada E, Kitaoka H; Kochi YOSACOI study. Frailty in patients with acute decompensated heart failure in a super-aged regional Japanese cohort. ESC Heart Fail 2021;8:2876-88. [PMID: 34080791 DOI: 10.1002/ehf2.13363] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
702 Scheiber D, Jelenik T, Zweck E, Horn P, Schultheiss HP, Lassner D, Boeken U, Saeed D, Kelm M, Roden M, Westenfeld R, Szendroedi J. High-resolution respirometry in human endomyocardial biopsies shows reduced ventricular oxidative capacity related to heart failure. Exp Mol Med 2019;51:1-10. [PMID: 30765687 DOI: 10.1038/s12276-019-0214-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
703 Gilbert EM, Xu WD. Rationales and choices for the treatment of patients with NYHA class II heart failure. Postgrad Med 2017;129:619-31. [PMID: 28670961 DOI: 10.1080/00325481.2017.1344082] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
704 Rakisheva A, Marketou M, Klimenko A, Troyanova-Shchutskaia T, Vardas P. Hyperkalemia in heart failure: Foe or friend? Clin Cardiol. 2020;43:666-675. [PMID: 32445223 DOI: 10.1002/clc.23392] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
705 Kapelios CJ, Laroche C, Crespo-Leiro MG, Anker SD, Coats AJS, Díaz-Molina B, Filippatos G, Lainscak M, Maggioni AP, McDonagh T, Mebazaa A, Metra M, Moura B, Mullens W, Piepoli MF, Rosano GMC, Ruschitzka F, Seferovic PM, Lund LH; Heart Failure Long-Term Registry Investigators Group. Association between loop diuretic dose changes and outcomes in chronic heart failure: observations from the ESC-EORP Heart Failure Long-Term Registry. Eur J Heart Fail 2020;22:1424-37. [PMID: 32237110 DOI: 10.1002/ejhf.1796] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
706 van den Berge JC, Akkerhuis MK, Constantinescu AA, Kors JA, van Domburg RT, Deckers JW. Temporal trends in long-term mortality of patients with acute heart failure: Data from 1985–2008. International Journal of Cardiology 2016;224:456-60. [DOI: 10.1016/j.ijcard.2016.09.062]